"gene","baseMean","log2FoldChange","lfcSE","stat","pvalue","padj","start","end","saccver","spid","gene_uni","evalue","protein_names","gene_ontology_biological_process","gene_ontology_i_ds"
"g30042",103.074624793797,5.94959004352315,0.749154655772848,7.94173806126239,1.99367618134954e-15,1.14397139285837e-10,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12054",656.839790427345,8.21057939978924,1.10766564124945,7.41250707255636,1.23933844067024e-13,3.55566198628291e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29611",80.5789027305859,4.5091597811953,0.61691237873424,7.30923861577725,2.68660314030927e-13,4.27375263689337e-09,0,35434,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",9.38e-173,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g30043",242.013915505197,6.33341652804645,0.868146592672459,7.29533074425827,2.97926290477056e-13,4.27375263689337e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52273",45.836482150381,6.55635597373981,0.904435201936762,7.24911631004631,4.19499541630896e-13,4.81417673975616e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55150",442.260090643792,6.49862492047997,0.907604116915635,7.16019771105119,8.05607876656267e-13,7.70429666042277e-09,0,9464,"sp|Q4R4T8|LGMN_MACFA","Q4R4T8","LGMN",5.67e-32,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]","GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0032801; GO:0051603; GO:1901185"
"g11730",138.81080422048,6.55899108648397,0.930792461278591,7.04667405392836,1.8324487507404e-12,1.5020844188212e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11904",93.2866020774975,3.82256935053903,0.556170783189269,6.87301358877419,6.28595755924994e-12,4.50860305937202e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36661",59.5461984321163,6.26092664096165,0.921433850284941,6.79476517931866,1.08489089888894e-11,6.91678219758304e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103777",72.3374550290661,4.35733426602626,0.646293054432778,6.74204099230262,1.56177002180906e-11,8.96143638514039e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52187",53.1407575256287,6.34305069713182,0.965922366486555,6.5668328192917,5.13966948113886e-11,2.68103849843407e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67692",47.4783045287035,4.44909160136295,0.68292024840545,6.51480405179248,7.27846083205081e-11,3.48031735452563e-07,0,11389,"sp|P22985|XDH_RAT","P22985","XDH",2.67e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g23420",56.2810669286816,3.79763212438019,0.584564945088763,6.49651019324044,8.22045485868883e-11,3.62838230608896e-07,0,32832,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g96133",24.4551148977147,3.9246319530185,0.620718469424755,6.32272462692405,2.56991044097604e-10,1.05329615073718e-06,1193,6945,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.5e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68732",53.7125545126075,4.32807141803139,0.692204075998954,6.25259452826154,4.03689248434364e-10,1.44773056719774e-06,0,11159,"sp|P22985|XDH_RAT","P22985","XDH",2.61e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g146797",21.5513680232584,4.73574996927768,0.756936445829366,6.25646974111383,3.93789465658286e-10,1.44773056719774e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29384",105.548268932224,2.54002306967977,0.412143622665208,6.1629561395472,7.13992890614258e-10,2.40993600373213e-06,0,36208,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",1.16e-172,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g122771",31.9208949159846,4.6275438183132,0.755986539873989,6.12119869103032,9.28740062329419e-10,2.96061693202567e-06,0,4239,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",1.85e-128,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g58468",38.4984077305074,2.43119065740844,0.400925706960539,6.06394305777887,1.3282419683134e-09,4.01129074430646e-06,0,13937,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.03e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g9738",115.763590486318,3.26483876167457,0.540048398535273,6.04545587123212,1.48988126801423e-09,4.27446935793282e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114167",41.1762531260627,2.93953046415012,0.489488530801891,6.00531019457088,1.90966448741142e-09,5.21793087084131e-06,0,5044,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",1.68e-27,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g41900",183.336601712265,0.704538752133014,0.118116450616037,5.96478092982382,2.44962471396306e-09,6.3890666403273e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3440",28.9845610667892,-2.94345186708314,0.496457875759818,-5.92890557447245,3.04960380772264e-09,7.29483957498462e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72496",42.2102168860812,5.4041950949714,0.911512571813471,5.9288212385482,3.05117026489423e-09,7.29483957498462e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72502",18.3924163062799,6.48855318915721,1.11015029168234,5.84475204643178,5.07323361075826e-09,1.16440857834124e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94663",48.6041304741743,3.50343789622128,0.601460176088801,5.82488755781568,5.71510651315581e-09,1.26128004509569e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58444",17.9461366294455,4.51743606422669,0.781980033960942,5.77691995707952,7.60804560517156e-09,1.61685058083239e-05,0,8264,"sp|Q5VYJ5|MALR1_HUMAN","Q5VYJ5","MALR1",6.67e-11,"MAM and LDL-receptor class A domain-containing protein 1","cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]","GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858"
"g94664",48.7951587965426,3.28924058064167,0.57392779558748,5.73110521206724,9.97783493275012e-09,2.04474345871858e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37881",18.6168461164931,2.6195141163138,0.458865240423524,5.70867846493677,1.13856751615691e-08,2.25279324403735e-05,0,21764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.78e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11932",34.9258738184469,1.85412068159323,0.328746359820498,5.63997326877054,1.70076565581893e-08,3.14806236551259e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146361",97.6124298313501,3.79380793452855,0.672170188439793,5.64411811141839,1.6603006922239e-08,3.14806236551259e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91194",18.3144615470049,5.17234485684401,0.923355418621579,5.60168354734463,2.12279841725175e-08,3.80644291193455e-05,0,6917,"sp|P22985|XDH_RAT","P22985","XDH",3.83e-12,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g113541",38.721759176123,4.72593413162184,0.847765309255598,5.57457834146524,2.48130125962883e-08,4.31445655386371e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56507",34.5040420601034,2.9146523458092,0.525948326492665,5.54170856526121,2.99534528769235e-08,5.03631226192035e-05,625,5588,"sp|P04323|POL3_DROME","P04323","POL3",4.37e-82,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g148164",37.132605542364,6.33648734634761,1.14433141441565,5.53728340105331,3.07199249158613e-08,5.03631226192035e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99479",26.3480767780624,3.88232281757709,0.704649084436002,5.50958328525252,3.59684181754102e-08,5.73296620806955e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139790",23.0570760305546,4.60295788938472,0.844686454729777,5.44930946105587,5.05657631099176e-08,7.84179320877587e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155721",220.187303287707,0.842587605878966,0.155278998331178,5.42628182133103,5.75400832292304e-08,8.6885525676138e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27050",80.2673249534014,-0.747628808076208,0.138288682746563,-5.40629061776776,6.43433653058714e-08,9.43428318821453e-05,9731,16074,"sp|Q32LE3|CETN1_BOVIN","Q32LE3","CETN1",2.44e-69,"Centrin-1","cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]","GO:0000278; GO:0000922; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0006289; GO:0007099; GO:0051301"
"g87706",26.6853803185961,5.49282703754521,1.01674443233963,5.40236746111867,6.57670490638866e-08,9.43428318821453e-05,0,6628,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",9.78e-17,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g65912",21.5889664133766,1.12874577859034,0.21022619147826,5.36919672402981,7.90881123660001e-08,0.000110684777745392,6578,11850,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.59e-69,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g59432",24.6820874504429,4.17923879230344,0.783886587803892,5.33143296151021,9.74407925474801e-08,0.000133122682770819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11930",22.2098312386045,1.84399452646232,0.348165272973807,5.29631950571087,1.18160019142313e-07,0.000154091406781499,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145502",53.1172358567564,2.3507599634935,0.443626182392945,5.29896578874892,1.16460450767236e-07,0.000154091406781499,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18751",26.4320393008176,1.79082155543912,0.339432100639274,5.27593457444466,1.32081208290685e-07,0.000168418216260433,436,32054,"sp|O02467|ASPG_SPOFR","O02467","ASPG",2.52e-75,"N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] (Fragment)",NA,"GO:0003948; GO:0005764; GO:0008233"
"g32791",18.1838997288547,4.6432691662407,0.889316791230485,5.2211643949915,1.77801612776473e-07,0.000221788185676392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148980",213.01956375971,-1.00395299807507,0.193715361769462,-5.18261943144116,2.18791176344518e-07,0.000267111440396775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104526",21.279869681457,4.1031178142369,0.793174966447921,5.17302989605422,2.30328143472182e-07,0.000275338101509037,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27859",1213.91696166697,1.12236979800092,0.217435461243793,5.16185258642101,2.44517814423972e-07,0.000286335350849949,23825,37860,"sp|C5FK77|DPEP1_ARTOC","C5FK77","DPEP1",3.83e-14,"Putative dipeptidase MCYG_02918 (EC 3.4.13.19)",NA,"GO:0046872; GO:0070573"
"g89290",216.969597763619,1.82345333640745,0.356437786274338,5.11576888485106,3.12465470784203e-07,0.000358585374271951,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120971",29.5345036509784,2.50409216936484,0.493031949602822,5.07896531123814,3.79495987143769e-07,0.000426970191025676,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g56502",54.9825442046895,0.634877800667094,0.125106133510612,5.07471362795527,3.88080015736866e-07,0.00042823137121118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21471",50.3974108460115,3.77692453584453,0.74566624840566,5.06516761878404,4.08041152486793e-07,0.000433581506105411,24355,27804,"sp|O19015|BGAL_FELCA","O19015","BGAL",7.75e-11,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"g149788",51.2556427009104,2.71696073916908,0.53605064324017,5.06847771461733,4.01009922571879e-07,0.000433581506105411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79937",26.4870121676747,4.63209194633254,0.920302902198118,5.03322540358063,4.82295479213614e-07,0.000503165719950494,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120970",30.0929024888008,2.43342972937221,0.484008928098579,5.02765463218188,4.96515071934365e-07,0.000508750621921319,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g119843",21.0104429574203,2.2383021742787,0.447427081697088,5.00260772277984,5.65599578867347e-07,0.000569370242726462,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70960",23.9192454890781,-1.14491313056279,0.229327262765214,-4.99248592059008,5.96070601713845e-07,0.000589698812523111,0,10700,"sp|O00255|MEN1_HUMAN","O00255","MEN1",3.26e-15,"Menin","brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006325; GO:0006357; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051219; GO:0051568; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807"
"g87028",55.600791035213,-0.850226518572005,0.171039964294294,-4.97092315284335,6.66348589619986e-07,0.000648052238515166,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88738",48.7608116733514,1.14319019721275,0.230662563287412,4.95611503193216,7.19166481954667e-07,0.000687762878909313,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4000",50.8121476358255,0.999640894144466,0.202878930972624,4.92727800443386,8.33830759038331e-07,0.000759447761168563,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46895",39.2708011150353,2.40053855312236,0.486939423242652,4.92985048763678,8.22925724978277e-07,0.000759447761168563,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111963",45.0912489568932,1.13405187692585,0.229931851538864,4.93212171056768,8.13412045726156e-07,0.000759447761168563,2926,5252,"sp|Q93112|GST1C_ANOGA","Q93112","GST1C",1.29e-13,"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g146559",18.0351993834413,2.4681038370389,0.501901465635648,4.91750673394248,8.76534426132385e-07,0.000785867896429316,0,2024,"sp|Q9NTJ4|MA2C1_HUMAN","Q9NTJ4","MA2C1",5.66e-13,"Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g99050",23.9698847537013,2.72832734255733,0.555453816540291,4.911888731904,9.02032396188093e-07,0.000790434182383251,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111234",24.6738774069311,7.61309081591584,1.55041977226994,4.91034167138468,9.09178390332774e-07,0.000790434182383251,0,2734,"sp|Q6DCX5|PCFT_XENLA","Q6DCX5","PCFT",2.11e-13,"Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)",NA,"GO:0005542; GO:0016021; GO:0022857"
"g58313",133.353384177551,0.826385190949698,0.168403619899456,4.90716999695781,9.2399941302273e-07,0.000791329646555884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154026",220.254559500933,1.0764155038004,0.219651400580465,4.90056289627925,9.5562457265972e-07,0.000806378499694335,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86828",24.2560913340053,2.38980901859861,0.489515605579381,4.88198740011584,1.05021968227209e-06,0.000873356599547426,0,8116,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g57249",19.681058483325,3.00562473728384,0.619196819399813,4.85407005190562,1.20952978133159e-06,0.000991468840754377,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97904",111.145957223461,1.50118015013843,0.310204345305077,4.83932663374546,1.30279779678065e-06,0.00105288081097569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135902",18.8786985057764,6.22934706818277,1.29279949803332,4.81849434321347,1.44645626001531e-06,0.00115274528055109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17476",94.2601932998323,0.879476369664349,0.182758745971782,4.81222589369342,1.49258508542686e-06,0.00117321276988758,162,12244,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.42e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g153882",28.2481210375033,2.80604320322734,0.583754522892668,4.80688901444842,1.53297035441436e-06,0.00118867349913914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132823",24.0781910318587,0.988084234915919,0.205760612923657,4.80210581061269,1.57005685893791e-06,0.00120119816754476,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99049",64.8115650175558,2.70409936547055,0.564812381903887,4.78760638418636,1.68782271967788e-06,0.00125775672279373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124730",356.456288496433,0.855124158183692,0.178566840045612,4.78881833808149,1.67766264709389e-06,0.00125775672279373,0,4064,"sp|Q6GMC7|AK1A1_XENLA","Q6GMC7","AK1A1",6.14e-11,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629]","GO:0005829; GO:0006629; GO:0008106; GO:0016324; GO:0046185; GO:0110095"
"g69922",94.9976270723595,1.0957817033943,0.229017033814585,4.78471703673125,1.71228385510495e-06,0.00125962625135797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21443",821.128864201099,-0.584192463138279,0.122408690336159,-4.77247539806177,1.81975342982372e-06,0.00132173989624411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133012",192.678392698104,0.582372234414627,0.122283635476859,4.7624707275311,1.91236945263923e-06,0.00137164698990549,0,1861,"sp|O00370|LORF2_HUMAN","O00370","LORF2",5.92e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g88617",174.763030410422,1.86453321993357,0.393445362404188,4.73898893747316,2.14787228818353e-06,0.00152154212217248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18004",255.901714165213,1.2214426844821,0.258173620104742,4.73109020196004,2.23317256594792e-06,0.00156267611992795,41025,51234,"sp|F4KHQ8|NCER3_ARATH","F4KHQ8","NCER3",6.14e-19,"Neutral ceramidase 3 (AtNCER3) (N-CDase 3) (NCDase 3) (EC 3.5.1.23) (Acylsphingosine deacylase 3) (N-acylsphingosine amidohydrolase 3)","cellular response to oxidative stress [GO:0034599]; ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512]","GO:0005576; GO:0005783; GO:0005794; GO:0017040; GO:0034599; GO:0042759; GO:0046512; GO:0046514; GO:0102121"
"g105347",224.917765445111,1.38088506997787,0.292154419578171,4.72655889297062,2.283565831112e-06,0.00157868683601454,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5581",42.7989871986287,1.84719734186322,0.39322675610426,4.69753726873422,2.63317149010644e-06,0.00176389195073767,71535,112204,"sp|P21328|RTJK_DROME","P21328","RTJK",9.87e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g26893",39.5511914601752,0.851806128605601,0.181339594037834,4.69729808939511,2.63625574836668e-06,0.00176389195073767,0,4706,"sp|Q8BTV1|TUSC3_MOUSE","Q8BTV1","TUSC3",2.1e-15,"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)","cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062"
"g90986",29.0857105295379,2.77511726927796,0.590862454839581,4.69672297934619,2.64368608859253e-06,0.00176389195073767,0,3881,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.91e-54,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g10833",83.0517431553235,-0.716522630351362,0.152778998126204,-4.68992884584485,2.73300070089939e-06,0.00178204068429099,12575,20351,"sp|Q9BY12|SCAPE_HUMAN","Q9BY12","SCAPE",2.5e-13,"S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)","antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0072520; GO:1990917"
"g19223",92.9708150013768,0.706914661939372,0.150669198640831,4.69183262615295,2.70768606093908e-06,0.00178204068429099,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6770",35.4666788459017,1.4131052524647,0.301827024329626,4.68183806802352,2.84314037811454e-06,0.00183302690894621,0,4854,"sp|P21328|RTJK_DROME","P21328","RTJK",5.56e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31622",20.70173881669,3.05021178122488,0.654447225003344,4.66074522847781,3.1506652399824e-06,0.00195209798604795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41649",428.073187022327,0.618288413575555,0.132683280861481,4.65988185972757,3.16390924891007e-06,0.00195209798604795,14645,18044,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.86e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g144112",166.929468151688,1.62183625020562,0.347904585142811,4.66172715010316,3.13566727016001e-06,0.00195209798604795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157582",38.4152398394016,4.53098127751807,0.971200309027415,4.66534167607042,3.08104647867439e-06,0.00195209798604795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122571",87.1424964255486,1.66030572376901,0.357502403000696,4.64418059804139,3.41428806052477e-06,0.0020841686054565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105743",67.7183042132228,0.646511361198568,0.139414688461186,4.63732601158851,3.52945489080099e-06,0.0021317907540438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41645",240.669911396485,0.657092898445368,0.141939485053959,4.62938764499231,3.66748650326123e-06,0.00219208724538676,0,9889,"sp|P30104|GSTT1_DROER","P30104","GSTT1",2.76e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g55151",67.5510133146744,7.45225442480826,1.61441376443783,4.61607463276509,3.91066359604765e-06,0.00231333893960015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28258",141.938903295536,1.97695508569649,0.428714610264577,4.61135458965683,4.00053454246161e-06,0.00234235379639232,34446,37594,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",2.62e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g20234",346.740735140372,1.86221144415926,0.404726204977449,4.60116350574094,4.20137456802186e-06,0.00242438365335395,0,49764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.71e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g100996",136.144053394322,1.1340328238478,0.246529476338994,4.59998877492615,4.2251370745102e-06,0.00242438365335395,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102257",27.8521703753018,0.875487348194348,0.191096116199146,4.58139791434578,4.61878057305556e-06,0.00262401613150424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135071",42.8217820123296,4.5699672666578,0.998442760900703,4.57709489779384,4.71477614726186e-06,0.0026522926993126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9739",38.2031987480501,2.55387776207208,0.55899152352056,4.56872359349497,4.90703402096399e-06,0.00270736165502802,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30962",94.7349719560295,0.558994044410733,0.122323763386039,4.56979109322051,4.88210623650122e-06,0.00270736165502802,11636,26574,"sp|Q7ZVM1|WASC5_DANRE","Q7ZVM1","WASC5",2.61e-33,"WASH complex subunit 5 (WASH complex subunit strumpellin)","actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]","GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0051125; GO:0060047; GO:0071203; GO:0140285"
"g75956",40.2118631183861,6.71020984117649,1.47357542860061,4.55369281472676,5.27123122975172e-06,0.00288060236155385,4775,9762,"sp|P04323|POL3_DROME","P04323","POL3",6.08e-70,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g56778",103.056614384166,0.477000539877391,0.105042164407304,4.54103875875792,5.59777385365736e-06,0.00303019116719679,0,7244,"sp|Q23381|MUTA_CAEEL","Q23381","MUTA",2.9e-28,"Probable methylmalonyl-CoA mutase, mitochondrial (EC 5.4.99.2) (MethylmalonylCoA mutase homolog 1) (MCM)","cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]","GO:0004494; GO:0005739; GO:0005759; GO:0006520; GO:0006631; GO:0031419; GO:0046872"
"g21070",278.770704654675,0.494300034016369,0.109019884754525,4.53403555809437,5.78672807797403e-06,0.0031032005337771,30746,43654,"sp|P46087|NOP2_HUMAN","P46087","NOP2",9.93e-22,"Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)","maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]","GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796"
"g44466",237.229550521212,-0.439123999706447,0.0970125140894047,-4.5264675782112,5.99777961050818e-06,0.00318659809306444,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143434",51.0366017898382,3.08729648502052,0.682430229968887,4.5239738063205,6.06892385832157e-06,0.00319481514670176,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4918",24.3443730595926,1.85088073768553,0.41015016608793,4.51269045027943,6.40104118777359e-06,0.00329517498620489,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14600",99.9334002901685,-0.516094300557449,0.114390910358471,-4.51167229057051,6.43185079217406e-06,0.00329517498620489,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87964",23.1084500908103,2.10779510086198,0.466906427215062,4.51438442052353,6.3500941579666e-06,0.00329517498620489,5318,7664,"sp|Q9Y4A0|JERKL_HUMAN","Q9Y4A0","JERKL",4.13e-41,"Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)","central nervous system development [GO:0007417]","GO:0003677; GO:0005634; GO:0007417"
"g18003",84.8667930612306,1.36240477986964,0.302166454093119,4.50878898505983,6.51987158642994e-06,0.00330885526331764,38106,43224,"sp|Q9JHE3|ASAH2_MOUSE","Q9JHE3","ASAH2",7.87e-15,"Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (N-acylsphingosine amidohydrolase 2) [Cleaved into: Neutral ceramidase soluble form]","apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; lipid digestion [GO:0044241]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of apoptotic signaling pathway [GO:2001234]; regulation of mitotic cell cycle [GO:0007346]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]","GO:0000139; GO:0005509; GO:0005576; GO:0005615; GO:0005739; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006670; GO:0006672; GO:0006915; GO:0007346; GO:0008270; GO:0010033; GO:0016020; GO:0017040; GO:0042759; GO:0044241; GO:0046512; GO:0046513; GO:0046514; GO:0070062; GO:0070774; GO:0071633; GO:0102121; GO:2001234"
"g147186",23.1244342780618,4.52698412696198,1.00442553841845,4.5070380568878,6.57388462910789e-06,0.00330885526331764,0,2234,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.98e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83832",35.0947100048228,3.19452514647935,0.709485723100194,4.50259257158895,6.71294993173796e-06,0.0033494701485489,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26334",144.448805247755,0.566307363181875,0.125842535595995,4.5001267695364,6.79129490225225e-06,0.00335036102731092,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50644",147.243380684196,2.29195225891262,0.509636286664554,4.49723129785929,6.88440823914661e-06,0.00335036102731092,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104459",189.313870423445,0.592237326671784,0.131694287615098,4.49706162200985,6.88990242632779e-06,0.00335036102731092,0,4484,"sp|Q7ZT42|SND1_DANRE","Q7ZT42","SND1",6.41e-20,"Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]","GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0031047"
"g68623",2556.11423564799,0.354301292151873,0.0789763862966015,4.48616743264587,7.2515763542113e-06,0.00346746209337204,3875,11232,"sp|Q08473|SQD_DROME","Q08473","SQD",4.68e-45,"RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)","dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; RNA export from nucleus [GO:0006405]","GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0010468; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0045451; GO:0048477; GO:0071011; GO:0071013"
"g153811",225.781912603556,3.90687279712166,0.870710548878453,4.48699375717227,7.22351904043317e-06,0.00346746209337204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103363",35.2773151701564,0.793219514441291,0.176920966028441,4.48346813974425,7.34395719170983e-06,0.00348261374925876,0,6127,"sp|O15438|MRP3_HUMAN","O15438","MRP3",2.35e-20,"ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)","bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0150104"
"g39675",18.5359685054807,1.15434853789713,0.257923420453444,4.47554757093295,7.62157260557131e-06,0.00355549460250148,17055,21289,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.03e-49,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g104479",53.0476615839602,3.13678539483393,0.700638186195176,4.47704029931381,7.56849671167613e-06,0.00355549460250148,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58503",23.351517520266,0.791342426779476,0.17713300230495,4.4675041719053,7.91374685149058e-06,0.00366202253498814,3734,10726,"sp|Q9UT21|YFY7_SCHPO","Q9UT21","YFY7",4.54e-25,"Uncharacterized GTP-binding protein C9.07c","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829"
"g27724",43.8119944609468,1.43582860910886,0.321808790070702,4.46174453094773,8.12951085067789e-06,0.00373177066089518,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109772",30.6738795569954,2.19440579575804,0.492585659407268,4.45487146012042,8.39434724759958e-06,0.00382275908783543,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15143",79.2338957653517,1.37009401845553,0.307781504710793,4.45151510888525,8.52665322775432e-06,0.00385243592290191,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31320",82.8332430325459,0.514245516219868,0.115805660702895,4.44059049530565,8.97123683942168e-06,0.004021637264422,9550,15004,"sp|P87115|NAT10_SCHPO","P87115","NAT10",2.51e-11,"RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase)","rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0005524; GO:0005634; GO:0005730; GO:0030686; GO:0051391; GO:0051392; GO:1904812; GO:1990883"
"g20154",157.036938582643,1.66360864779752,0.374932126770991,4.43709282030574,9.11819818097836e-06,0.00404586359595736,0,49874,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.73e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28257",100.815651604879,1.78567638200795,0.402545672571718,4.43595970265912,9.16629953772146e-06,0.00404586359595736,30686,36144,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",5.24e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g68955",103.972728287319,0.991970153613166,0.223794896845282,4.43249675303791,9.31481057187415e-06,0.0040800292413293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10279",830.986437516543,-0.851294593935941,0.192244735221771,-4.42818157258714,9.50308869582189e-06,0.0041309638588353,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61350",19.4330375061552,2.94186123138314,0.665761532576166,4.41879124496665,9.9254459798658e-06,0.0042501648531694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99309",32.6620306867864,2.55274762086072,0.577592292946619,4.41963587816891,9.88673424894363e-06,0.0042501648531694,0,5224,"sp|O46108|LIP3_DROME","O46108","LIP3",9.99e-15,"Lipase 3 (DmLip3) (EC 3.1.1.-)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0016042"
"g5778",49.3475594911471,1.70487031375922,0.386044732514358,4.41625068332156,1.00427610974357e-05,0.00426854542052488,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21400",408.855767335369,-0.575374513013569,0.130992784592467,-4.39241378678698,1.12099087708271e-05,0.00472959239169161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5463",345.763864017258,-0.851801304097484,0.194378452802527,-4.38217966969234,1.17497847805833e-05,0.00478458922376657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10773",284.836780387892,-0.884636497327593,0.20164945996975,-4.38700156925934,1.14923960886898e-05,0.00478458922376657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11892",20.9363963649473,1.40100162548292,0.31955847606853,4.38417920475523,1.16423906065811e-05,0.00478458922376657,1015,30236,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g85374",120.253944293335,0.883843089523879,0.201696599391379,4.38204259363263,1.17571816059792e-05,0.00478458922376657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151147",959.415426337081,0.385328117098486,0.0878842396145916,4.38449622808717,1.16254497073633e-05,0.00478458922376657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43487",33.4825303862634,2.2817164557582,0.521410502514958,4.37604621455192,1.20851401762547e-05,0.00486433771529468,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146509",102.338786874552,1.62744470775024,0.371955948743691,4.37536948460444,1.21226959443559e-05,0.00486433771529468,0,1792,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",7.49e-22,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g18607",119.21489076968,-0.723284054320207,0.165404135545461,-4.37282932458128,1.22646606336834e-05,0.00488712657750525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23704",37.2797025916442,-0.90205922483615,0.206392194246879,-4.3706072709181,1.23901466509062e-05,0.00490308010226896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45295",26.1460064057587,2.57270145805019,0.589236141032694,4.36616371416268,1.26447720147159e-05,0.00496956861783836,7505,12128,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.46e-72,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g90822",50.9948851975869,0.848736615045617,0.195072670018269,4.35087403564084,1.35595936374088e-05,0.00529285362526882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106928",42.015318366722,0.945867134254075,0.217648625103155,4.34584474772482,1.38740677581894e-05,0.00537901356733047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50646",24.0414314286665,2.56338928735277,0.590129124826941,4.34377694560407,1.40053721211174e-05,0.00539347820342093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117047",17.9804608272034,1.28870364572799,0.296838408898088,4.34143159071584,1.41557353829772e-05,0.00541504064183486,0,4764,"sp|Q01415|GALK2_HUMAN","Q01415","GALK2",5.23e-19,"N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)","carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]","GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858"
"g62055",40.1513691461596,0.605213114340584,0.139516614152663,4.33792862603692,1.4383184434155e-05,0.00545303649294769,0,12822,"sp|P21328|RTJK_DROME","P21328","RTJK",4.66e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g99410",123.419618925926,1.66709737234643,0.384390965578599,4.33698375256312,1.44451297826429e-05,0.00545303649294769,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143206",43.8725724013774,1.02241106060865,0.235873907585083,4.33456617171552,1.46047853305752e-05,0.00547727177953205,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33909",379.690314151564,-1.16488343165998,0.270690371595664,-4.30337963183998,1.68212253678713e-05,0.00625301095604331,10185,30381,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.56e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g35652",173.882740552129,0.408019659966692,0.0948340323507743,4.30246030726079,1.68911937641463e-05,0.00625301095604331,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8962",120.413175092411,0.550882907514143,0.128149809834004,4.29874151376204,1.71770658556003e-05,0.00627783464200219,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39021",305.131174736954,0.312478850891821,0.0726807322438804,4.29933548059612,1.71310989512861e-05,0.00627783464200219,14005,24645,"sp|P17027|ZNF23_HUMAN","P17027","ZNF23",9.85e-38,"Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837"
"g91166",36.0625146382666,-0.69373894227497,0.161469327362531,-4.29641315540621,1.73583926920101e-05,0.00628089619001024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103134",43.6201174342452,6.20951752074035,1.44547678935498,4.29582651653041,1.74043655317467e-05,0.00628089619001024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34192",19.625331984515,1.77298642167741,0.413105228489769,4.29185180773213,1.77189192275535e-05,0.00631497879054049,26015,28500,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.15e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g53587",19.0503289747646,0.898101580200625,0.209237979692217,4.29224933982687,1.76872168826642e-05,0.00631497879054049,13102,14384,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.65e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73940",186.644903928667,2.47569162676205,0.578839312172001,4.27699289716937,1.89434844542537e-05,0.00665572712326309,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99315",18.9565880462139,2.45306489149968,0.573674095113566,4.27606007033325,1.90229914293333e-05,0.00665572712326309,835,2860,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",6.89e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g120101",126.500583032945,-0.534613526668505,0.124992788747017,-4.27715496251989,1.89297035636079e-05,0.00665572712326309,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4920",102.173132901368,2.33734621292413,0.547662617850086,4.26785786859007,1.97359002018737e-05,0.0068219635758043,14296,26864,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",2.51e-64,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g80973",56.1886336724218,1.05281339450245,0.246635807112326,4.26869645096975,1.96618619188627e-05,0.0068219635758043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2955",248.056281212363,-0.563550669211244,0.132142649717866,-4.26471446133755,2.00158008719178e-05,0.00684434594156918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105245",369.549187495414,4.03291189561736,0.94570429078956,4.26445341836222,2.00392143287491e-05,0.00684434594156918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115973",69.2729502002246,-0.562986128423404,0.132073606029674,-4.26266947157417,2.01999195225433e-05,0.00685841054558306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28922",20.6987456237169,1.67415340304406,0.39328818815246,4.25681079034865,2.07363705443196e-05,0.00691774966182012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55782",64.1307661735311,0.576050939805192,0.13525754279035,4.25891915468311,2.05417741256939e-05,0.00691774966182012,0,3886,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.16e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g113402",805.345596345044,0.707955929154037,0.166281234248434,4.25758163483624,2.06650209823276e-05,0.00691774966182012,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129274",274.251915788498,-0.974354016299593,0.22928380450603,-4.24955446983595,2.14196120138654e-05,0.0071043776725757,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90212",474.964748392974,-0.467606100185131,0.110116134389051,-4.24648125163051,2.17153942008371e-05,0.00716108804163238,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16072",483.293851896936,0.762208768319909,0.179718082698836,4.241135654653,2.22391667856383e-05,0.00729190508662816,9950,60394,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.45e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61855",56.326886681203,-0.753030129190081,0.17760986130077,-4.23979909490992,2.23719924730656e-05,0.00729377800059376,10537,12484,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.13e-35,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g17510",1751.56994577303,-0.397764993357422,0.0941193153979379,-4.22617814075321,2.37693846112685e-05,0.00770557790392422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18907",847.399324456093,-0.653499500792869,0.154735173982858,-4.22334162279913,2.40706537614274e-05,0.00775940512826237,2233,22804,"sp|P20482|CNC_DROME","P20482","CNC",5.28e-19,"Segmentation protein cap'n'collar","blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005703; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465; GO:2000378"
"g46650",2955.38711294484,-0.524010526916084,0.124312963177843,-4.21525248470212,2.49498897957263e-05,0.00795347042488209,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116231",88.3237125411464,1.38654754878721,0.328888905960993,4.21585381463631,2.48834920066139e-05,0.00795347042488209,20,4288,"sp|Q64581|CP3AI_RAT","Q64581","CP3AI",3.78e-14,"Cytochrome P450 3A18 (EC 1.14.14.1) (CYPIIIA18) (Cytochrome P450(6)beta-2)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0005506; GO:0005789; GO:0008202; GO:0008390; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"g17579",132.337390609166,1.97656852441147,0.469631276090052,4.20876680290021,2.5676821749357e-05,0.00802097487912696,34425,50323,"sp|P21328|RTJK_DROME","P21328","RTJK",1.79e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27179",30.9912566490333,1.22645098960105,0.291515527312328,4.20715493582282,2.58605847444839e-05,0.00802097487912696,37067,39249,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.1e-13,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g36577",18.4609880711132,3.0859097248758,0.733428650052621,4.20751183452459,2.58197885460705e-05,0.00802097487912696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38947",42.6267609243462,2.30943827586949,0.548539642459283,4.2101574747005,2.55192750775084e-05,0.00802097487912696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66310",109.381151403169,0.550929476455079,0.130848085533169,4.2104511824548,2.54861192677877e-05,0.00802097487912696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10916",125.716568688068,-0.479086723815089,0.113941248977746,-4.20468204546941,2.61449432919457e-05,0.00806557444135399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158393",24.7823788572752,1.95248538118732,0.464666967045713,4.20190269517315,2.6468090634748e-05,0.00812159914771036,0,1311,"sp|P21328|RTJK_DROME","P21328","RTJK",5.3e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g44922",91.6067097106111,-0.696903986756842,0.166104704372346,-4.19557043486643,2.72185682828843e-05,0.00830745451102075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2451",217.263029620008,-0.605558667676551,0.144633623643483,-4.18684571693533,2.82857956499072e-05,0.00856386650411973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41210",145.581518475827,-0.342149583563187,0.0817313036554682,-4.18627341373987,2.83571738547011e-05,0.00856386650411973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86110",529.288219346474,0.310610203594739,0.0742834012662276,4.18142139832193,2.89692397845051e-05,0.00870290564835027,0,8212,"sp|P21328|RTJK_DROME","P21328","RTJK",1.37e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g85761",115.42832209017,0.529295564706576,0.126787390957054,4.17467037306464,2.98417820783278e-05,0.00891834091486691,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2800",29.1301705873625,-0.811567728301924,0.194581773063444,-4.17083119104537,3.03490625595175e-05,0.00899294918788172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9964",968.624025429408,0.382296793684577,0.091668820879853,4.17041246974956,3.04048822315973e-05,0.00899294918788172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33519",103.69296042244,-0.822024649479056,0.197271644285778,-4.16696810357715,3.08677668649154e-05,0.00908303827030177,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89205",143.521788139068,0.321349422218168,0.0771920871055475,4.16298398278538,3.14115409932111e-05,0.0091958888887268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65208",70.6017836918661,2.14087733678335,0.514775103152516,4.15885951685014,3.19840522542938e-05,0.00923427492082561,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74523",5882.10456021371,-0.274591173376323,0.0660618978324016,-4.15657409771906,3.23055426467362e-05,0.00923427492082561,0,6289,"sp|Q9NL83|ORCKA_PROCL","Q9NL83","ORCKA",9.52e-50,"Orcokinin peptides type A [Cleaved into: Orcomyotropin-like peptide; Orcokinin; Orcokinin-like peptide 1; Orcokinin-like peptide 2; Orcokinin-like peptide 3; Orcokinin-like peptide 4]","neuropeptide signaling pathway [GO:0007218]","GO:0005184; GO:0005576; GO:0007218"
"g128634",90.8798494185036,1.4975538579479,0.360311222743461,4.15627869302907,3.23473206532929e-05,0.00923427492082561,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146477",2396.38316961347,0.496360788770291,0.119393854451909,4.15733951340204,3.21975310666056e-05,0.00923427492082561,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150994",53.3466866834632,0.616688005997258,0.148292520518722,4.15859143697946,3.20216051368098e-05,0.00923427492082561,0,1824,"sp|Q9HD20|AT131_HUMAN","Q9HD20","AT131",9.2e-14,"Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase)","cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]","GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569"
"g17631",127.706750799648,2.23344941968315,0.537680105652283,4.15386285675134,3.26909151248684e-05,0.00928616193002451,10075,44675,"sp|P21328|RTJK_DROME","P21328","RTJK",3.95e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g2450",888.882190626193,-0.364990585505581,0.0879197302318411,-4.15140702255472,3.30437504033916e-05,0.00929599402659743,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41593",816.356302532751,0.535130188903326,0.128904575343074,4.1513669121449,3.30495430712073e-05,0.00929599402659743,0,18081,"sp|P30104|GSTT1_DROER","P30104","GSTT1",6.13e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g56373",36.8759925106232,0.61953408872397,0.149362989125071,4.14784206149756,3.35623795138769e-05,0.00939419188539638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138378",71.0855438671054,3.23047591477974,0.77965180230653,4.14348547033775,3.42066752791387e-05,0.00952805353163583,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21054",73.3719812922951,1.15568300312997,0.279423871449904,4.13594943457495,3.53490030693205e-05,0.00957477264477501,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32947",155.495344252357,-1.02482957345637,0.247618939571072,-4.13873662180926,3.49223574729973e-05,0.00957477264477501,23721,30164,"sp|Q80U96|XPO1_RAT","Q80U96","XPO1",1.26e-35,"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]","GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0051028; GO:1990904"
"g34469",164.119707920957,1.23719209005592,0.298984305748208,4.13798338665252,3.50371733777513e-05,0.00957477264477501,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79278",948.741458049118,0.401817596522217,0.0971565005076422,4.13577675629239,3.53755977813228e-05,0.00957477264477501,2216,7571,"sp|P60060|SC61G_MOUSE","P60060","SC61G",4.72e-14,"Protein transport protein Sec61 subunit gamma","posttranslational protein targeting to membrane, translocation [GO:0031204]","GO:0008320; GO:0016020; GO:0016021; GO:0031204; GO:0043022; GO:0071261"
"g138964",219.666363971564,0.687750468969166,0.166236043574163,4.13719223690704,3.51581545773255e-05,0.00957477264477501,0,2924,"sp|P20000|ALDH2_BOVIN","P20000","ALDH2",2.21e-34,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)","aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627]","GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:1903179; GO:1905627"
"g140086",31.7253616008171,0.644970128143374,0.155864768656551,4.13801100596741,3.50329570317724e-05,0.00957477264477501,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4979",278.29870838831,-1.02979345867777,0.249391700765195,-4.1292210427136,3.63994335287854e-05,0.00966944211056346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73630",110.956891191708,2.90685778229615,0.703779799829855,4.1303512590144,3.62209382297451e-05,0.00966944211056346,3116,8914,"sp|P00688|AMYP_MOUSE","P00688","AMYP",2.2e-23,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]","GO:0004556; GO:0005509; GO:0005615; GO:0016052; GO:0016160; GO:0031404"
"g78144",34.3905793874804,0.90979273674466,0.220329630837529,4.12923460764813,3.6397286272608e-05,0.00966944211056346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103355",60.1193576365259,-0.689354929134916,0.166872794440396,-4.13102046649756,3.61156422195053e-05,0.00966944211056346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30758",339.681684092475,0.361842137060458,0.087705389034292,4.12565454693987,3.69681829012075e-05,0.00970131314906657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33176",1001.37938942302,0.321901766800006,0.078021295403246,4.12581930530999,3.69417240344373e-05,0.00970131314906657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116616",29.1758664549812,0.705077225614698,0.170915753109039,4.1252910442075,3.70266221618261e-05,0.00970131314906657,1864,4806,"sp|P0C6T1|CTF8_RAT","P0C6T1","CTF8",1.95e-12,"Chromosome transmission fidelity protein 8 homolog","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005634; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"g24136",134.248409216976,1.4025920008175,0.34009869619249,4.12407344256227,3.72230119597888e-05,0.00970843830114854,13175,35182,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.45e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g9804",22.5692328670976,-2.5475810413475,0.618744514887001,-4.11733919259512,3.83271779438852e-05,0.00995119217384676,3785,7410,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",1.89e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g38948",39.0210895699246,1.96232799239293,0.476998882035759,4.11390480417484,3.89021915410682e-05,0.0100549898676869,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55668",139.547561782492,0.459558584904421,0.111784324029397,4.11111834234975,3.93747310032103e-05,0.0100862592185902,2086,14916,"sp|Q91W96|APC4_MOUSE","Q91W96","APC4",1.27e-64,"Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]","GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979"
"g85356",17.6649586892401,-0.907114785090942,0.22059484629863,-4.11213045232677,3.92024667713586e-05,0.0100862592185902,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69936",27.0771174403178,1.88274164497531,0.459064350337125,4.10125866578982,4.10908914882602e-05,0.0104790904604283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126551",20.9241054957119,-0.929483269555948,0.226766181129642,-4.09886194196023,4.1518658411581e-05,0.0105413301754713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32960",726.346077492102,0.436534689279769,0.106600083010887,4.09506894319384,4.22042778274095e-05,0.0106682002719681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4291",360.670753966182,0.738772517585496,0.180572275610105,4.09128430756817,4.28990825132489e-05,0.0107491238192586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33907",101.406108788663,-0.844828711817932,0.206454158456575,-4.0920886173171,4.2750520903594e-05,0.0107491238192586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73734",185.701743727246,2.38420886392912,0.584053506188071,4.08217541486924,4.46161002027367e-05,0.011130747085361,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9144",108.221857892649,-0.439783955543588,0.107820708018,-4.07884499766195,4.52599994401164e-05,0.0111857913424897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13019",761.960884743314,0.519283393584286,0.127351124981904,4.07757209571626,4.55084209837594e-05,0.0111857913424897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17924",218.533331302273,-0.538244921726957,0.132018657817871,-4.07703676604183,4.56132825614665e-05,0.0111857913424897,41776,52524,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g18683",150.842096356926,0.515837930098501,0.126554060566595,4.07602828221429,4.58114493810574e-05,0.0111857913424897,46,4414,"sp|Q6DJ55|FAKD4_XENTR","Q6DJ55","FAKD4",4.38e-45,"FAST kinase domain-containing protein 4 (Protein TBRG4) (Transforming growth factor beta regulator 4)","mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528]","GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0016071; GO:0035770; GO:0044528; GO:0090615"
"g140128",19.5702620018245,1.09179135239207,0.267853794345497,4.07607200435549,4.58028410868622e-05,0.0111857913424897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g311",32.9236665001584,-0.858780628393562,0.210818430383319,-4.07355574572911,4.63007625649286e-05,0.011257363372778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52019",403.174142220272,1.05536593162536,0.259252127666202,4.07080914292124,4.68501225729098e-05,0.0113428693385382,1429,16384,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.44e-53,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g1344",48.9121823591244,-0.816474368060774,0.200901077520467,-4.0640616672531,4.82260754408402e-05,0.0115782937606503,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119583",23.4025615671992,1.18777194498747,0.292216466954018,4.06469887672132,4.80945146374098e-05,0.0115782937606503,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4292",30.1588676788414,1.03183437795479,0.253980209433152,4.06265661508706,4.85173747105865e-05,0.0115996956703894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2444",40.4909647763144,-0.806994158208401,0.198955990152861,-4.05614406275668,4.98894949549015e-05,0.0118782540270218,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38625",27.1896253453661,1.22721514461181,0.302762170171553,4.05339657829919,5.04793215789601e-05,0.0119690226123997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3678",740.120741958277,-0.552674065343625,0.136552348482906,-4.0473420741849,5.18025097339173e-05,0.0122322140268814,0,51393,"sp|P21328|RTJK_DROME","P21328","RTJK",1.1e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g160502",98.7972066857064,1.27000121042675,0.314112165667796,4.04314556784755,5.27388547804441e-05,0.0124022765873028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19705",126.2287278735,0.478895864353006,0.118777417212302,4.03187639193259,5.53332894477758e-05,0.0127511009980457,0,14836,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",3.87e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g60891",1413.65519518621,-0.21839923924024,0.0541462800848684,-4.03350403569595,5.49512365270921e-05,0.0127511009980457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86267",26.3482754878876,0.768698933762856,0.190492958776786,4.03531415911072,5.45292860576293e-05,0.0127511009980457,0,5514,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",1.2e-29,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g129575",90.2038370943242,0.55366651013237,0.137305820262669,4.03236009277098,5.5219489515332e-05,0.0127511009980457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155268",113.229344952436,1.22285161727569,0.303202919998204,4.03311293071629,5.50428108923654e-05,0.0127511009980457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33250",127.445796640762,-0.552856306134383,0.137239482672704,-4.02840564076493,5.61563910076838e-05,0.0127886386312313,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54019",161.511424467231,-0.376753830263981,0.0934838518073476,-4.03014876879912,5.57415626006458e-05,0.0127886386312313,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117546",31.7823437411522,0.711983205269761,0.176742240179793,4.02837038019597,5.61648123923022e-05,0.0127886386312313,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8760",120.762942366981,-0.612595367793291,0.152376260809097,-4.02028087932132,5.81287943110003e-05,0.0129783276948062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63887",75.518120209311,1.72670029371142,0.429160372966757,4.02343832860163,5.73546079013297e-05,0.0129783276948062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67644",50.7459296337334,0.874155011495183,0.217419029020175,4.02060029167948,5.80500287650716e-05,0.0129783276948062,0,11114,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.01e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104316",23.8309553579322,2.4395346471296,0.606745893255667,4.02068588225556,5.80289397203276e-05,0.0129783276948062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131580",32.8536604819013,0.706473944378216,0.175685914079773,4.02123270996803,5.78943755659473e-05,0.0129783276948062,0,3502,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.85e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g3492",50.400903972049,-0.611807525281939,0.152449358585123,-4.01318530271366,5.99048498021847e-05,0.0133230243474781,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41501",45.9535726408784,0.997360955087408,0.24872034082639,4.00996939684791,6.07266180125014e-05,0.0134536422453951,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10524",208.955464183846,0.781252750849437,0.195055436746047,4.00528569663296,6.19425694637986e-05,0.0134858913852703,4159,13604,"sp|Q99NB1|ACS2L_MOUSE","Q99NB1","ACS2L",5.16e-30,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"g21562",131.305332597595,-0.790835986411002,0.197467775631895,-4.00488628527026,6.20473218144189e-05,0.0134858913852703,0,30170,"sp|P47736|RPGP1_HUMAN","P47736","RPGP1",2.84e-11,"Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1)","activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0007165; GO:0016020; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0051056; GO:0090630; GO:1903697; GO:1904425; GO:1904442; GO:1990792"
"g31820",282.637980505628,-0.650148095761865,0.16233830680038,-4.00489637089366,6.20446746272366e-05,0.0134858913852703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137245",24.10616440648,2.71591847581958,0.677598406581341,4.00815357509781,6.11953224614647e-05,0.0134858913852703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157842",43.5785966640134,1.08156317833503,0.26993310259963,4.00678230242558,6.15515465559149e-05,0.0134858913852703,0,1264,"sp|Q3LSM4|AGT_AEDAE","Q3LSM4","AGT",2.1e-21,"Alanine--glyoxylate aminotransferase (EC 2.6.1.44)","glyoxylate catabolic process [GO:0009436]","GO:0005777; GO:0008453; GO:0009436; GO:0030170"
"g10906",971.612390855834,0.558242720986219,0.139483635989357,4.00220941350293,6.27537170205407e-05,0.0135368732430024,40406,62154,"sp|Q02253|MMSA_RAT","Q02253","MMSA",1.33e-34,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","beta-alanine catabolic process [GO:0019484]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0016790; GO:0018478; GO:0019484; GO:0019859; GO:0050873; GO:0102662"
"g17633",65.1806916085966,1.68773948051735,0.421655960589954,4.00264584936964,6.26380295875169e-05,0.0135368732430024,43915,53258,"sp|Q04519|ASM_MOUSE","Q04519","ASM",3.3e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g127088",37.4732348513825,-0.644084267420815,0.160997049404787,-4.00059671777851,6.31829563869449e-05,0.0135784196160408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27152",157.31783778519,-0.665250874806747,0.166460047758989,-3.99645971368421,6.42968175959999e-05,0.0136663373240793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45918",491.77349163627,-0.431991392446296,0.108078416072679,-3.99701816647456,6.41453800762601e-05,0.0136663373240793,0,12193,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.56e-90,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g114986",28.8325923914156,1.17654957727354,0.294400604149446,3.99642378680815,6.43065715842003e-05,0.0136663373240793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87960",59.2342119712256,0.594835873526724,0.14887692640696,3.99548733227283,6.45613094475615e-05,0.0136698447826608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63143",22.1600049085873,0.988902435876229,0.247626715217189,3.99352079200696,6.50993672816289e-05,0.0136827900901827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143778",161.159175962413,0.519573355215642,0.130077168242395,3.99434706517776,6.4872778764477e-05,0.0136827900901827,0,1564,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",1.98e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g2954",115.467092294813,-0.571996987390425,0.143414855060829,-3.98840822415374,6.65181271033498e-05,0.0138090471332275,3695,16900,"sp|Q640T2|WIPI3_XENTR","Q640T2","WIPI3",8.23e-24,"WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B)","autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]","GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025"
"g4714",1521.39557345975,0.279149780064537,0.0699989766836492,3.98791229943426,6.66572944417104e-05,0.0138090471332275,48571,57994,"sp|Q94613|RS19_MYAAR","Q94613","RS19",3.68e-17,"40S ribosomal protein S19","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g84238",21.9383733843292,-1.23165975222589,0.308680400805567,-3.99008083769366,6.60507799375801e-05,0.0138090471332275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101034",19.8458374070984,-0.618959679707097,0.155209699489317,-3.98789303596132,6.66627057494602e-05,0.0138090471332275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18709",25.3225269705004,1.94220305691721,0.487347753909178,3.9852508631427,6.7408871080346e-05,0.0139133849733462,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38673",48.0564422970125,0.446079943029014,0.11198442116942,3.98341071347902,6.7933201625046e-05,0.0139713516460399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13459",2757.97882037067,0.573125126894765,0.143964062440841,3.98102913447778,6.86175373812715e-05,0.0140358712226028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17339",22.298650361515,0.720636854283138,0.181074809036686,3.97977420557232,6.898075435298e-05,0.0140358712226028,0,5072,"sp|P19971|TYPH_HUMAN","P19971","TYPH",2.35e-16,"Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]","GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333"
"g50088",77.1016638848903,1.57103697950074,0.394707928395486,3.98025189381706,6.88422820341485e-05,0.0140358712226028,3755,7349,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.94e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g307",61.9289870699013,-0.668937440553055,0.168137450292146,-3.97851543121862,6.93469112618052e-05,0.0140605150819872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41621",452.242071679065,-0.497400657695523,0.125056298737095,-3.97741387453986,6.96688440871866e-05,0.0140760502595872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70822",303.684796713727,0.31232524444463,0.0786127748699949,3.9729578934357,7.0985601262169e-05,0.0141526484137388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81992",6429.57555459091,0.501013825132972,0.126074262200582,3.97395801798045,7.06880280471067e-05,0.0141526484137388,0,1274,"sp|Q4R6V2|TCPE_MACFA","Q4R6V2","TCPE",0,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]","GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g122431",263.681887701691,-0.435570547251656,0.109630810573263,-3.97306692319472,7.0953103507532e-05,0.0141526484137388,135,4267,"sp|Q94HW2|POLR1_ARATH","Q94HW2","POLR1",3.02e-19,"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g132349",376.247656324439,0.486913656346131,0.122562027548889,3.97279374439122,7.10345546036385e-05,0.0141526484137388,0,3278,"sp|O16797|RL3_DROME","O16797","RL3",1.66e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g134669",45.6285513683609,-1.11099794153866,0.279739220990403,-3.97154870741839,7.14068967807335e-05,0.0141776046272612,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56253",707.420485248688,-0.479398080786555,0.12073659368592,-3.97061127990445,7.16884624617574e-05,0.0141844275036401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4154",1649.26937604668,0.375780127110995,0.0947394690918774,3.96645802127693,7.2948616704286e-05,0.0143390227529297,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7875",85.5828453189988,-0.986592153333642,0.248941794452997,-3.96314389675504,7.39691658220146e-05,0.0143390227529297,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22455",279.285697683453,0.363989856181862,0.0918411565508906,3.96325427348216,7.39349602092595e-05,0.0143390227529297,0,10750,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.19e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22467",64.9339960907534,-0.575910013202727,0.145240415124131,-3.96521872173472,7.3328676838472e-05,0.0143390227529297,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38063",51.0265797739348,-0.509137694769579,0.128420492224459,-3.96461410441945,7.3514775838508e-05,0.0143390227529297,15986,26149,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.15e-71,"PiggyBac transposable element-derived protein 4",NA,NA
"g144353",29.7662162180806,-0.724820435949317,0.182827031656905,-3.9645145981997,7.35454462635556e-05,0.0143390227529297,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3491",38.0177603934999,-0.715649489971344,0.180631058334257,-3.96194041363052,7.43430962964294e-05,0.0143629860790879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5442",77.2667863381214,-0.636049073816042,0.160796156377082,-3.95562361779622,7.63352630889578e-05,0.0143838181438491,48662,54264,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.1e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g8449",33.7401177723244,-0.822985227318011,0.208015833673457,-3.95635857513584,7.61009064777995e-05,0.0143838181438491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13015",59.9278583146901,0.53372067674998,0.13481866499391,3.95880404819383,7.53260045135113e-05,0.0143838181438491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16100",678.932946472918,-0.905931106331917,0.229071487510586,-3.95479645318168,7.65998381132619e-05,0.0143838181438491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17629",54.012819472169,2.3927319192489,0.604999286152669,3.95493345862412,7.65559560270015e-05,0.0143838181438491,0,6370,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.14e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g120975",168.089281238772,-1.05285813338091,0.266245596067901,-3.95446215422994,7.6707012060262e-05,0.0143838181438491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131016",119.925836349264,-0.39546858406608,0.0999008763494602,-3.95860975916471,7.53872953696442e-05,0.0143838181438491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131470",18.1198644641122,0.675309776077363,0.170769791138168,3.9545037302937,7.66936753437929e-05,0.0143838181438491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134094",22.2213966198823,3.0459772370778,0.769910475536126,3.95627457199713,7.61276581686102e-05,0.0143838181438491,314,3224,"sp|O42563|CP3AR_ONCMY","O42563","CP3AR",7.86e-14,"Cytochrome P450 3A27 (EC 1.14.14.1) (CYPIIIA27)","progesterone metabolic process [GO:0042448]","GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0020037; GO:0042448; GO:0050649; GO:0070330"
"g23925",1365.62553475122,0.788905097118655,0.199658193351077,3.95127835165498,7.77348471604627e-05,0.0145290733878415,2288,4934,"sp|P70691|UD12_MOUSE","P70691","UD12",3.24e-12,"UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2)","flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]","GO:0001972; GO:0005783; GO:0005789; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0046982; GO:0052696; GO:0052697"
"g22396",26.023181767501,1.0301467929425,0.260991920255832,3.94704476649208,7.91217672239823e-05,0.0146609940016116,16969,27844,"sp|A1ZAY1|DLISH_DROME","A1ZAY1","DLISH",2.66e-26,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219"
"g67413",272.097477663858,0.920255629696852,0.233211395846839,3.9460148435509,7.9462689691551e-05,0.0146609940016116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91021",204.823796701991,0.303662416725994,0.076952650064321,3.94609433816999,7.94363262081488e-05,0.0146609940016116,0,7562,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.79e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g142948",50.5790207899378,0.618099148248458,0.15657280051177,3.94767894697006,7.89125307773259e-05,0.0146609940016116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17401",443.178852488714,-0.60711224393367,0.154059222176148,-3.940771836687,8.12198520951081e-05,0.0149371638244144,0,31413,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.61e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g10915",164.095659933045,0.674578035060515,0.171270726220683,3.93866511776987,8.19361977240228e-05,0.0149902346725237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41024",37.3210282420939,0.956800706718784,0.243002436729416,3.93741198481966,8.23651274577443e-05,0.0149902346725237,0,17758,"sp|P04323|POL3_DROME","P04323","POL3",8.46e-89,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g72805",7178.16619302628,0.379367351561656,0.096362831629666,3.93686388357298,8.25534011243898e-05,0.0149902346725237,0,5886,"sp|Q01768|NDKB_MOUSE","Q01768","NDKB",4.29e-33,"Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18) (nm23-M2)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; CTP biosynthetic process [GO:0006241]; dTMP biosynthetic process [GO:0006231]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]","GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006165; GO:0006183; GO:0006228; GO:0006231; GO:0006241; GO:0007189; GO:0007229; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0042802; GO:0042981; GO:0043066; GO:0043209; GO:0045618; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0071944; GO:1901363"
"g87501",1042.36697538731,0.470876547642311,0.119602660859009,3.9370072894732,8.2504101714802e-05,0.0149902346725237,455,6717,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.24e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g16039",161.971390439715,0.81491071310921,0.207058499315345,3.93565449283065,8.29702686989434e-05,0.015018403842099,26206,36094,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g87705",142.883113592283,-0.462416641161676,0.117673980357634,-3.92964221789985,8.50723487843803e-05,0.0153504760165023,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10302",155.73381420939,0.762676316520538,0.194863886956707,3.91389255562773,9.08200601439893e-05,0.0162851720345691,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132561",455.590230536167,4.94724282011425,1.2638120338387,3.91454004840221,9.05767037084746e-05,0.0162851720345691,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75461",44.4005416367255,0.818737693568761,0.209323295238241,3.91135488592856,9.17797950177088e-05,0.016355045459988,4485,8448,"sp|Q16851|UGPA_HUMAN","Q16851","UGPA",2.89e-14,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062"
"g117608",629.966678514985,0.922520640528,0.235837547104373,3.91167840683029,9.1656910322997e-05,0.016355045459988,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5108",91.5292644510462,-0.516312308785927,0.132041155658712,-3.91023773012443,9.22053278309855e-05,0.0163800052970339,43095,53844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.01e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g102901",39.4100386949409,0.879935703462253,0.225169475432308,3.90788183777061,9.31088203998358e-05,0.0164820917544389,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119744",589.756243906138,0.569311843756962,0.145734416097702,3.90650238290513,9.36417203197471e-05,0.0164820917544389,0,4512,"sp|Q7YRU4|MDHC_FELCA","Q7YRU4","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005813; GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g123234",166.455870838032,0.573346178326138,0.146753821847761,3.90685687845945,9.35045001193308e-05,0.0164820917544389,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17387",172.462121983261,-0.708516844587677,0.181476217174678,-3.90418565924647,9.45431845848394e-05,0.0165392924740185,0,27002,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.42e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g25658",67.8636835404998,-0.50110674149784,0.128330175862785,-3.90482392881344,9.42940119328402e-05,0.0165392924740185,14200,20344,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.82e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g28103",549.106393773262,-0.440341713549943,0.112823947405133,-3.90291000871246,9.50430473523875e-05,0.0165762007813982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83009",25.2160519690539,-0.635318422259119,0.162895458147826,-3.9001604432861,9.61289621018686e-05,0.0166140959198952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89746",32.0388463013606,2.62019367156612,0.671767572557071,3.90044678934472,9.60153283129544e-05,0.0166140959198952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119755",113.072138063234,0.850367766257878,0.218022225213626,3.90037192503955,9.60450252693768e-05,0.0166140959198952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29962",3277.72852841611,0.354148737755586,0.0908600784981248,3.89773752796059,9.70955696593347e-05,0.0167307621232812,8955,35418,"sp|P29775|ETS4_DROME","P29775","ETS4",4.28e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g15055",134.751124190362,-0.444766029070747,0.114221463980292,-3.89389186210647,9.86486392530265e-05,0.0168894095008975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39067",128.127926227536,-0.366685192976323,0.0941941955657722,-3.89286400052411,9.90676952188625e-05,0.0168894095008975,6745,24934,"sp|Q96IR2|ZN845_HUMAN","Q96IR2","ZN845",1.22e-114,"Zinc finger protein 845","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g75088",459.806471111838,-0.870249323857505,0.223567586180561,-3.89255588757245,9.91936389299835e-05,0.0168894095008975,2761,9912,"sp|Q292F9|GDAP2_DROPS","Q292F9","GDAP2",8.31e-15,"Protein GDAP2 homolog","response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","GO:0006979; GO:0042594"
"g148463",257.455442918338,-0.418504409629151,0.107508336352022,-3.89276240178077,9.91092078518103e-05,0.0168894095008975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88041",206.196961846006,0.727698584315006,0.187188070376651,3.88752650129234,0.000101270933871985,0.0171920893064334,0,7324,"sp|Q6NVG7|GT252_MOUSE","Q6NVG7","GT252",1.35e-103,"Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)",NA,"GO:0005788; GO:0050211"
"g17577",43.4009830284009,2.3566402271811,0.606677666917625,3.88450136817231,0.000102540115429573,0.0173155248529602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113121",32.6877326942012,1.32287194348359,0.34056405252038,3.88435577299933,0.00010260157633333,0.0173155248529602,0,2824,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.07e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g3892",117.03976877519,-0.574808649921207,0.14801463344198,-3.88345825378491,0.000102981219616638,0.0173286286850519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33312",429.423615401445,0.521899257774702,0.134521446064227,3.87967326433231,0.0001045968723629,0.0175490308075533,0,5414,"sp|Q9SF16|TCPH_ARATH","Q9SF16","TCPH",4.42e-17,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)","protein folding [GO:0006457]","GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g69919",50.0317176715626,0.990456592970075,0.255349323510174,3.87882990780907,0.00010496011015674,0.0175586330052295,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65016",119.16792650109,0.567784671698783,0.146428644260622,3.87755192684983,0.000105512812291984,0.0175997824689362,777,11544,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.53e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g42349",24.948734420349,-0.731105522222893,0.188597030108383,-3.87654843664685,0.000105948726243302,0.0176212693096831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84103",94.3043132258836,-0.546304119417248,0.1409584967742,-3.87563809148991,0.000106345647825673,0.0176361655266969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4638",96.2558686767819,4.25773241998188,1.09920597161817,3.87346187149435,0.000107300200298286,0.0176684291082109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32321",4166.98437148432,3.47977561440214,0.898230941586505,3.87403222634033,0.000107049247536687,0.0176684291082109,5250,13374,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.93e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g49350",2719.01559168737,-0.706184184106916,0.18233093367078,-3.87309037413264,0.000107463955363639,0.0176684291082109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31683",93.0775857252453,0.405887612991642,0.104863081541476,3.87064357660617,0.000108548402728914,0.0177957352816716,21915,28562,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.2e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g101166",92.2651059375701,0.626120301785574,0.161891315978414,3.86753482113307,0.000109941133514789,0.0179727129375459,0,4064,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.14e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g20414",330.003789923779,-0.449900121098564,0.116498942904975,-3.86183865604288,0.000112536879978762,0.0183447902647197,21735,43649,"sp|Q24210|CSKP_DROME","Q24210","CSKP",6.88e-24,"Peripheral plasma membrane protein CASK (dCASK) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase) (CAKI) (Camguk)","adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cellular protein localization [GO:0034613]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]","GO:0004674; GO:0004683; GO:0004712; GO:0005102; GO:0005516; GO:0005524; GO:0005886; GO:0005911; GO:0007269; GO:0007274; GO:0007298; GO:0007615; GO:0007616; GO:0007628; GO:0008049; GO:0008344; GO:0008582; GO:0016080; GO:0016081; GO:0031594; GO:0034613; GO:0040011; GO:0040012; GO:0042043; GO:0046928; GO:0048149; GO:0048488; GO:0061174; GO:0072375; GO:0106310; GO:1900073; GO:1900244; GO:2000331"
"g19215",83.5864791990897,0.503701602361895,0.130600309343546,3.85681783522352,0.000114872703925392,0.0183604338474623,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25703",172.637218800651,-0.913748179412546,0.236868712835864,-3.85761449231888,0.000114499049875781,0.0183604338474623,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29989",3077.97201173762,0.352815752485585,0.0914726239608872,3.85706386466453,0.00011475718679789,0.0183604338474623,9085,35022,"sp|P29775|ETS4_DROME","P29775","ETS4",4.19e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g86841",31.6049870538602,-0.517950794978971,0.134203787198874,-3.85943501140865,0.000113649474924219,0.0183604338474623,0,8114,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.27e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g93463",115.047421220098,1.33752593905502,0.346508378356627,3.86001038531437,0.000113382206212246,0.0183604338474623,0,6382,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",2.26e-15,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g125769",34.2983801057393,0.626142885346892,0.162328016819366,3.85726935876785,0.00011466078603121,0.0183604338474623,0,3953,"sp|Q498P2|RT35_DANRE","Q498P2","RT35",8.96e-18,"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005763; GO:0032543"
"g137545",18.6358098882463,1.82455432405908,0.472777836297734,3.8592213593322,0.000113748870321996,0.0183604338474623,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1504",147.698041562417,-0.649896136976179,0.168614992775337,-3.85431998827115,0.0001160517324982,0.0184446107130558,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36240",319.578873574894,0.627236707722407,0.162791142995184,3.85301495021115,0.000116672263714433,0.0184446107130558,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109499",241.992683853424,0.474747753483909,0.123151568174194,3.85498748024381,0.000115735551811881,0.0184446107130558,152,3654,"sp|Q66HV4|COPB_DANRE","Q66HV4","COPB",4.6e-11,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; notochord development [GO:0030903]; somite development [GO:0061053]","GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006891; GO:0030126; GO:0030903; GO:0061053"
"g113228",323.557925870384,0.526161730567096,0.136559402885264,3.8529879265009,0.000116685146197966,0.0184446107130558,0,5132,"sp|Q2T9X2|TCPD_BOVIN","Q2T9X2","TCPD",1.86e-31,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0016887; GO:0042470; GO:0051082"
"g9950",426.356876645154,-0.439516200015536,0.114112480312743,-3.85160500245875,0.000117346194169717,0.0184981445644461,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94306",40.3394562542685,0.677603218051925,0.176147086773152,3.84680343265946,0.000119668901714579,0.0188126070695413,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24981",643.868265583097,0.519011125001171,0.134947266392843,3.84602918513581,0.000120047470080807,0.0188205569214118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41854",286.926022991305,-0.754262169691896,0.1961563466905,-3.84520910191088,0.000120449681087484,0.0188321599476835,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92689",29.6689561693493,1.78781087306387,0.465222651538871,3.84291449943402,0.000121581833941662,0.0189575153031864,0,6631,"sp|Q8CHN6|SGPL1_RAT","Q8CHN6","SGPL1",2.81e-15,"Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)","androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]","GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0006807; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0016021; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190"
"g111725",50.0695785898042,0.589575667107469,0.153457327907135,3.84195186471808,0.000122059777238412,0.0189804607532251,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32416",52.8990796870311,1.59043391640139,0.414122214694962,3.84049408596177,0.000122786930542548,0.0189906039744781,22096,32145,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.19e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g64976",171.983370094401,0.52228642042736,0.135989772814475,3.84063014164965,0.000122718892327481,0.0189906039744781,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28331",445.204692186485,-0.387303388393894,0.100887141785442,-3.83897671734596,0.00012354814429896,0.0190374367068068,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55089",461.918165077463,1.26654488749628,0.329952331398856,3.8385692931057,0.000123753291942122,0.0190374367068068,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44751",142.219161963901,1.46628484559874,0.382102298212168,3.83741435856155,0.000124336575246979,0.0190760232290686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95295",143.317069716466,0.827428175480057,0.215903487317945,3.83239838206766,0.000126900022607557,0.0194173954592576,0,4768,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g2359",1777.66733717518,-0.407752198827944,0.10649942078658,-3.8286799666738,0.00012883240613338,0.0194879735083903,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68959",312.376261476448,0.381318613016854,0.0996065968197243,3.82824657393921,0.000129059427207883,0.0194879735083903,100,4131,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",4.9e-17,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g85684",2614.491355317,-0.381204247480244,0.0995760161557826,-3.82827373695957,0.000129045187526648,0.0194879735083903,1745,8145,"sp|P48613|TIPE_DROME","P48613","TIPE",2.29e-16,"Protein tipE (Temperature-induced paralytic E)","cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]","GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433"
"g103969",87.066263159261,1.17863986011221,0.307805717634262,3.82916818170572,0.000128577118667592,0.0194879735083903,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116613",25.2404124163842,0.657229889390275,0.171567230119667,3.83074255457677,0.000127757123397663,0.0194879735083903,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149135",106.968505385546,0.852331072078757,0.222731513957308,3.82671969913573,0.000129862246771069,0.0195577315478319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95785",303.264590563436,-0.359777331904413,0.0940535342998524,-3.82523989749716,0.0001306448045761,0.0196240808549126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27191",353.987723584052,-0.584655744223112,0.152868577578318,-3.82456456051982,0.000131003415293174,0.0196265691110244,10036,28194,"sp|P21328|RTJK_DROME","P21328","RTJK",4.28e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g11801",663.57262366439,0.408654069381316,0.106943334481755,3.82122056845941,0.000132792817874759,0.0196479292066304,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12402",61.8949284878145,-0.8905063463657,0.233059627834687,-3.82093782024466,0.000132945170489492,0.0196479292066304,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28589",52.117407470813,-0.575187360574228,0.150604158670939,-3.81919971965036,0.000133885331470765,0.0196479292066304,0,4650,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.52e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g45973",24.1342354137503,-0.560555631890997,0.146692862799133,-3.82128769726559,0.000132756671176533,0.0196479292066304,0,11714,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.85e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g47305",30.8842975641108,2.74152558764537,0.71709278558945,3.82311137796741,0.000131778217679411,0.0196479292066304,2322,4874,"sp|Q9VZ49|ENDOU_DROME","Q9VZ49","ENDOU",8.24e-17,"Endoribonuclease CG2145 (EC 4.6.1.-) (Poly(U)-specific endoribonuclease homolog) (Uridylate-specific endoribonuclease homolog)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003723; GO:0004521; GO:0005576; GO:0016829; GO:0046872; GO:0090502"
"g53304",168.439580033966,0.532896474693458,0.139504720706873,3.81991714684106,0.000133496509192352,0.0196479292066304,2128,15634,"sp|Q16U49|MED14_AEDAE","Q16U49","MED14",4.95e-12,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"g68509",143.718198686828,1.55381254436029,0.406641442865983,3.82108752469772,0.000132864485056166,0.0196479292066304,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87617",26.1844719882326,3.82301275376363,1.00098170807462,3.81926335209178,0.000133850801675166,0.0196479292066304,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69555",892.505441956617,0.573038469031794,0.150068298740972,3.81851779382732,0.000134255902069189,0.0196520501549236,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46920",182.901612207061,-0.789933392621394,0.206959879246021,-3.81684312678967,0.00013517005063701,0.0197355152813019,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70052",215.861480009465,0.436407664971856,0.114366594839799,3.8158665612381,0.000135705830940126,0.019763453247067,425,10902,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.04e-52,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g2637",454.379385074343,-0.533849690806128,0.140040726085671,-3.81210313405216,0.000137789357124908,0.019783556689878,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8261",536.599377203568,0.763162732016193,0.200071679722217,3.81444656772903,0.000136488463128485,0.019783556689878,6445,16804,"sp|Q24319|OST48_DROME","Q24319","OST48",1.99e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0012505; GO:0016021; GO:0018279"
"g9302",173.180195271078,-0.525029048064015,0.137690059690777,-3.81312237966284,0.000137222121642361,0.019783556689878,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32170",107.047656665016,0.628929776509721,0.164938401607944,3.81311914253102,0.000137223919699391,0.019783556689878,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45625",239.128100323557,-0.669085265582847,0.175526214282564,-3.81188227819776,0.000137912559706365,0.019783556689878,16286,19654,"sp|Q9NJB5|ONEC_DROME","Q9NJB5","ONEC",3.61e-19,"Homeobox protein onecut","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0045944"
"g137707",147.213710329914,0.369285921337974,0.0968490418439859,3.81300541860659,0.000137287101465694,0.019783556689878,0,2664,"sp|Q14746|COG2_HUMAN","Q14746","COG2",6.7e-11,"Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085"
"g55718",3298.49511444622,0.281460866219229,0.0738625603785494,3.81060262163575,0.000138628450300033,0.0197873146224276,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57008",194.603111779749,-0.358726525967311,0.0941255609835789,-3.8111488762324,0.000138322426686049,0.0197873146224276,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2860",185.548587882785,0.466442392521828,0.122611498185757,3.80423043045414,0.000142245721226951,0.0199074621561036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30332",2750.92954252896,-1.00794714620103,0.264857250579885,-3.80562413901905,0.000141447047347455,0.0199074621561036,9354,31614,"sp|A2SXS5|MEN1_CANLF","A2SXS5","MEN1",3.4e-25,"Menin","chromatin organization [GO:0006325]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000403; GO:0000785; GO:0000976; GO:0003682; GO:0006325; GO:0006357; GO:0008285; GO:0035097; GO:0045786"
"g34302",110.6659710865,-0.501951373969299,0.131942568408937,-3.80431713602522,0.000142195910390474,0.0199074621561036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41209",124.394567224967,1.40482146089373,0.369125045276574,3.80581453052351,0.000141338270705756,0.0199074621561036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57992",17.7597070997434,1.27394269082747,0.334642864369799,3.80687241972593,0.00014073529909639,0.0199074621561036,0,14087,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.43e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g101476",1273.49300406007,0.479317437953641,0.125940388192626,3.80590726162066,0.000141285319056054,0.0199074621561036,0,6329,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.31e-16,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g141291",61.8200019566917,0.984919077558077,0.258781395044312,3.80598874733412,0.000141238804209908,0.0199074621561036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157688",38.7332737904449,1.54846661660666,0.406923381690533,3.80530263504071,0.000141630911669848,0.0199074621561036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63839",287.62030279386,0.514339408724989,0.135247876072384,3.80293889753742,0.000142989632531689,0.0199628834906772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21025",26.0041857127267,-0.655853162349371,0.172491866046179,-3.80222660571015,0.000143401472199003,0.0199717875601427,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81364",28.7640572498426,-0.633818673542359,0.166759720897521,-3.80078996373387,0.000144235524550629,0.0199909043447224,0,3326,"sp|P97471|SMAD4_MOUSE","P97471","SMAD4",1.13e-27,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)","adrenal gland development [GO:0030325]; aging [GO:0007568]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to glucose stimulus [GO:0071333]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesendoderm development [GO:0048382]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of cell population proliferation [GO:0042127]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]","GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006357; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0007568; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010666; GO:0010718; GO:0010862; GO:0014033; GO:0017015; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0030513; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032991; GO:0033686; GO:0035556; GO:0036302; GO:0042060; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048663; GO:0048729; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0072133; GO:0072134; GO:0072520; GO:0090575; GO:1902895; GO:1905305; GO:2000617"
"g132716",53.2293047615343,3.17801461235676,0.836127927925757,3.80087126169878,0.000144188204777666,0.0199909043447224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29610",80.1594976959102,0.861330439760862,0.22676190516204,3.79839126481747,0.0001456382950396,0.019992165955436,25796,33754,"sp|P11586|C1TC_HUMAN","P11586","C1TC",1.69e-26,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0048702; GO:0048703; GO:0061053; GO:0070062"
"g34468",35.4332991155265,1.25341527106037,0.329947999124952,3.79882670719182,0.000145382695637059,0.019992165955436,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121833",632.845676031325,0.181308323882324,0.0477212583846618,3.79931984234092,0.00014509374136093,0.019992165955436,0,4324,"sp|Q3KNM2|MARH5_MOUSE","Q3KNM2","MARH5",4.68e-17,"E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCHF5)","negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140]","GO:0000209; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051020; GO:0051865; GO:0061630; GO:0070585; GO:0090140; GO:0090141; GO:0090344"
"g123940",92.509141739335,0.570654843391441,0.150228047309082,3.79859056689572,0.000145521254661818,0.019992165955436,0,4138,"sp|P48605|TCPG_DROME","P48605","TCPG",2.9e-20,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing TCP1 subunit 3)","lumen formation, open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]","GO:0005524; GO:0005832; GO:0006457; GO:0007430; GO:0016887; GO:0035149; GO:0051082"
"g55172",1314.16171753977,0.48255086572173,0.127084341915266,3.79709143116524,0.00014640380082566,0.0200492842276286,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22016",98.2094042772638,0.775952668568138,0.204562779587813,3.79322509271559,0.000148703244194639,0.0203156955997342,0,13202,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.21e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13396",647.377312637574,0.571402901113933,0.150685390862324,3.79202587486404,0.000149423340910858,0.0203655850391093,0,2024,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.17e-28,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g69532",414.86501702885,-0.597371569621435,0.157648165759356,-3.78927066321405,0.000151090223666539,0.020522888702568,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156417",152.965552083536,1.03346478506392,0.272758449681048,3.78893774426569,0.000151292818424299,0.020522888702568,0,1340,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",3.51e-19,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g33314",239.558744290513,0.504318032404497,0.133206853983007,3.78597660199101,0.000153106081416183,0.020719874885992,6495,10395,"sp|P80313|TCPH_MOUSE","P80313","TCPH",1.25e-20,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g136703",28.2505587296044,0.559111151449054,0.147751649174797,3.78412799161111,0.000154248433753268,0.0208253532441471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44",128.538213407193,0.385507980539067,0.101945138312737,3.78152393453473,0.000155871232364154,0.0209535952772849,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3881",430.882355557277,0.383423192246442,0.101396286676214,3.78143228726724,0.000155928636866515,0.0209535952772849,105965,115318,"sp|Q5R664|COPB2_PONAB","Q5R664","COPB2",7.35e-29,"Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0016192; GO:0030117; GO:0030663"
"g4290",254.974099158836,0.632797547608749,0.167602956464518,3.77557509102003,0.000159638922536637,0.0209612846113324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15100",152.34816074621,0.5590930670214,0.148040842145891,3.77661366226509,0.000158975029268136,0.0209612846113324,36305,43009,"sp|Q27640|ALDH_ENCBU","Q27640","ALDH",4.29e-16,"Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase [NAD(+)])","ethanol catabolic process [GO:0006068]","GO:0004029; GO:0006068; GO:0043878"
"g15413",157.645284333649,-0.386887416534761,0.102362586123244,-3.77957837123176,0.000157094143342017,0.0209612846113324,47084,51764,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.27e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g25704",988.457571433638,-0.711580481607507,0.188399273832612,-3.77698102084899,0.000158740822731744,0.0209612846113324,13205,20660,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",7.44e-48,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g28255",25.0529366609113,1.87945270895324,0.497548947310029,3.77742274225359,0.000158459636728329,0.0209612846113324,28044,33514,"sp|P04069|CBPB_ASTAS","P04069","CBPB",2.75e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g33590",264.305263902754,0.407143643959359,0.107810515664233,3.77647432118192,0.000159063950099574,0.0209612846113324,6934,19994,"sp|Q0P5L5|SUMF1_BOVIN","Q0P5L5","SUMF1",3.56e-19,"Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)","post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]","GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135"
"g41347",156.423949479961,0.551629174074426,0.145973459154683,3.77896898017525,0.000157479037955071,0.0209612846113324,5510,11304,"sp|Q28104|COPE_BOVIN","Q28104","COPE",4.17e-11,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g41714",538.73729600261,-0.786578432848826,0.208329321242844,-3.77564918925615,0.000159591469897591,0.0209612846113324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64376",53.1427175100864,0.561018405637943,0.148490099301245,3.77815361615319,0.000157995414490145,0.0209612846113324,10477,11614,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.52e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g103853",29.4710379077097,0.808621042913604,0.213911556238853,3.78016530350843,0.000156724270970304,0.0209612846113324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69950",190.723181645364,0.737799562545414,0.195508305734263,3.77375047967649,0.000160811604256669,0.0210670544571865,0,3160,"sp|Q3T0R7|THIM_BOVIN","Q3T0R7","THIM",2.55e-17,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029"
"g9181",35.6350616403664,0.527693083902709,0.139880119556768,3.7724666348212,0.000161641587399485,0.0211275496241058,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104685",83.6701169083966,-1.18752546987153,0.31493957462948,-3.77064543656868,0.000162825876824889,0.0212110749711358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146918",35.0341418872983,0.521488936361744,0.138313203170335,3.77034819820868,0.000163019938345606,0.0212110749711358,0,2257,"sp|Q71U00|SKP1_XENLA","Q71U00","SKP1",1.23e-11,"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0019005; GO:0031467"
"g53749",67.437042948121,-1.15663005996891,0.30704632928195,-3.76695615503294,0.000165250008597986,0.0214525916139195,11533,14844,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.25e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22384",248.809104504682,0.693305850107198,0.184151438550616,3.7648679563078,0.000166637117086313,0.0215838324569134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28131",637.229904848336,-0.643239177798134,0.171020051601485,-3.76119157826607,0.000169105844652859,0.0216261220821562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30756",124.11935329492,0.412531892936452,0.109691243793011,3.760846159379,0.000169339556836019,0.0216261220821562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61803",118.045571366301,0.666509858790606,0.177240061255691,3.76049214871959,0.000169579397493547,0.0216261220821562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64675",477.904947782267,0.435717170797156,0.115842633489756,3.76128509574748,0.000169042622459323,0.0216261220821562,0,5904,"sp|Q963B6|RL10A_SPOFR","Q963B6","RL10A",1.38e-20,"60S ribosomal protein L10a","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934"
"g87800",108.55241015367,0.691012297402249,0.183679251769724,3.76205962700981,0.000168519857057251,0.0216261220821562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92129",213.070459874609,-0.357791381237567,0.0951456670777551,-3.76045901223407,0.00016960186366278,0.0216261220821562,0,7363,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.19e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g96285",725.607811653388,0.264039320268259,0.0701825112126309,3.76218114322388,0.000168437978532663,0.0216261220821562,0,2323,"sp|Q8MQI6|ELOF1_DROME","Q8MQI6","ELOF1",1.96e-15,"Transcription elongation factor 1 homolog","transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000993; GO:0006368; GO:0008023; GO:0046872"
"g72884",18.481428452904,1.08241137985242,0.287915497419858,3.75947592106853,0.000170269663603167,0.0216631336974495,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10731",1007.00549916802,0.371943526783947,0.0989720908919339,3.75806475777163,0.000171232571205901,0.0217198719991043,34875,57870,"sp|P21328|RTJK_DROME","P21328","RTJK",7.78e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g43508",56.1340564328851,0.984218042448377,0.261919355948193,3.75771404478809,0.000171472673677139,0.0217198719991043,0,16314,"sp|Q9W3Z3|AGT_DROME","Q9W3Z3","AGT",7.06e-18,"Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44)","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]","GO:0004760; GO:0005777; GO:0008453; GO:0009436; GO:0019265"
"g22402",39.9842490151012,1.17741161183703,0.313501914681122,3.75567598378031,0.000172874234305166,0.021849170846763,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10775",1294.84796641487,-0.633650714476756,0.168775286806455,-3.75440460784641,0.000173754000339941,0.021883154822974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18128",95.8457777050875,0.718967992546304,0.191511033140552,3.75418575502459,0.00017390586614284,0.021883154822974,9862,56101,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.99e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85988",2161.90110377484,0.295906493250953,0.0788712929967945,3.75176419718363,0.000175594580673436,0.022047302054796,1975,4788,"sp|Q567C6|ZN367_DANRE","Q567C6","ZN367",5.46e-20,"Zinc finger protein 367","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872"
"g22734",189.088465974838,1.4040743261846,0.374448280638293,3.7497149774361,0.000177035673303431,0.0221797094632116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5120",64.7180508728004,0.933393727541362,0.249181805527557,3.74583419349266,0.000179795318505818,0.0223788619866895,13311,40384,"sp|A7NF38|ARLY_ROSCS","A7NF38","ARLY",1.77e-21,"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","arginine biosynthetic process via ornithine [GO:0042450]","GO:0004056; GO:0005737; GO:0042450"
"g14626",788.897266585504,-0.329043149452914,0.0878304178838556,-3.74634616777107,0.000179428948915221,0.0223788619866895,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46846",20.7683350901445,-0.74876409031205,0.199835967189973,-3.74689351892415,0.000179038040022455,0.0223788619866895,0,14444,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68472",21.4561614189955,0.74621907104025,0.199283246072081,3.74451483377756,0.000180742698843147,0.0224480867091337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146181",21.1230987079939,2.654427908042,0.708993651989204,3.74393748180191,0.000181158747175536,0.022451163958817,1014,2326,"sp|O61866|LIPL5_CAEEL","O61866","LIPL5",4.16e-17,"Lipase lipl-5 (EC 3.1.1.-) (Lipase-like 5)","defense response to Gram-negative bacterium [GO:0050829]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; triglyceride catabolic process [GO:0019433]","GO:0005576; GO:0005764; GO:0006629; GO:0016788; GO:0019433; GO:0043202; GO:0050829; GO:0055088"
"g23737",276.384050641322,-0.410314541904983,0.109633930382302,-3.74258717601555,0.000182135315618135,0.0225193285824676,2324,21644,"sp|Q9UQ26|RIMS2_HUMAN","Q9UQ26","RIMS2",1.3e-17,"Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669]","GO:0006886; GO:0007188; GO:0017156; GO:0017157; GO:0030073; GO:0030154; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0070062; GO:0097151; GO:1903861; GO:2000463"
"g83170",49.1356769488674,0.658706872885234,0.176026306529756,3.74209336019831,0.000182493687536553,0.0225193285824676,1076,8384,"sp|P21439|MDR3_HUMAN","P21439","MDR3",2.91e-19,"Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)","bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140"
"g42038",43.8802699466049,0.440022057935348,0.117611511439733,3.74131794200115,0.000183057761935235,0.0225404600425832,0,21784,"sp|P21328|RTJK_DROME","P21328","RTJK",1.82e-39,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g41311",21.4482728774712,-0.643553698502014,0.172044655782907,-3.74062010571301,0.000183566800664366,0.0225547388053989,13517,14374,"sp|B3LYS5|FOXO_DROAN","B3LYS5","FOXO",3.37e-34,"Forkhead box protein O","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]","GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627"
"g38678",84.8687533365394,-0.329202655790317,0.0880355072864819,-3.73943044048168,0.000184437674746036,0.02261332003617,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3883",2659.49959672687,-0.386090707473463,0.103274199211779,-3.73850110114848,0.000185120682228671,0.0226486668364204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19221",90.0911589912547,0.389405071015793,0.104203663939284,3.73696141090285,0.000186257495524305,0.0227392661557119,0,31074,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.53e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g18111",713.368211575545,0.260969106189789,0.069910562570668,3.73289953039632,0.000189288112022762,0.0229778653962245,2566,16454,"sp|A2AKG8|FOCAD_MOUSE","A2AKG8","FOCAD",9.63e-27,"Focadhesin","regulation of posttranscriptional gene silencing [GO:0060147]","GO:0005925; GO:0016021; GO:0060147"
"g28675",41.0559873904653,-0.478644088038393,0.128210755252417,-3.73326003029977,0.000189017276052438,0.0229778653962245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112406",26.2565806713793,-0.738416158485259,0.197821843756951,-3.73273317274555,0.000189413215970969,0.0229778653962245,1306,5212,"sp|Q9VS29|DSCL_DROME","Q9VS29","DSCL",8.45e-19,"Down syndrome cell adhesion molecule-like protein Dscam2","axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]","GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632"
"g87119",182.69053305998,-0.824208713155398,0.220887708108671,-3.73134711846396,0.000190458578979008,0.0230073963406641,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109418",20.2249904600376,-1.0116504659532,0.271118578259991,-3.731394847398,0.000190422491822772,0.0230073963406641,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98919",31.912520228848,2.40924120947481,0.645951127477199,3.72975772777772,0.000191663971577428,0.0231043669939345,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g313",11042.6207031033,-0.446741633440164,0.119796813838245,-3.72916122830591,0.000192118203756337,0.0231105713449447,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145678",178.707909316193,-1.0060936582536,0.269918449595566,-3.72739862636691,0.000193466337305551,0.0232240553024948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116298",103.085448924214,1.04454230795987,0.280414905144997,3.72498853946353,0.000195324095599086,0.0233981139989051,0,3054,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.38e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g130772",12743.2402001332,0.813095234195912,0.218333450538281,3.72409831013663,0.000196014537335184,0.0234319044839434,0,1214,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",3.13e-12,"Collagen-like protein 4",NA,NA
"g71374",37.4327818274214,-0.669135185303147,0.179728408119459,-3.72303517459742,0.000196842085876963,0.0234666433742021,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78621",176.24361807021,0.430787329744319,0.115719828551307,3.72267514683812,0.000197123076095598,0.0234666433742021,2455,7480,"sp|Q2TBL4|RPC3_BOVIN","Q2TBL4","RPC3",9.16e-47,"DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]","GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0045089; GO:0051607"
"g4941",284.823553460493,-0.478087430438659,0.128464288083249,-3.72155902291572,0.000197996572466691,0.0235218288367262,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115718",49.0887837549803,1.30756720649896,0.351483121007072,3.72014224396469,0.000199110604875214,0.0236053027019417,406,4834,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",7.61e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g89184",297.577434996724,2.45755352343512,0.660777010263068,3.71918738888438,0.000199864739440998,0.0236458530909782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10917",896.792111060749,-0.451013783449359,0.121303891701641,-3.71804875443463,0.000200767528937189,0.0236551146004433,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38725",1814.6215590616,-0.404937496182019,0.108898114327604,-3.71849869653228,0.000200410326315576,0.0236551146004433,8941,25494,"sp|P21521|SY65_DROME","P21521","SY65",2.79e-28,"Synaptotagmin 1 (p65)","calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073"
"g31152",25.6485181781854,-1.03999469665164,0.279762377251613,-3.71742157351017,0.000201266436990327,0.023665303595297,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73030",71.6711956043081,1.49291418851782,0.401790323093177,3.7156549142962,0.000202678042402301,0.023782548206634,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24983",652.060011131454,0.507367992764653,0.136582847319848,3.71472701529283,0.000203423177340794,0.0237877284525736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43054",24.2606037898497,-0.808802448863044,0.217772420393547,-3.71398016057965,0.000204024795891706,0.0237877284525736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48146",625.769217682694,2.38602572021718,0.642460972778775,3.71388430007994,0.00020410213591846,0.0237877284525736,15250,18064,"sp|P55115|NAS15_CAEEL","P55115","NAS15",1.27e-13,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)",NA,"GO:0004222; GO:0005576; GO:0008270"
"g102578",232.077184803786,-0.712193008442879,0.191809271696715,-3.71302701972084,0.000204795013167853,0.0237877284525736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127988",263.567260871421,0.539311200553046,0.145230915597348,3.71347380366507,0.000204433635040529,0.0237877284525736,0,3790,"sp|Q90YV8|RL10A_ICTPU","Q90YV8","RL10A",1.36e-19,"60S ribosomal protein L10a","hemoglobin biosynthetic process [GO:0042541]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934; GO:0042541"
"g107688",54.3595225437397,2.00608341676215,0.540365759150881,3.71245472680294,0.000205258784985681,0.0237934324898553,0,5676,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.54e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113463",72.3373212581034,0.548781051482955,0.147913045251659,3.71015991557242,0.000207128369648374,0.0239617456661768,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6438",182.641079842756,-0.394320185258432,0.10631712731102,-3.70890556612658,0.000208157038154552,0.0239840378500165,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90591",175.050680389084,0.780467354594399,0.210427601580349,3.70895903737414,0.000208113089649929,0.0239840378500165,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30496",364.226581225297,-0.594719842586391,0.160460944340797,-3.70632146675696,0.000210291352659279,0.024181398428035,1865,5553,"sp|Q641Z2|PTN9_RAT","Q641Z2","PTN9",1.76e-12,"Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)","negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]","GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078"
"g63142",153.575424127584,1.39072339849723,0.375309607137748,3.7055363679694,0.000210943857943113,0.0242079171375516,1399,8094,"sp|Q9CPP7|LIPG_MOUSE","Q9CPP7","LIPG",3.19e-13,"Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]","GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0016042; GO:0016615; GO:0043231"
"g8169",86.6766276812254,0.444419464397037,0.120020245775208,3.7028708075587,0.000213173452829292,0.0244149555356184,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8401",33.472183877889,-0.793972802648679,0.21460115553099,-3.6997601466038,0.000215803327379241,0.0246669221613962,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15593",57.4092675164843,0.505559814361766,0.136704891764708,3.69818378724823,0.000217147644834887,0.0247088306602484,31524,44598,"sp|P55786|PSA_HUMAN","P55786","PSA",1.1e-16,"Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955"
"g17462",161.313634549267,0.619949337620524,0.167614038613566,3.69867191762986,0.000216730529691051,0.0247088306602484,482,13744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.67e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g57575",54.7571749731226,0.925369162366391,0.250315384764343,3.69681297550915,0.000218323059336806,0.0247088306602484,889,11704,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.42e-52,"PiggyBac transposable element-derived protein 4",NA,NA
"g116543",174.632595084717,1.22867538198935,0.332334602099334,3.69710338384236,0.00021807354857248,0.0247088306602484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131232",592.505203652659,2.99428692457783,0.80988728503176,3.69716500051042,0.000218020643684748,0.0247088306602484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122595",31.5937719093283,-1.01737410495629,0.275371148966973,-3.69455590672031,0.000220271426840635,0.024880264708889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75090",123.454144464932,1.66492671666735,0.450767156555315,3.69354042870035,0.00022115333089946,0.0249308018212397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28644",99.279137908655,-0.625243830242237,0.169385752516768,-3.69124215556643,0.000223161549396806,0.0250216856752948,6188,17364,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.96e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g114579",65.6001181131148,0.626709420807461,0.169788363119555,3.69112116574307,0.000223267742519186,0.0250216856752948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137406",509.686636371739,-0.206589591174144,0.0559624145503786,-3.69157751383596,0.000222867452256112,0.0250216856752948,0,3045,"sp|E9Q5F9|SETD2_MOUSE","E9Q5F9","SETD2",1.68e-11,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010452; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634"
"g105377",150.191675604,2.53955403418074,0.688116733094303,3.69058607652359,0.000223737960957437,0.0250255052626467,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63943",74.2917641386776,1.459926919114,0.395742744544955,3.68908069506794,0.000225065831064078,0.0251250532810443,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5498",58618.0963386741,0.298530523408999,0.0809431851369795,3.68814895168503,0.000225891407754854,0.0251592967499267,56627,94494,"sp|P13607|ATNA_DROME","P13607","ATNA",0,"Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)","adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]","GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0016887; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573"
"g55724",59.8782814541386,-0.481585139200863,0.130601575671688,-3.68743743499308,0.000226523764529164,0.0251592967499267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113371",1040.34766117164,0.391335733691585,0.106132054783338,3.68725296509592,0.000226687982218754,0.0251592967499267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27178",39.6330192605059,1.17370570132403,0.318417851055778,3.68605496655535,0.000227757179571021,0.0252291640227513,35810,37004,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.07e-11,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g25873",134.117162759434,-0.343746149973422,0.0932810536330138,-3.68505861142808,0.000228650016337526,0.0252760980554882,0,41218,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.02e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g53609",128.121318706606,0.459415677320501,0.124691500343886,3.68441855341768,0.000229225306039897,0.0252760980554882,3834,9714,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",5.08e-14,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g116942",24.6159770763343,-0.943147544404525,0.25600411938363,-3.684110813042,0.000229502389106123,0.0252760980554882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107204",49.8650403505482,1.72527058934031,0.468585895815215,3.68186623786189,0.000231532886122025,0.0254022122479575,175,3899,"sp|P21328|RTJK_DROME","P21328","RTJK",2.16e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g108963",439.13424793394,2.99343155761449,0.812995021514043,3.68198018241221,0.00023142940423428,0.0254022122479575,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77463",64.9966921456174,0.501520596032357,0.136251424510476,3.68084662479104,0.000232460810624923,0.0254068596450631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111757",41.3382002191489,1.5307358011485,0.415833347063073,3.68112805757331,0.000232204337547006,0.0254068596450631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18849",117.40516080262,0.313841666893033,0.0852919912452388,3.6796147247946,0.000233586587665297,0.0254813657799139,0,32014,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.76e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g19281",1137.97371548259,0.786151190544012,0.213732835374853,3.6781956743578,0.000234889733462992,0.0255749011501072,6098,10686,"sp|Q9CY50|SSRA_MOUSE","Q9CY50","SSRA",1.17e-26,"Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)",NA,"GO:0005783; GO:0005789; GO:0016021"
"g20451",2237.27617401019,-0.628672005094148,0.170994624523289,-3.67656004887174,0.00023640022730525,0.0256457334354432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65173",279.032358501365,1.0330851071453,0.280995112612992,3.67652340120285,0.000236434175450496,0.0256457334354432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64090",57.0985227983449,2.58278375569734,0.702606170404916,3.67600494343634,0.000236914933200656,0.0256493940887805,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125421",75.9582310401763,0.590117627249178,0.160581661223226,3.6748755913594,0.000237965340608652,0.025666261737076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128201",18.2776472608036,-1.44485048240562,0.393151705453081,-3.67504569448714,0.000237806849108541,0.025666261737076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30501",278.067029681352,-0.508047808278318,0.138291513830613,-3.67374536734482,0.00023902093255737,0.0256835601313519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142209",19.9514088958732,3.15321355951518,0.85825133485166,3.67399785059487,0.000238784741139245,0.0256835601313519,0,2667,"sp|P04746|AMYP_HUMAN","P04746","AMYP",5.01e-14,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]","GO:0004556; GO:0005509; GO:0005576; GO:0005615; GO:0005975; GO:0016052; GO:0031404; GO:0044245; GO:0070062"
"g34741",465.070128101695,-0.506212594594388,0.137855837428395,-3.67204323035884,0.000240618965850033,0.0258069462812615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g945",143.680651247022,0.27279335795521,0.0744115017146174,3.6660106525121,0.000246363667035128,0.0260043893967384,55990,61154,"sp|P21328|RTJK_DROME","P21328","RTJK",1.13e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g7372",18.6516052689125,1.54430924037087,0.421005168939082,3.66814793334361,0.000244313819521507,0.0260043893967384,67786,78254,"sp|P21328|RTJK_DROME","P21328","RTJK",6.07e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g18404",265.124423354155,0.391789010328967,0.106887121842412,3.66544634728399,0.000246907573157931,0.0260043893967384,48225,55293,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g27170",1316.85541644674,0.564797332315003,0.154011859572628,3.66723273053306,0.000245189616116961,0.0260043893967384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50117",1605.17517772398,-0.339570345851547,0.0926378095635443,-3.66556967885366,0.000246788603813017,0.0260043893967384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51206",122.148573993814,-0.477126400105748,0.13015632379418,-3.66579499325934,0.000246571397588948,0.0260043893967384,2470,6444,"sp|P21328|RTJK_DROME","P21328","RTJK",9.99e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g70521",53.2526132204729,-0.414469028958096,0.113077334881902,-3.66535901638438,0.000246991847703423,0.0260043893967384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137244",22.216349889552,2.64313607560763,0.720717099733033,3.66736973021273,0.000245058328119165,0.0260043893967384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144102",60.7355771353192,0.757546052865915,0.206486709799531,3.66874000559835,0.000243748804561282,0.0260043893967384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147631",117.733522969192,-0.977497184688079,0.266414156435803,-3.66908875175942,0.000243416569758629,0.0260043893967384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16166",154.127233928578,-0.534428727084897,0.145901391824383,-3.66294468066604,0.000249332399575154,0.0261153710327278,21556,46034,"sp|Q95YM8|MBLK1_APIME","Q95YM8","MBLK1",4.32e-16,"Mushroom body large-type Kenyon cell-specific protein 1","memory [GO:0007613]; positive regulation of transcription, DNA-templated [GO:0045893]","GO:0005634; GO:0007613; GO:0043565; GO:0045893"
"g19117",106.248624371139,-0.474077573915726,0.129421960936536,-3.66303810022008,0.000249241449416529,0.0261153710327278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41689",3069.03692882077,-0.334840196328734,0.0914148687609535,-3.66286361143644,0.000249411351096808,0.0261153710327278,3139,22741,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g42491",682.731627971249,0.326725892987498,0.0892136765295079,3.66228481660467,0.000249975708208856,0.0261267871348345,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4132",1853.77836907016,-0.372728257228965,0.1018164201881,-3.66078729285877,0.000251441440321897,0.0261678187113566,5397,14164,"sp|Q80T69|RSBN1_MOUSE","Q80T69","RSBN1",6.46e-19,"Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1) (Rosbin)","chromatin organization [GO:0006325]","GO:0005634; GO:0006325; GO:0035575; GO:0046872"
"g94956",96.0645746674201,1.23168953199942,0.336413838474527,3.66123325242663,0.000251004107630138,0.0261678187113566,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103418",172.687383309882,0.713340797035068,0.19487593209924,3.66048690236309,0.000251736422597923,0.0261678187113566,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4116",161.174759243605,-0.71497184288554,0.195373445572876,-3.65951391597303,0.000252694121099783,0.0262198710103175,0,14784,"sp|Q8MQJ9|BRAT_DROME","Q8MQJ9","BRAT",2.14e-109,"Brain tumor protein","asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]","GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0099738; GO:1900242; GO:1902692"
"g132705",63.7734812443371,-1.64171257703557,0.448731536986253,-3.65856295294409,0.000253633443201331,0.026269832077423,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83194",24.2133866238584,-0.592370491835454,0.161960239620993,-3.65750565213829,0.000254681645158589,0.0263308699084681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26714",2234.57890219111,-0.254877155143624,0.0696969765808274,-3.65693273434959,0.000255251328242503,0.0263423043427245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31381",41.4219605153429,2.29074087237765,0.626541793683649,3.65616610970134,0.00025601549397769,0.026373732575296,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31292",31.3148608543859,0.460723461572936,0.126061310137726,3.6547570469447,0.000257425635465778,0.0264714748441332,1801,26226,"sp|P21328|RTJK_DROME","P21328","RTJK",8.92e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g34301",131.405248802024,-0.466783187633343,0.127763773714436,-3.6534862274548,0.000258703671112112,0.0265553070633506,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134850",183.539538249007,0.533315404797272,0.14601475886195,3.65247601649294,0.00025972386030637,0.0266124198292491,0,3243,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.66e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g79538",1138.90332627161,0.924976818185249,0.253339855598327,3.65113028110274,0.000261088748287997,0.0267045853418276,85,5342,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",4.02e-22,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g53974",11997.4835513416,-0.47761621874483,0.130927900702326,-3.64793306990177,0.000264358478175215,0.0269909065439392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48064",69.2023440832385,0.870228504042448,0.238810704796143,3.64400961332661,0.000268423387123395,0.0273572539132156,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42134",351.736421574102,-0.641649226907322,0.176136693441343,-3.64290491873576,0.000269578436431632,0.0273583626493522,0,14130,"sp|Q66KB0|UBE2Z_XENTR","Q66KB0","UBE2Z",1.03e-30,"Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0043066; GO:0061631"
"g94365",26.0023425388843,0.814332239536875,0.223556007733959,3.64263187463057,0.000269864643770188,0.0273583626493522,0,4474,"sp|O96553|C1TC_DROME","O96553","C1TC",9.07e-23,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0008652; GO:0009086; GO:0035999"
"g132516",81.7621741095495,1.07774399507101,0.295867438740309,3.64265834611486,0.000269836883654141,0.0273583626493522,0,3426,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.23e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g111412",527.091253657181,2.26882073651638,0.623011550732604,3.64169931335696,0.000270844312145713,0.027409253317321,0,4944,"sp|Q95029|CATL_DROME","Q95029","CATL",2.01e-24,"Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"g27607",669.376950710011,-0.269805130309997,0.0741417063173679,-3.63904668116324,0.000273649196098648,0.0275957660318813,10892,38204,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.7e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73664",432.240237918177,0.316515548785795,0.0869757794657398,3.63912287685185,0.000273568248679621,0.0275957660318813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9411",262.398142998275,0.362345500993902,0.0996356420477151,3.63670563612543,0.000276147201750521,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15116",133.142337190954,1.04011463515951,0.286055793535412,3.63605512863263,0.00027684510872228,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23932",508.686930550558,0.764645689468419,0.210400114583013,3.63424559432324,0.000278795199729879,0.0276316622276332,28766,40034,"sp|A0A291PQH4|UGT2_DACCO","A0A291PQH4","UGT2",1.46e-13,"UDP-glucosyltransferase 2 (DcUGT2) (EC 2.4.1.-)","organic acid biosynthetic process [GO:0016053]","GO:0005783; GO:0005789; GO:0016021; GO:0016053; GO:0035251"
"g41474",43.0100226912092,0.761967977207696,0.209612616659038,3.6351245900772,0.000277846325247474,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68625",76.3892632632829,3.72623969657596,1.0248520045423,3.6358807711364,0.000277032451550238,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78298",146.31713230221,-1.26960575868061,0.349157129711464,-3.63620172880268,0.000276687682343661,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87001",21.9751497336247,0.990533053502872,0.272272844935179,3.63801632049899,0.000274746018887765,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97861",7102.08915425954,0.471827017301275,0.129794836932734,3.63517554666522,0.00027779141060785,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111224",253.826202583279,0.562545749259734,0.154791245350558,3.63422199999574,0.000278820711568484,0.0276316622276332,0,5322,"sp|Q5ZIK9|COPE_CHICK","Q5ZIK9","COPE",6.62e-26,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g112759",36.5087913043379,0.619514831212256,0.170437425000407,3.63485209431423,0.000278140159812634,0.0276316622276332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15756",44.5486177468195,-0.446503337673574,0.122940664881926,-3.63186044342938,0.000281385288344376,0.0277655236015388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17345",579.7831640884,0.770730578472638,0.212252337074154,3.63119949159086,0.000282107010451327,0.0277655236015388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32412",42.858139680934,1.89731903147713,0.52247493470326,3.63140680146639,0.000281880453277911,0.0277655236015388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119460",87.7341411348454,1.5837428202435,0.436006056323917,3.6323872048853,0.000280811333840836,0.0277655236015388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17573",35.5246386279031,2.19503488787606,0.604931819268848,3.62856576221944,0.000285000156061527,0.027811744477002,0,7989,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.48e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g21027",34.5666407039132,-0.637213823184149,0.175695161669774,-3.62681486005755,0.000286938876444496,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35164",1366.38272397907,-0.388859425898216,0.107215134013472,-3.62690798716304,0.000286835449312772,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35214",200.757774601278,0.400433303284987,0.110314937074727,3.62991009108525,0.000283519958179784,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50521",111.893394869056,2.43999161148833,0.67260820063131,3.62765664944042,0.000286005251761763,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69921",125.157415446705,0.989340797987266,0.272712600759643,3.62777809030991,0.000285870797409996,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90287",35.5658335701637,1.36318216748213,0.37573466994275,3.6280446722945,0.00028557585642135,0.027811744477002,0,7655,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.74e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g108699",143.434102324222,0.430056456313651,0.118494486093703,3.62933728387641,0.000284149775139638,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118271",57.8173133157819,0.723592612727844,0.199497930074184,3.62706827313333,0.00028665751721125,0.027811744477002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7179",14542.4994448113,0.309126730271985,0.0852706068144215,3.62524370144043,0.000288689083893664,0.0278257852036107,1455,18689,"sp|P82013|VDAC2_MELGA","P82013","VDAC2",7.11e-36,"Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2)",NA,"GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930"
"g35215",49.1694469775027,0.46355871883107,0.127924058202423,3.62370241645671,0.000290415727001945,0.0278257852036107,6805,12034,"sp|A4FUY7|MOC2B_BOVIN","A4FUY7","MOC2B",2.2e-22,"Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"g40226",54.8867044565118,1.35535564205485,0.373899382496778,3.62492078217468,0.000289050039757456,0.0278257852036107,0,4642,"sp|P35502|ESTF_MYZPE","P35502","ESTF",1.98e-17,"Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase)",NA,"GO:0080030"
"g57552",158.237107273974,0.843814215129482,0.232876758768068,3.62343678945598,0.000290714274397723,0.0278257852036107,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95442",272.102061135321,0.30769821360811,0.0849155927159813,3.62357729324547,0.000290556321518338,0.0278257852036107,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100360",27.8235031513894,1.62476984013684,0.4482923009951,3.62435365615301,0.00028968499095597,0.0278257852036107,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104222",186.124454371853,-0.570820441762427,0.157481716541432,-3.62467754542318,0.000289322206450974,0.0278257852036107,1949,4644,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g131151",19.2456979147595,0.718276027696914,0.198252956420307,3.62302807819991,0.000291174200719834,0.0278257852036107,0,3461,"sp|P21328|RTJK_DROME","P21328","RTJK",2.15e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g146747",142.680057747661,0.351125887189743,0.0969215390520821,3.62278488996198,0.000291448185907459,0.0278257852036107,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56002",105.982803036637,0.430944686673539,0.118985053072083,3.62183884065226,0.000292516340165784,0.0278813747486922,0,3514,"sp|Q9GZR7|DDX24_HUMAN","Q9GZR7","DDX24",3.25e-16,"ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)","RNA metabolic process [GO:0016070]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887"
"g7284",666.606293525594,0.468718087348169,0.129475505494713,3.62012942569517,0.000294455691466791,0.0279259875387807,0,10835,"sp|Q66X93|SND1_RAT","Q66X93","SND1",7.37e-18,"Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (SND p102) (p100 co-activator) (p105 coactivator)","gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; regulation of cell cycle process [GO:0010564]","GO:0003713; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172"
"g54121",68.108556012114,0.564475290376329,0.155920222332987,3.62028274415119,0.000294281259453045,0.0279259875387807,2470,13014,"sp|Q7ZUC7|PGES2_DANRE","Q7ZUC7","PGES2",8.6e-15,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2)","prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004362; GO:0005739; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220; GO:0097573"
"g98731",1685.79773514844,0.71028883393101,0.196237286202493,3.61954064732673,0.000295126451256081,0.0279259875387807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125773",24.7184473654935,0.764469615027992,0.211123980374242,3.6209511286822,0.000293521961466307,0.0279259875387807,0,3973,"sp|O88342|WDR1_MOUSE","O88342","WDR1",1.4e-22,"WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1)","actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]","GO:0002102; GO:0002446; GO:0003779; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0015629; GO:0030036; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043209; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:1990266"
"g153583",45.0227460543407,0.518752389988757,0.143330063702948,3.6192852817248,0.000295417818683162,0.0279259875387807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15806",508.353892568879,-0.312255413883689,0.0863225183432351,-3.61731121701178,0.0002976792987646,0.0280934838209091,0,24344,"sp|O75182|SIN3B_HUMAN","O75182","SIN3B",3.57e-12,"Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)","histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0030336; GO:0030849"
"g67045",505.836145682576,0.688425915473965,0.190381967973815,3.61602478848549,0.000299161740919861,0.0281439931854698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79157",27.276643577558,-1.40401819292567,0.388279840824948,-3.61599559210353,0.000299195466070697,0.0281439931854698,0,2414,"sp|A2SXS5|MEN1_CANLF","A2SXS5","MEN1",3.63e-22,"Menin","chromatin organization [GO:0006325]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000403; GO:0000785; GO:0000976; GO:0003682; GO:0006325; GO:0006357; GO:0008285; GO:0035097; GO:0045786"
"g35255",226.145271020414,-0.536168744070041,0.148323362847715,-3.61486372595617,0.000300505648634812,0.0281924576498625,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82311",285.460551844411,0.5133170725288,0.142008132061457,3.61470195457996,0.000300693344052211,0.0281924576498625,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g14787",931.191418134567,-0.694608028636453,0.192354734631979,-3.61107840659814,0.000304926451917385,0.02850872255994,9645,22910,"sp|Q28298|RRBP1_CANLF","Q28298","RRBP1",1.68e-19,"Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp)","protein transport [GO:0015031]; signal transduction [GO:0007165]","GO:0007165; GO:0015031; GO:0030176"
"g27721",1140.02624794524,0.468993249657692,0.129880320886056,3.61096466699632,0.000305060223977051,0.02850872255994,35909,38234,"sp|Q9TZH6|PHS_CAEEL","Q9TZH6","PHS",7.37e-21,"Putative pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Pterin carbinolamine dehydratase) (PCD)","tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0006729; GO:0008124"
"g31396",975.249516369531,0.366375293698221,0.101489829999193,3.60997051331284,0.000306231815193705,0.0285716773265281,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45248",183.489573488806,0.489571469296741,0.135649073426852,3.6091029369304,0.000307257678898366,0.0285744661510344,10798,12764,"sp|P51688|SPHM_HUMAN","P51688","SPHM",0,"N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)","glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]","GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062"
"g113123",35.6174058364026,0.848516124797597,0.235081598823313,3.60945360693816,0.000306842643091453,0.0285744661510344,0,2414,"sp|Q640T1|ALLC_XENTR","Q640T1","ALLC",4.1e-16,"Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)","allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]","GO:0000256; GO:0004037; GO:0006144"
"g26579",107.195402135166,0.340238538618318,0.0942905407348849,3.60840584820657,0.000308084280412119,0.0286049773625363,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126020",31.822052805273,0.726608619388497,0.201393896178841,3.60789792131167,0.000308687886355461,0.0286147187707211,0,3953,"sp|Q9YH58|FTCD_CHICK","Q9YH58","FTCD",3.25e-15,"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (p60) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]","histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005794; GO:0005814; GO:0005829; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0035999"
"g9805",19.8412045292816,-2.50477689960424,0.694634092625071,-3.60589398965218,0.000311080120695618,0.0286513279703283,7465,8508,"sp|P20825|POL2_DROME","P20825","POL2",1.44e-28,"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g95735",125.291278063474,-0.550003237956938,0.152513135232697,-3.60626799205046,0.000310632334377599,0.0286513279703283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99169",70.1065731578529,-0.483733039245587,0.13412275394917,-3.60664410029124,0.000310182635423946,0.0286513279703283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142349",401.030400132346,0.680950649344873,0.188799061879383,3.60674805566517,0.000310058447325084,0.0286513279703283,0,2544,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",5e-15,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g11337",130.811094301599,-0.48641285466068,0.134919043337042,-3.60522015743596,0.000311888413513005,0.0286634425873428,15568,18984,"sp|Q9VSH9|PHAF1_DROME","Q9VSH9","PHAF1",4.24e-13,"PHAF1 protein CG7083","Golgi to plasma membrane protein transport [GO:0043001]","GO:0000407; GO:0005802; GO:0043001"
"g53816",1248.65252249314,-0.370639140369053,0.102813892957157,-3.60495191562777,0.000312210728774647,0.0286634425873428,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3418",65.1211148072299,1.18725836203717,0.329544060415231,3.60273027085121,0.000314892235616382,0.0286946963393151,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49826",86.5690880374494,0.37216755759415,0.103287716143005,3.6032121871963,0.000314308741863849,0.0286946963393151,7108,17442,"sp|P21328|RTJK_DROME","P21328","RTJK",1.36e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g52791",39.05141219141,-0.636144320829927,0.176579283930748,-3.60259882512274,0.00031505156315386,0.0286946963393151,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100573",162.139257322333,0.876438997565649,0.243235371112497,3.60325471397124,0.000314257300008191,0.0286946963393151,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124101",93.1096534503929,1.15763980657306,0.321298363531326,3.60300561088975,0.000314558735870928,0.0286946963393151,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28546",39.5073295176006,0.501520205763677,0.139282127882993,3.60075060157748,0.000317299831265992,0.0287275242394638,0,13604,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.17e-14,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g104668",22.8885805870928,2.22438378048254,0.617644864505481,3.60139605833766,0.000316512965403986,0.0287275242394638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111336",545.788948364118,0.6867397870727,0.190747974485624,3.60024681218545,0.000317915264762277,0.0287275242394638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126094",123.287372652466,0.806382889023333,0.223960706163579,3.60055521719225,0.000317538382017686,0.0287275242394638,0,2861,"sp|Q2KJI2|STT3A_BOVIN","Q2KJI2","STT3A",1.15e-54,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"g159718",1939.42887826101,0.537431315832434,0.149271085263801,3.60037119635495,0.000317763212181328,0.0287275242394638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109848",69.6305065162415,1.26783705465316,0.352211954772116,3.59964231047597,0.000318655204083197,0.0287491125948016,3209,5014,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",3.12e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g20915",335.75220040659,-0.429423952283261,0.11934447009785,-3.59818893938847,0.000320440803000002,0.0288513669762014,0,49280,"sp|Q8K4P8|HECW1_MOUSE","Q8K4P8","HECW1",4.93e-66,"E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (mNEDL1)","negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]","GO:0000209; GO:0005737; GO:0005829; GO:0016567; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:2000650"
"g82025",63.6357284712791,0.480651066152355,0.13359203279489,3.59790218096555,0.000320794216291678,0.0288513669762014,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5019",1123.17690313028,0.320939324926775,0.089227946870036,3.59684758178103,0.000322097089825822,0.0289232097248915,4411,11874,"sp|G4WAW9|SELM_ERISI","G4WAW9","SELM",9.44e-11,"Selenoprotein M",NA,"GO:0005783"
"g73581",442.5429171479,0.567543763011808,0.157859737967566,3.59524075181487,0.00032409172598641,0.029056848807969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28958",92.1771104143116,-0.400924577989284,0.111538832795186,-3.59448425218405,0.000325034803097813,0.0290959391603003,28715,33252,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.12e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1849",321.202745233832,-0.382325901197602,0.106388864803649,-3.59366463683225,0.000326059460762996,0.0291104029279642,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35076",654.477897865141,0.560374316531553,0.155939200662044,3.59354360002148,0.000326211033159306,0.0291104029279642,0,22254,"sp|P80147|GABT_PIG","P80147","GABT",1.12e-23,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)","behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537"
"g142014",874.495888785097,0.557898305089479,0.155310427042075,3.59214970761968,0.000327961340637219,0.0292211517480801,0,2684,"sp|P35979|RL12_MOUSE","P35979","RL12",1.78e-13,"60S ribosomal protein L12","cytoplasmic translation [GO:0002181]; translation [GO:0006412]","GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0014069; GO:0015934; GO:0022625; GO:0022626; GO:0070180"
"g17568",626.842476158078,-0.444061015626195,0.12365653768752,-3.5910840132718,0.000329305454838773,0.0292500727533263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63233",71.3389344093983,1.2412830819016,0.34563985148249,3.59126147224515,0.000329081276351236,0.0292500727533263,0,12502,"sp|Q4V8V2|NUD17_DANRE","Q4V8V2","NUD17",1.11e-13,"Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)","NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]","GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872"
"g147236",52.6792987083272,1.31646571843626,0.36664312670217,3.59059156591158,0.000329928297292184,0.0292601015434707,0,1489,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.38e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1798",121.125847349834,-0.597107659183264,0.166457773790496,-3.58714192546383,0.000334322374588921,0.0293726495536753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9806",33.7543524194147,-2.48494215644099,0.692618261912617,-3.58775142540856,0.000333542045184614,0.0293726495536753,8585,10271,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",6.37e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g17816",78.9866611399077,0.555777518649229,0.154866209541298,3.58875909919536,0.000332255679416954,0.0293726495536753,43296,47674,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.45e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g20349",308.595010780219,-0.448135442618054,0.124954603757712,-3.58638600852987,0.000335292531503265,0.0293726495536753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35163",3246.29068152514,-0.300051025783345,0.0836222237808028,-3.58817324171936,0.000333003001239911,0.0293726495536753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64959",177.1275923247,0.554285153644551,0.154549374870247,3.58646001712984,0.000335197431384564,0.0293726495536753,0,11564,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.5e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g80998",39.3214661598563,0.691433776800826,0.192735821922948,3.58746895051635,0.000333903479456628,0.0293726495536753,0,8000,"sp|Q55F21|AATM_DICDI","Q55F21","AATM",2.53e-13,"Aspartate aminotransferase, mitochondrial (EC 2.6.1.1) (EC 2.6.1.7) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]","GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0016212; GO:0030170"
"g158120",701.530244896461,3.1934705470201,0.890432847589347,3.58642491195796,0.000335242537941287,0.0293726495536753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138000",18.3720151923198,1.39078738666731,0.387870328815522,3.58570193011282,0.000336172759568115,0.029404867292711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51107",100.182680333252,-0.419421004033529,0.11700401719397,-3.58467182659386,0.000337502310546643,0.0294314324911343,10556,13894,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g94751",403.536939561853,-0.493699158029649,0.137723650367303,-3.58470863002089,0.000337454723867259,0.0294314324911343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55020",663.797472730433,0.914355881100691,0.255103502016967,3.58425452363989,0.000338042320921329,0.0294337911600393,6045,13768,"sp|P29413|CALR_DROME","P29413","CALR",7.44e-26,"Calreticulin","olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005509; GO:0005615; GO:0005788; GO:0005789; GO:0006457; GO:0012505; GO:0030246; GO:0030431; GO:0030433; GO:0042048; GO:0045169; GO:0051082"
"g24123",41.8435470377631,-0.420480874115977,0.117337524376373,-3.58351581346849,0.000339000230510275,0.0294724745858781,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83162",173.420844241293,0.528092240799299,0.147431503813469,3.58194976744891,0.000341039378351611,0.0296049009528221,0,4510,"sp|Q18515|C1GLT_CAEEL","Q18515","C1GLT",6.95e-19,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)","O-glycan processing, core 1 [GO:0016267]","GO:0016021; GO:0016263; GO:0016267; GO:0046872"
"g60890",434.755226687141,-0.341251680726614,0.0953301566625015,-3.57968236572559,0.000344012103730672,0.0298178466949637,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11411",42.2188775372086,1.66675744980243,0.465730737432889,3.57880061554368,0.000345174673625504,0.0298734883448438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85683",153.46716124322,-0.604678853197844,0.168980063174792,-3.57840352191352,0.000345699432944706,0.0298738455758542,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86709",50.1761709422813,0.623951627470497,0.174390069773829,3.57790800978355,0.000346355298970081,0.0298779443523128,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88006",216.197274951045,0.934227336008436,0.261162415255785,3.57718906487155,0.000347308973213535,0.0298779443523128,1809,7804,"sp|P30039|PBLD_HUMAN","P30039","PBLD",7.36e-15,"Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue)","biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0060392; GO:0070062"
"g114888",109.528199173628,-0.809102415588526,0.226176437689079,-3.57730638900939,0.000347153176226227,0.0298779443523128,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101950",32.4870775699752,0.742323815163875,0.207553129738966,3.57654840520823,0.000348160871828852,0.0299063934514064,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68362",28.6790815115913,0.660680428796183,0.18477486539711,3.57559686149021,0.000349429767516218,0.0299705232587154,3126,8804,"sp|Q5PRA2|DHTK1_DANRE","Q5PRA2","DHTK1",9.92e-17,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g6683",4165.87092288784,-0.58615215586392,0.164069170501532,-3.57259169454049,0.000353465656221229,0.0300026544714455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16506",475.571803654137,-0.357270699516675,0.100010555614311,-3.57232991379914,0.000353819279849138,0.0300026544714455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17414",366.268858071176,0.65951115441313,0.184604962018758,3.57255377754211,0.000353516855501129,0.0300026544714455,36066,42324,"sp|P28765|SODM_PALVU","P28765","SODM",1.42e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g26429",103.753618847416,0.328528211464197,0.0919540526777881,3.57274314613819,0.000353261220464893,0.0300026544714455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45313",65.8488223316663,0.716062704085435,0.200398869345485,3.57318734593733,0.000352662258464521,0.0300026544714455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61199",335.979268048923,0.506587449028025,0.141737174294032,3.57413255591729,0.000351390890488874,0.0300026544714455,0,13063,"sp|Q4R963|TCPG_MACFA","Q4R963","TCPG",2.93e-34,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g146288",6948.67425167523,0.996867471367949,0.278858535142305,3.574814272259,0.000350476600577873,0.0300026544714455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148584",72.5886158459539,2.62352313103425,0.734426700730928,3.57220554266781,0.000353987401135738,0.0300026544714455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15081",431.244956466261,-0.636653843631616,0.17828257674461,-3.57103792898182,0.000355569394640551,0.0300922888856561,15285,44351,"sp|Q9P281|BAHC1_HUMAN","Q9P281","BAHC1",4.43e-18,"BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)",NA,"GO:0003682"
"g3911",2030.99685016555,0.259794328165379,0.0728002919129506,3.56858909956052,0.000358908799884522,0.03012741802969,58846,71244,"sp|A6QL88|SAC1_BOVIN","A6QL88","SAC1",0,"Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)","phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0016791; GO:0043812; GO:0046856; GO:0140268"
"g45495",116.498224381618,0.301656060535224,0.08453481077803,3.56842415282986,0.000359134784459881,0.03012741802969,14692,19594,"sp|P30044|PRDX5_HUMAN","P30044","PRDX5",9.67e-11,"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)","cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]","GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057"
"g48123",202.913160628885,0.26894058510449,0.0753503878139154,3.56919974677055,0.000358073342114996,0.03012741802969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59417",1780.8701310818,0.418710704280526,0.117307727456591,3.56933608176383,0.000357887063728478,0.03012741802969,0,9649,"sp|O16797|RL3_DROME","O16797","RL3",6.9e-26,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g89536",38901.5887476034,0.682593094951878,0.191273766312657,3.56867074931807,0.000358796985187426,0.03012741802969,3932,7064,"sp|H6VGI3|KARG0_SCYPA","H6VGI3","KARG0",0,"Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)","phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]","GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314"
"g102625",40.919334930267,2.10238949348566,0.589133311893306,3.56861418467271,0.000358874443783477,0.03012741802969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93508",369.407807136357,0.770703707546005,0.216013861414044,3.56784376012222,0.000359931007288305,0.0301501331360627,0,3733,"sp|P54985|PPIA_BLAGE","P54985","PPIA",1.09e-17,"Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)","protein folding [GO:0006457]","GO:0003755; GO:0005737; GO:0006457"
"g65388",330.464181006238,0.490982158289637,0.137668058664434,3.56642029424127,0.000361890810616699,0.0302260476174472,4326,11975,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.22e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g144250",107.734515510297,-0.665418342363959,0.186571676223627,-3.56655605948666,0.000361703461795202,0.0302260476174472,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34419",202.555016643544,0.372863383319149,0.104572947409154,3.56558165909084,0.000363050095409896,0.0302348540995933,0,28565,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.62e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g36598",22.059842569642,0.60832969994071,0.170603689477128,3.56574762131547,0.000362820402790757,0.0302348540995933,23361,24474,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.45e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g51992",13263.3288359367,0.456713836166934,0.128112358516953,3.5649475308543,0.00036392898519777,0.0302641234357218,11136,16394,"sp|A2I3Z2|RSSA_MACHI","A2I3Z2","RSSA",4.49e-24,"40S ribosomal protein SA","ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003735; GO:0006412; GO:0022627"
"g48218",177.627101813534,-0.516347458572932,0.144856274440344,-3.56455017615118,0.000364480724772262,0.0302661418052567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36879",112.607335882226,-0.690489252529509,0.193761610047965,-3.56360195581871,0.00036580052037366,0.0303318408367639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18256",131.330442886834,-0.625114854685707,0.175509767526534,-3.56170977544712,0.000368447547211299,0.0304194536100494,44555,55668,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.9e-43,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g86473",117.453081909293,2.58417987173878,0.725526373703301,3.56180004670038,0.000368320858375301,0.0304194536100494,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119056",23.7217358361771,0.938882884293685,0.263559922885471,3.56231279025558,0.00036760203410603,0.0304194536100494,0,4575,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.3e-17,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g9079",189.783707833337,-0.50320762238134,0.141449414829477,-3.55750939647207,0.000374387713080315,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13368",166.22167928423,-0.455409124714225,0.128095663634205,-3.55522670942796,0.000377653310974852,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29311",117.234290959911,0.497776408859167,0.139857997674803,3.55915583759888,0.000372048731055911,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33793",186.782285555277,-0.338276756423453,0.0950000052257504,-3.56080776647959,0.000369715687500881,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38276",107.993843021216,-0.443767378595583,0.124663374542059,-3.55972538226026,0.000371242804547147,0.0304778438589831,14560,18224,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g43008",1787.77396030297,0.334621693490801,0.0940441168991014,3.55813531483114,0.00037349690045772,0.0304778438589831,17605,19730,"sp|Q17237|SGF3_BOMMO","Q17237","SGF3",3.77e-108,"Silk gland factor 3 (SGF-3) (POU domain protein M1)","cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0000981; GO:0003677; GO:0005634; GO:0007399; GO:0030154"
"g48892",216.044028663643,0.323157427930394,0.090804734068003,3.5588169630934,0.000372529026648258,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55699",215.161090280432,0.541466439501664,0.15225934702068,3.55621149109567,0.000376241236450023,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64613",4638.32484353294,0.555118708497624,0.15607741156324,3.55668833137137,0.000375559271929238,0.0304778438589831,8105,12153,"sp|Q26365|ADT_DROME","Q26365","ADT",1.7e-16,"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)","action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]","GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171"
"g65099",8742.20665172194,1.16652493929368,0.32811548095274,3.55522676317031,0.000377653233778929,0.0304778438589831,0,5129,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",1.38e-117,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g67159",152.6625531815,0.672972599694783,0.189127555438881,3.55830010139512,0.000373262704452177,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75451",158.797903213747,0.515417911485698,0.144945110092607,3.55595239574755,0.000376612273045616,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79416",51.70131340963,0.823496049772385,0.231370148347214,3.55921477189259,0.000371965261074032,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109289",59.9257963363509,-0.757770575969051,0.212870473472441,-3.55977305639411,0.000371175417982618,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114308",135.709668537051,1.5445757820862,0.434328479736345,3.55623877813358,0.000376202180036151,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121505",176.110914638323,-0.360022642725303,0.101251885007042,-3.55571298944472,0.000376955418013804,0.0304778438589831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60596",157.571141389723,0.661113328794819,0.186008309171293,3.55421395818403,0.00037911065661913,0.0305096346098257,0,4147,"sp|P50143|TCPG_XENLA","P50143","TCPG",2.18e-13,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g136814",33.2219218430199,0.758261140395004,0.213335840762803,3.55430731978166,0.000378976089959612,0.0305096346098257,0,3086,"sp|P04069|CBPB_ASTAS","P04069","CBPB",1.83e-25,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g5683",69.4822310697889,-0.705941664382735,0.198666983578913,-3.55339197115422,0.000380297356013126,0.0305195276755709,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155444",292.640965816377,0.454047713037131,0.127765909756521,3.553746957247,0.000379784438708624,0.0305195276755709,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98071",230.457534296095,0.466616426039515,0.131363433682013,3.552102841412,0.000382165461926392,0.0306266120186262,2707,6718,"sp|Q9YHT1|SDHA_CHICK","Q9YHT1","SDHA",4.81e-32,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0050660"
"g26983",46.2143378126474,0.591680656168004,0.166657619938418,3.55027664733625,0.000384826523951462,0.0307968562682495,32730,36234,"sp|P51659|DHB4_HUMAN","P51659","DHB4",4.89e-15,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386"
"g101830",31.2154057562029,-0.893357914611609,0.251668350583476,-3.54974279658295,0.000385607696347305,0.03081639222341,0,6287,"sp|Q9M2U3|ALPL_ARATH","Q9M2U3","ALPL",7.14e-25,"Protein ALP1-like (EC 3.1.-.-)",NA,"GO:0000118; GO:0004518; GO:0046872"
"g4131",1290.27598266839,-0.367850430825603,0.10367729949395,-3.54803252612755,0.000388120288730268,0.0309114659197836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13983",742.665569794361,-0.508442571245428,0.14333656976145,-3.5471936581963,0.000389358271112323,0.0309114659197836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51338",401.857568594494,-0.624811339101728,0.176146894662702,-3.54710391175592,0.000389490935169111,0.0309114659197836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87745",257.305783579159,1.2532833137766,0.353214680743167,3.54821977144234,0.000387844458943626,0.0309114659197836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95498",80.4001638133219,0.791671437907364,0.223155401022551,3.54762391714356,0.000388722844443517,0.0309114659197836,0,5243,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.13e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g87009",88.667784620802,0.732013149740663,0.206434113169523,3.54598926747895,0.000391142137139224,0.0309568770055844,0,2227,"sp|P61166|TM258_MOUSE","P61166","TM258",4.59e-19,"Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258)","protein N-linked glycosylation [GO:0006487]","GO:0005737; GO:0005783; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0032991; GO:0034998; GO:0043227"
"g126175",58.1747198597738,2.08027323809565,0.586601717889144,3.54631289792571,0.000390662047663356,0.0309568770055844,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26658",641.806063919681,0.929611749028334,0.262281877682481,3.54432321913496,0.000393622372429635,0.0310324518910588,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31954",35.8415264574826,2.06983757202753,0.583997403698766,3.5442581746394,0.000393719501162266,0.0310324518910588,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33792",280.150504698221,-0.341879564833466,0.0964476108867185,-3.54471781820513,0.000393033610807835,0.0310324518910588,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37542",52.8808317521975,0.751453544830148,0.212298683436987,3.53960529883921,0.000400725870263511,0.0315413586223872,17028,26464,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.89e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g10048",95.1206396253966,-0.617448510633926,0.174477065595173,-3.53885198910067,0.000401871111962247,0.0315881704169777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61710",32.3126457520799,-1.48135626573333,0.418720439195845,-3.53781694673965,0.000403449653576004,0.0316688661042286,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107245",372.45722426902,0.834793072892912,0.236045154774441,3.53658211578466,0.000405340469568394,0.0317738198686263,201,5723,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.03e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g9921",269.634491322875,1.08306159262641,0.306317661271626,3.53574648007646,0.00040662471684979,0.0318310044377094,89,22211,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.06e-54,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5684",1676.15483359367,-0.356812776106437,0.100937111258138,-3.53500086993692,0.000407773815974066,0.0318774680662015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22202",29.8366204750337,0.506060342094475,0.143233390318443,3.53311711025885,0.000410690504076275,0.0319908381355925,4785,6984,"sp|O16129|SYFM_DROME","O16129","SYFM",4.92e-11,"Probable phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)","phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]","GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033"
"g90460",125.354668364165,1.29351511659226,0.366055225669247,3.5336611141867,0.000409846209695722,0.0319908381355925,1128,7574,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.4e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g91849",227.870349917865,2.11431992987692,0.59845152167974,3.53298446621445,0.000410896613906094,0.0319908381355925,0,1650,"sp|P80067|CATC_RAT","P80067","CATC",3.7e-11,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g8055",146.251767201688,0.393925042934109,0.111529164625867,3.53203616520897,0.000412372954538522,0.0320622766008406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83627",70.1159777930722,2.7397822796292,0.77580058914285,3.53155478092157,0.000413124281023369,0.0320772276659282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75936",21.4058694608498,-0.743122272987689,0.210506734800117,-3.53015913573173,0.000415309784523702,0.0321165437142453,0,6411,"sp|P21328|RTJK_DROME","P21328","RTJK",9.63e-41,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g95860",113.627075299679,0.419157197994675,0.118735979782424,3.53016161371435,0.000415305894588268,0.0321165437142453,0,6976,"sp|Q7ZVF3|SDHA_DANRE","Q7ZVF3","SDHA",1.57e-18,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0050660"
"g104480",48.95286170235,2.66762841194248,0.755665519916438,3.53017087803274,0.000415291351768951,0.0321165437142453,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69696",180.381855186689,0.505995881944439,0.143419413977332,3.52808499150899,0.000418577736087398,0.0323256938044346,0,10980,"sp|O62742|SCP2_RABIT","O62742","SCP2",2.52e-23,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"g8262",164.578395129268,0.815844300150609,0.231310008000921,3.52706010086411,0.000420201369218719,0.0323771134674507,2466,10744,"sp|P45971|OST48_CAEEL","P45971","OST48",7.64e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (Oligosaccharyl transferase 48 kDa subunit) (Oligosaccharyl transferase beta subunit 1)","protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0006487; GO:0008250; GO:0016021; GO:0018279"
"g97119",38.5722150694986,-0.461860863923471,0.130951821944702,-3.52695256213009,0.000420372072730059,0.0323771134674507,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36533",81.4037857084742,-0.725703339199845,0.205799644579141,-3.52626138244263,0.000421470775667432,0.0323967495571565,4109,17324,"sp|A6NP11|ZN716_HUMAN","A6NP11","ZN716",4.85e-45,"Zinc finger protein 716","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g79766",187.785282197985,-0.551307964011223,0.156351426371261,-3.52608208832152,0.0004217562202718,0.0323967495571565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9883",18.9915744286899,0.971348880079113,0.275628562229539,3.52412272596841,0.000424887404729505,0.0325936354055869,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83623",85.4664933321847,2.64885972375333,0.751984537238744,3.52249227554577,0.000427509499758655,0.0327424659777917,2180,8566,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.08e-12,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g140532",812.324430704497,-0.715529613376222,0.20314804981359,-3.52220764133741,0.000427968795457369,0.0327424659777917,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35295",140.414091975196,0.399618634103995,0.113475820384517,3.52161925553721,0.000428919696287218,0.0327694144012008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136687",29.6980239557624,0.531700404508701,0.15099619398344,3.52128348723157,0.000429463221152021,0.0327694144012008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2464",236.274605354984,0.909974888394125,0.258622762804187,3.51854136320979,0.000433926164825038,0.032888166812739,48821,69124,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.22e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g8314",108.550922022823,-0.684071609223615,0.194461349758436,-3.51777672053282,0.000435178357354472,0.032888166812739,0,65240,"sp|G5ECJ6|CSK1_CAEEL","G5ECJ6","CSK1",2.07e-16,"Tyrosine-protein kinase csk-1 (EC 2.7.10.2) (C-terminal src kinase)","embryo development ending in birth or egg hatching [GO:0009792]; larval feeding behavior [GO:0030536]; muscle cell development [GO:0055001]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]","GO:0002119; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0005911; GO:0009792; GO:0030536; GO:0043050; GO:0046872; GO:0055001"
"g25614",309.065058477506,-0.991265788300871,0.281864270711061,-3.51681958766961,0.000436750529419007,0.032888166812739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32447",1984.95485892614,0.977329489312427,0.277763215464984,3.51857062021819,0.000433878319905288,0.032888166812739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74970",87.1903212483091,0.441729236921584,0.125498356209563,3.51980097798226,0.000431870729313871,0.032888166812739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84127",21.1136798688395,1.71352832982065,0.487114257900197,3.51771335375637,0.000435282279139408,0.032888166812739,0,6481,"sp|O97396|AMY_PHACE","O97396","AMY",1.28e-17,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]; digestion [GO:0007586]","GO:0004556; GO:0005576; GO:0005975; GO:0007586; GO:0046872"
"g86924",208.136372253561,1.47518331287277,0.41946521388069,3.51681918799675,0.000436751187021735,0.032888166812739,0,3784,"sp|P04040|CATA_HUMAN","P04040","CATA",1.91e-27,"Catalase (EC 1.11.1.6)","aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]","GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009410; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034774; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0061692; GO:0062151; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813"
"g87840",51.5519683462862,0.865062750778395,0.245899661416609,3.51795015005241,0.000434894050634399,0.032888166812739,0,1974,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",1.1e-16,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g102393",426.470064349256,0.309122839002822,0.0878938242156508,3.51700294942655,0.000436448932167757,0.032888166812739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106122",43.1238626970206,-0.76884334241583,0.218447555947003,-3.51957859671525,0.000432232948377864,0.032888166812739,0,5393,"sp|Q62101|KPCD1_MOUSE","Q62101","KPCD1",7.82e-29,"Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0007399; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0030154; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:0106310; GO:1901727; GO:2001028"
"g51514",74.3100398256024,1.46651387510757,0.417053709081407,3.51636694069376,0.000437495885786358,0.032901066744982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17239",3495.06598410263,-0.236161600040219,0.0671690643627724,-3.51592808803675,0.000438219661147553,0.0329123614615793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143740",121.523774239292,0.858458211117458,0.244210272701715,3.5152420150892,0.000439353403188557,0.0329543768300123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35569",30.444729302081,1.16744397654726,0.332265855641432,3.51358394708821,0.000442104690720426,0.0330772708021789,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143303",54.4876930648369,1.32296096681176,0.376530076917886,3.51355986656087,0.000442144766561018,0.0330772708021789,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156625",24.8971143141685,-0.934563959574432,0.266067213077824,-3.51251080042348,0.000443893962457635,0.0331648900596603,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g782",17.7245561758699,-0.869486435438581,0.247636886353734,-3.51113458193208,0.000446198442396188,0.0332855052386221,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9293",7064.7577958922,0.24221653404229,0.0690033723772647,3.51021298956245,0.000447747887460168,0.0332855052386221,57916,72634,"sp|Q5REX3|ZFR_PONAB","Q5REX3","ZFR",6.75e-26,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g77718",346.947513773359,0.358248759692408,0.10206037562017,3.51016501277316,0.000447828686723881,0.0332855052386221,0,8661,"sp|Q5R922|COPB_PONAB","Q5R922","COPB",1.17e-33,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005793; GO:0005886; GO:0006886; GO:0016192; GO:0030126"
"g83424",338.470204183316,0.480193753933332,0.136778945970647,3.51072857394574,0.000446880433464778,0.0332855052386221,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5619",115.439764907096,0.508095221144767,0.144799275805755,3.50896244692802,0.000449858417780188,0.0333069367899705,66756,79944,"sp|Q96EZ8|MCRS1_HUMAN","Q96EZ8","MCRS1",2.53e-23,"Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)","cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]","GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006464; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0042766; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751"
"g34754",18.2871957852914,1.00954279854432,0.287653246362064,3.50958249667597,0.000448810807233171,0.0333069367899705,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154620",41.5520834760153,0.658049715316474,0.187533220240122,3.50897678008138,0.000449834175327907,0.0333069367899705,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14151",356.696005213856,0.719328758020278,0.205069275522766,3.50773540398265,0.000451938309240527,0.0333671877218856,33745,56447,"sp|Q9GMB0|RPN1_PIG","Q9GMB0","RPN1",9.43e-29,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0016021; GO:0018279; GO:0042470"
"g31803",4684.76903961849,0.480394077696837,0.136959428678433,3.50756484845415,0.00045222811768258,0.0333671877218856,23519,32887,"sp|Q7PQV7|ADT2_ANOGA","Q7PQV7","ADT2",5.54e-70,"ADP,ATP carrier protein 2 (ADP/ATP translocase 2) (Adenine nucleotide translocator 2) (ANT 2)","mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]","GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544"
"g66062",156.437702930501,-0.680706753064621,0.194131010103795,-3.50642976977594,0.000454161268922841,0.0333671877218856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76938",2157.53031177401,0.640175080301335,0.182570793938292,3.50644846578095,0.000454129365409224,0.0333671877218856,5325,9603,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.26e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g121585",1301.93755300182,2.73797216311341,0.780702238644656,3.50706329197504,0.000453081369120185,0.0333671877218856,1436,4284,"sp|P04069|CBPB_ASTAS","P04069","CBPB",3.01e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g140395",41.2450262068648,0.970174322440767,0.276657066565837,3.50677585967207,0.000453571027945722,0.0333671877218856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22306",159.669745277487,-0.377500756597612,0.107693445420139,-3.50532713597274,0.000456046545093101,0.0334201159098878,16322,33184,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.41e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g41432",36.1095268496048,0.862055771488605,0.245914115088095,3.50551561946652,0.000455723760611057,0.0334201159098878,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117081",164.226344058945,0.613368702173592,0.175012514780959,3.50471337973327,0.000457099102854973,0.0334545236247683,0,4761,"sp|Q94572|TBA3_HOMAM","Q94572","TBA3",1.29e-154,"Tubulin alpha-3 chain (Alpha-III tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g109022",174.1821484486,0.347092742600806,0.0990487282014436,3.50426248679231,0.000457873803054012,0.0334685335276932,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81248",267.923891483209,2.365147448441,0.67516914096141,3.50304435577896,0.000459972861117816,0.0335503224051339,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110926",38.8370628077674,0.466085907708539,0.133055834253167,3.50293476663121,0.000460162142433607,0.0335503224051339,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132828",170.535383025716,0.391237097905249,0.111717966503111,3.5020069748079,0.000461767530206814,0.0336246457909479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1700",392.513625329049,0.401861848554249,0.114774383098136,3.50132004813866,0.000462959506572438,0.0336687154462947,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142735",270.732215871978,0.560844845576489,0.160205641807722,3.50078086669141,0.000463897121238753,0.0336941985021261,0,2625,"sp|O16797|RL3_DROME","O16797","RL3",1.2e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g8065",928.83379085105,-0.330091848289318,0.0943063373159091,-3.50020855102844,0.000464894293140442,0.0337124377873173,40375,52312,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27569",455.652455527323,-0.271366530171204,0.0775341210279044,-3.4999626818951,0.000465323296053596,0.0337124377873173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7501",23.8595318788588,0.56252518897196,0.160845461147297,3.4973022238832,0.000469989057349167,0.0340075310349246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8834",51.3023241307178,-0.35527808418531,0.101717494978661,-3.49279230932537,0.000477998121678164,0.0344693562080661,76572,85724,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.21e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g88315",67.9423583994233,0.581998889523218,0.166647645906076,3.49239190484118,0.000478715310699954,0.0344693562080661,0,7494,"sp|Q9VUL9|FUCTA_DROME","Q9VUL9","FUCTA",3.76e-11,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)","fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]","GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920"
"g119470",129.400420546452,0.662388474507072,0.189652473118254,3.49264348424316,0.000478264574301674,0.0344693562080661,0,1994,"sp|P15857|HM17_APIME","P15857","HM17",9.01e-36,"Homeobox protein H17 (Fragment)",NA,"GO:0000981; GO:0003677; GO:0005634"
"g123676",88.9788349508478,-0.475839319123077,0.136251550788488,-3.49235892266468,0.000478774431819949,0.0344693562080661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85383",52.6283326257362,-0.440496483372299,0.126154680639821,-3.49171731986658,0.000479925871594126,0.034508955528911,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21591",763.470239516357,-0.527812954031541,0.151187660715352,-3.49111132174522,0.000481015785518668,0.0345440372629051,5617,13164,"sp|P80363|CCB23_FAXLI","P80363","CCB23",2.93e-19,"Crustacean calcium-binding protein 23 (CCBP-23)",NA,"GO:0005509"
"g133688",1381.88090116363,1.02672617911051,0.294169249179395,3.49025665318393,0.000482556868468972,0.034611391390937,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80419",37.4462954709821,0.634964973881932,0.181957809544785,3.48962748820984,0.00048369427933087,0.0346496601098693,0,5669,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",3.2e-69,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g43303",56.3853897171914,-0.367614283140395,0.105361146099006,-3.48908774013291,0.000484672033510828,0.0346764105771213,2368,15854,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",1.67e-70,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g99034",20.3243377037482,1.60472323238058,0.459982128694682,3.48866430296846,0.000485440380311041,0.0346881307873568,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56551",20.5878861096834,0.551786310602702,0.158197674839588,3.48795461856321,0.000486730684255221,0.0347370729633888,0,9034,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.85e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g22739",65.7345558871412,0.424151735960445,0.12162868335418,3.48726734733555,0.000487983285891299,0.0347524358429086,20136,39984,"sp|P53034|RFC2_DROME","P53034","RFC2",4.42e-32,"Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) (Replication factor C subunit 4) (DmRfc4)","DNA damage checkpoint signaling [GO:0000077]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA strand elongation involved in DNA replication [GO:0006271]; leading strand elongation [GO:0006272]; sister chromatid cohesion [GO:0007062]","GO:0000076; GO:0000077; GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006272; GO:0006281; GO:0007062; GO:0016887; GO:0031391"
"g75525",152.776146247367,0.269674347310071,0.0773390183644626,3.48691194966068,0.000488632202521866,0.0347524358429086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112760",30.883348217662,0.878686651563847,0.252000822032377,3.48684041773068,0.000488762909118635,0.0347524358429086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6614",21.3130190825409,0.667640404888648,0.191493468105569,3.48649179261083,0.000489400400595994,0.0347546967650967,101676,105144,"sp|Q3SYU1|NOC2L_BOVIN","Q3SYU1","NOC2L",8.16e-14,"Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)","apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]","GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0140297; GO:2001243"
"g32261",4272.41371432736,0.422683597842028,0.121283094694971,3.48509904785233,0.000491954900362042,0.034767746767663,24369,27074,"sp|P60868|RS20_RAT","P60868","RS20",2.12e-43,"40S ribosomal protein S20","positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022626; GO:0022627; GO:0045202; GO:0097371; GO:1901798; GO:1990948"
"g58642",24.855433768897,-0.665040592554957,0.190853945471733,-3.48455249856732,0.000492960745315316,0.034767746767663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67368",82.0069270184876,-0.469511655587254,0.134736553999061,-3.48466427002821,0.000492754890241715,0.034767746767663,0,9500,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.61e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g90811",44.1439159993799,0.746162694694924,0.214143075697377,3.48441196272621,0.00049321969098776,0.034767746767663,3478,7345,"sp|Q4FAT7|BGLR_PIG","Q4FAT7","BGLR",9.77e-11,"Beta-glucuronidase (EC 3.2.1.31)","glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246"
"g95397",51.5522545930319,-0.736030096075491,0.211138593601898,-3.48600454099489,0.00049029268199381,0.034767746767663,215,4252,"sp|Q8N8E2|ZN513_HUMAN","Q8N8E2","ZN513",5.65e-23,"Zinc finger protein 513","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]","GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041"
"g117162",3068.31139983903,0.522683545899171,0.149959272543002,3.48550334391152,0.000491212083731227,0.034767746767663,95,4282,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.12e-52,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g5151",75.0469537788451,1.60396956798886,0.460447315350775,3.48350292099529,0.000494897720682221,0.0348322768599706,109046,124074,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.57e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g37575",819.653583478866,-0.372812620125592,0.107039911225411,-3.48293095404854,0.000495956259926734,0.0348322768599706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94305",312.872491097129,0.463603373594035,0.133096427098937,3.48321426576999,0.000495431671324129,0.0348322768599706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128648",751.737860142464,2.98528522942215,0.85721937882654,3.48252186448321,0.000496714656552082,0.0348428936344236,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51339",329.381169808809,-0.574791373419692,0.165099517748612,-3.48148426632533,0.000498643075232061,0.0349354574564294,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22595",526.967802690929,-0.366043052906809,0.105151486252761,-3.48110203622725,0.000499355223242562,0.0349426862312905,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10838",105.356938003882,-0.551196746891535,0.15837842484234,-3.48025147642572,0.000500943339172863,0.0349768940956147,63365,69712,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.11e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g153196",19.600307409758,-0.694079001943903,0.199437250471764,-3.48018737874732,0.000501063209247042,0.0349768940956147,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86270",25.4717120531171,0.733748846569074,0.210862162063129,3.47975587175,0.000501870873531731,0.0349907056175586,3724,8087,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",8.73e-30,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g6379",3355.8500964789,-0.799259955084664,0.229810938429441,-3.47790214228667,0.000505354380102976,0.0350606723524225,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18736",42.3337442081049,0.876019390047879,0.251868864866038,3.4780773340675,0.000505024199794216,0.0350606723524225,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32118",737.734740749487,-0.313702848532828,0.0901767919677484,-3.47875369801383,0.000503751356870768,0.0350606723524225,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94469",3690.05746792407,-1.17936863096813,0.339080609838854,-3.47813645707614,0.000504912817285127,0.0350606723524225,3865,5762,"sp|Q24133|DNAJ1_DROME","Q24133","DNAJ1",7.77e-121,"DnaJ protein homolog 1 (DROJ1)","chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]","GO:0000122; GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087"
"g140450",30.3197083401229,-0.867805436731867,0.249564896643054,-3.47727364066376,0.000506540560825345,0.0350606723524225,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142416",1528.99399276787,0.744629294639894,0.214132439436159,3.47742404934352,0.000506256456201857,0.0350606723524225,0,2649,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",1.55e-16,"Collagen-like protein 4",NA,NA
"g818",535.927540616348,-0.457269666312772,0.131583920703319,-3.47511811373801,0.00051062846491249,0.0350688583549406,88745,155139,"sp|Q9VX32|RG190_DROME","Q9VX32","RG190",3.93e-17,"Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)","defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]","GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770"
"g7863",299.361340901236,0.908359209440464,0.261368601726132,3.47539529783406,0.000510101074408547,0.0350688583549406,58975,62999,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.7e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g15142",28.3292485554688,1.27079884135003,0.365663495756298,3.47532323050636,0.000510238146048734,0.0350688583549406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33297",264.61579641616,0.398827773174953,0.114772032998917,3.47495607382607,0.00051093700914483,0.0350688583549406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33404",20.6658712698002,-0.574212787173596,0.165192793477318,-3.47601596344722,0.000508921992040719,0.0350688583549406,27535,31040,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68114",28.6039893509697,-0.513742396313506,0.147833156838676,-3.47515000896673,0.000510567752875397,0.0350688583549406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80553",33.4117371898881,0.595995876464588,0.171421078042912,3.47679458832589,0.000507446426263488,0.0350688583549406,0,9032,"sp|P08548|LIN1_NYCCO","P08548","LIN1",8.56e-17,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g21717",34.4940088543316,0.711095177623187,0.204671006133496,3.47433274041453,0.000512125534682977,0.035082240804379,46085,48446,"sp|Q9GKZ4|TRAM1_BOVIN","Q9GKZ4","TRAM1",2.37e-13,"Translocating chain-associated membrane protein 1 (Protein TRAM1)","cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0006613; GO:0006616; GO:0006986; GO:0030176; GO:0045048"
"g120826",28.2266888316016,-0.643619463402427,0.185256208012735,-3.47421266097697,0.000512354789021778,0.035082240804379,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55280",5145.38355443474,0.390762520461125,0.112512929967197,3.4730454586424,0.000514588188490831,0.0351812505076684,4125,8400,"sp|B4LYI3|EI3D1_DROVI","B4LYI3","EI3D1",1.95e-119,"Eukaryotic translation initiation factor 3 subunit D-1 (eIF3d-1) (Eukaryotic translation initiation factor 3 subunit 7-1) (Eukaryotic translation initiation factor 3 subunit p66)","cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0002191; GO:0003743; GO:0005634; GO:0005852; GO:0006446; GO:0016282; GO:0033290; GO:0098808"
"g60469",155.443902537923,0.470606728270281,0.135521361574771,3.47256493590224,0.000515510285668679,0.0351812505076684,3297,5864,"sp|A9URZ4|PESC_MONBE","A9URZ4","PESC",2.7e-16,"Pescadillo homolog","maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545"
"g130746",78.1617917337068,-0.771387825771434,0.222142093488727,-3.47249732662927,0.000515640147733515,0.0351812505076684,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4102",585.237073928124,-0.549784246837131,0.158408380765633,-3.47067651458759,0.00051914900408187,0.0353785865251992,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20655",184.333210177465,-0.444489704303799,0.128136990991628,-3.46886329126333,0.000522665341538302,0.0354498076802219,0,13589,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.24e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g41895",31.8161362407859,0.754801544207592,0.217575980812082,3.46914002818862,0.00052212724120781,0.0354498076802219,0,15346,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.03e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g80319",125.903054145592,-0.603033214060231,0.173815994794745,-3.46937699704989,0.00052166687817319,0.0354498076802219,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103595",397.288616417319,1.15058781915985,0.331614605549193,3.46965362775365,0.000521129942054768,0.0354498076802219,0,3215,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.68e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g54323",58.4110694186797,-0.614244682577147,0.177138938970335,-3.46758700344261,0.000525153710754866,0.0355602605459512,3259,6264,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",2.72e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g139384",91.3878927735115,0.42603999940814,0.122870416851351,3.46739280557308,0.000525533303293249,0.0355602605459512,157,2891,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.71e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g73930",40.701428832756,0.557325664379619,0.160782714754915,3.46632823826345,0.000527618726772169,0.0355794860164986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74862",24.2217793094296,1.52379714724552,0.439603591065158,3.4662982246195,0.000527677633322418,0.0355794860164986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135363",2963.62521174942,0.830328844382599,0.239515898605551,3.46669615343587,0.000526897132530797,0.0355794860164986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14067",673.632391640333,-0.465329876865653,0.134262049859504,-3.46583325185776,0.000528590999619382,0.0355992389180283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140552",195.446526661965,-0.533556919507737,0.154017109076301,-3.4642704483137,0.000531671691586761,0.0357647381749687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15718",92.0124287773626,0.901859253366007,0.260410337930697,3.46322369738646,0.000533744456758945,0.0358621275513211,55349,57004,"sp|P08548|LIN1_NYCCO","P08548","LIN1",9e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g44465",118.384137879265,-0.346129204573316,0.0999885994088875,-3.46168669847925,0.000536801654613723,0.035983269791747,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124965",2384.20094022881,0.320593396071007,0.0926069981867061,3.46187007837846,0.000536436043919807,0.035983269791747,796,3854,"sp|O57592|RL7A_TAKRU","O57592","RL7A",6.23e-12,"60S ribosomal protein L7a (Surfeit locus protein 3)","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254; GO:1990904"
"g85707",1118.02869278009,0.497892618010001,0.143878077039157,3.46051760112485,0.000539137987283895,0.0360977102804549,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92576",960.749878551103,-0.334151907730644,0.096588876501223,-3.45952784455892,0.000541123325913386,0.0361884107702915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9628",1577.74199236291,-0.681184891533917,0.196945837040185,-3.45874227031734,0.000542703944411299,0.0362518653437955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40052",34.639670520437,0.475180846007326,0.137422879568778,3.45780009484886,0.000544605326042222,0.0363365739631427,13622,14614,"sp|Q86AQ5|RPC1_DICDI","Q86AQ5","RPC1",3.74e-39,"DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)","transcription by RNA polymerase III [GO:0006383]","GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872"
"g29753",252.371539392668,-0.227722679920718,0.0658752001980692,-3.45688027111897,0.000546467585507544,0.0363861461608977,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121506",101.883875210378,-0.478650287969728,0.138466021790879,-3.4568068164233,0.000546616556129206,0.0363861461608977,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40784",66.2322448675868,-0.491014792016535,0.142074390980262,-3.45604009722448,0.000548173769604334,0.0364475213208536,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71365",619.025500272293,-0.370157214356234,0.107126445052163,-3.45532995308483,0.000549619764138489,0.0365013681322529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7593",981.806167733727,0.484101576969771,0.140160234265747,3.4539152956316,0.000552510882833768,0.0365701287690212,32771,36564,"sp|P55216|CGL2_CAEEL","P55216","CGL2",6.32e-30,"Putative cystathionine gamma-lyase 2 (EC 4.4.1.1) (Gamma-cystathionase)","cysteine biosynthetic process via cystathionine [GO:0019343]; transsulfuration [GO:0019346]","GO:0004123; GO:0005737; GO:0005783; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146"
"g12557",312.154368645685,-0.335201796549501,0.0971028768970296,-3.45202745027789,0.000556391119124355,0.0365701287690212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29023",1467.745380676,2.51728388924399,0.729146473144011,3.45237065796903,0.00055568381509367,0.0365701287690212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34290",103.049549506267,-0.70498746060089,0.204114471424457,-3.45388279273382,0.000552577474795188,0.0365701287690212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48875",49.6391849451216,0.397523799230514,0.115111895539931,3.4533685451528,0.000553632060994451,0.0365701287690212,0,8214,"sp|B1P1W2|SDHF2_ARTSF","B1P1W2","SDHF2",1.01e-18,"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]","GO:0005739; GO:0005759; GO:0006121; GO:0018293"
"g95950",207.448496816926,-0.595189245592856,0.172389816449441,-3.4525777557598,0.000555257420168081,0.0365701287690212,1526,6966,"sp|Q96GN5|CDA7L_HUMAN","Q96GN5","CDA7L",1.64e-38,"Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2)","positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]","GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284"
"g101322",841.490402940127,2.40517078298287,0.696350386100675,3.45396632355014,0.000552406351875931,0.0365701287690212,0,1363,"sp|P25784|CYSP3_HOMAM","P25784","CYSP3",3.78e-29,"Digestive cysteine proteinase 3 (EC 3.4.22.-)",NA,"GO:0008234"
"g130275",26.3073666416303,0.688919280597556,0.199520837712988,3.45286882560393,0.000554658649805611,0.0365701287690212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144190",34.0011821422577,0.76953611764735,0.222913127225615,3.45217945315749,0.00055607775862543,0.0365701287690212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15692",105.357790570375,-0.554270533911638,0.16063964713346,-3.45039685907146,0.000559763014860542,0.0366657554711163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23999",182.398367848476,0.44393935736309,0.128659242611158,3.45050498007976,0.000559538843849088,0.0366657554711163,33015,35277,"sp|Q6NV04|HACL2_DANRE","Q6NV04","HACL2",1.06e-22,"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660"
"g25702",570.944910106963,-0.732952166635181,0.212413838835198,-3.45058575587368,0.000559371423183387,0.0366657554711163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10726",376.158473598564,-0.397194552277031,0.115162720788364,-3.44898548382651,0.000562696950730541,0.0367551040987293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67890",1013.41576393324,-0.382342141066652,0.110861825522704,-3.44881693282554,0.000563048286560716,0.0367551040987293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98418",52.2936968129918,0.4314090723316,0.125100148766623,3.44850966673432,0.000563689292556322,0.0367551040987293,0,4964,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g120709",24.0573267264853,1.93927461703264,0.562327584392351,3.44865638972381,0.000563383120301258,0.0367551040987293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6558",3929.91977799815,-0.484437200486016,0.140586927194613,-3.44581968005756,0.000569330123051138,0.0368715151926347,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25600",136.712775314762,-0.735193902739169,0.213351703177952,-3.44592469517789,0.000569108926714653,0.0368715151926347,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31589",70.8009829359273,0.533780471179453,0.154840551205436,3.44729121037069,0.000566237883574781,0.0368715151926347,714,5232,"sp|Q9W3K5|GSH1_DROME","Q9W3K5","GSH1",1.28e-12,"Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase)","axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688]","GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471"
"g46559",39.175648398846,-0.659111055998536,0.191277624450317,-3.44583459718644,0.000569298697800403,0.0368715151926347,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70278",540.036343068901,0.591945427113529,0.171774340382116,3.44606432949609,0.000568814934925714,0.0368715151926347,0,374,"sp|Q6DIY9|MDHC_XENTR","Q6DIY9","MDHC",1.88e-20,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g91319",186.384175093284,0.514984693272026,0.149441868816678,3.44605362171805,0.000568837474510612,0.0368715151926347,6995,7523,"sp|B3NQ53|KAD2_DROER","B3NQ53","KAD2",5.79e-86,"Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]","GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034"
"g99918",158.063585321896,-0.533724045198323,0.154912502094811,-3.44532583220214,0.000570371402747192,0.0368973067526876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28943",37.4313197692071,1.4719321626804,0.427309101181426,3.44465436989477,0.000571790028092106,0.0369474232116273,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28975",110.710004744148,-0.307702231219782,0.0893639684070398,-3.44324716890642,0.000574773742554493,0.0369864466937564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43117",372.171991382402,-0.441741122994295,0.128306788408299,-3.44285075228119,0.000575616885631308,0.0369864466937564,2915,11501,"sp|P17019|ZN708_HUMAN","P17019","ZN708",1.53e-61,"Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g88981",627.316300814112,0.499833219625113,0.145178613384053,3.44288465066726,0.000575544741760825,0.0369864466937564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89937",42.628868920009,1.07921762792945,0.31337634610944,3.44383882615235,0.000573517478715903,0.0369864466937564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137887",104.226689625753,-0.976656175749087,0.283675174385721,-3.44286798400307,0.000575580211354961,0.0369864466937564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19173",35.1886990371402,0.625784029309141,0.181836202830179,3.44147105784856,0.000578560361018269,0.0369964513187928,48075,53406,"sp|Q5RBL1|GARS_PONAB","Q5RBL1","GARS",7.56e-18,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005739; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070062"
"g25355",30.5588617280034,-0.776161731244438,0.22553453505431,-3.44143184571504,0.000578644221635937,0.0369964513187928,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38277",68.5733356883769,-0.440164452319415,0.127864221951701,-3.44243640324721,0.000576499400200876,0.0369964513187928,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41343",30.7092430628161,1.43764181209846,0.417796702547726,3.44100803891393,0.000579551314068745,0.0369964513187928,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49628",28.735540220495,0.648323339955366,0.188394752838138,3.4413025319892,0.000578920857287967,0.0369964513187928,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128260",150.526106210066,1.08139833332935,0.314271720018134,3.44096609541243,0.000579641159560731,0.0369964513187928,1716,3324,"sp|Q924Z4|CERS2_MOUSE","Q924Z4","CERS2",1.54e-53,"Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297)","ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148]","GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0019216; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045"
"g76736",155.538746610079,2.16901274226875,0.630461598303147,3.44035663410195,0.000580948126280248,0.03700778354022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78291",67.9759443757167,-0.36452978528308,0.105959278391912,-3.44028187823998,0.000581108626171805,0.03700778354022,0,7944,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.02e-32,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g2452",33.9911113736725,-0.684358865006625,0.199044488892632,-3.43822061496905,0.000585550428873164,0.0370553626269213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8446",39.4376231327527,-0.63697370447885,0.185262626090076,-3.43822020621229,0.000585551312826605,0.0370553626269213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49815",28.6380705302905,0.48543199949818,0.141202656951615,3.4378389895632,0.000586376250701368,0.0370553626269213,0,17446,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.11e-30,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51831",48.2268204745573,-0.583370220257809,0.169668548741484,-3.43829321689232,0.00058539344390893,0.0370553626269213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108434",41.9945578248975,0.491316473191523,0.142854824175743,3.43927113435873,0.000583282736978905,0.0370553626269213,2288,5304,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.37e-59,"PiggyBac transposable element-derived protein 4",NA,NA
"g131223",375.549230750851,0.624767785719531,0.181640292422175,3.43958808581646,0.000582600160496951,0.0370553626269213,0,1034,"sp|P38377|S61A1_CANLF","P38377","S61A1",3.26e-26,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g152522",86.4124021435292,0.516116142991349,0.150125055998975,3.437908079747,0.000586226662024812,0.0370553626269213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53690",45.5603105850728,-0.64896287938365,0.188805265252069,-3.43720752976479,0.000587745085718995,0.0371010044208536,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2250",54.5716861354205,-0.904790239466551,0.26347409966323,-3.43407659661062,0.000594576155139863,0.037204776207116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7876",155.643532027345,-0.636887094983698,0.185459595028402,-3.43410161596741,0.000594521276196562,0.037204776207116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12517",195.969004974773,-0.218464793019859,0.0636147164802689,-3.43418638181966,0.000594335380786695,0.037204776207116,38735,57230,"sp|P21328|RTJK_DROME","P21328","RTJK",3.08e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13719",1577.97558430756,0.300091332412584,0.0873607488194877,3.43508196149576,0.000592374636276973,0.037204776207116,0,8843,"sp|Q26250|VATL_NEPNO","Q26250","VATL",2.97e-15,"V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (Vacuolar proton pump 16 kDa proteolipid subunit c)",NA,"GO:0005774; GO:0016021; GO:0033179; GO:0046961"
"g29144",40.7036972482223,-0.529440082838575,0.154134718256329,-3.43491777081726,0.000592733657076574,0.037204776207116,4386,31434,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.16e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g42618",53.0109199144663,-0.548528259685717,0.159706409612529,-3.43460391487435,0.000593420500976836,0.037204776207116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88193",104.112736445957,0.481179425014689,0.140082470577085,3.43497243468378,0.000592614106093876,0.037204776207116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117210",26.4754542634917,0.58225250710283,0.169502203225825,3.43507338560729,0.000592393383379588,0.037204776207116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77598",31.0698149298976,2.00919135074302,0.585191435259862,3.43339158723472,0.000596080528556308,0.0372177374630696,0,3464,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",5.94e-22,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g134025",39.2828071942105,0.475632194567379,0.138529550366504,3.43343491196652,0.000595985276719208,0.0372177374630696,0,2564,"sp|Q9VBX1|NEMF_DROME","Q9VBX1","NEMF",5.23e-20,"Ribosome quality control complex subunit NEMF homolog (Protein Caliban)","CAT tailing [GO:0140708]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0000049; GO:0005634; GO:0006611; GO:0032473; GO:0043023; GO:0072344; GO:0140708; GO:1902167; GO:1902231; GO:1990112; GO:1990116"
"g63602",70.1636814402229,-1.21739594215106,0.354695901374496,-3.43222444193316,0.000598651901460216,0.0373376588106382,0,12409,"sp|P04323|POL3_DROME","P04323","POL3",2.6e-31,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g9445",17.8031558644522,0.559745135185926,0.163172055733012,3.43039825459944,0.00060269595284853,0.0374994911913048,30145,42154,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.18e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g49698",61.5593736989033,-0.607518238843648,0.177129570731688,-3.42979569325498,0.0006040358805544,0.0374994911913048,5050,14734,"sp|Q29397|SV2A_BOVIN","Q29397","SV2A",1.8e-11,"Synaptic vesicle glycoprotein 2A (p87)","cellular calcium ion homeostasis [GO:0006874]; synaptic vesicle priming [GO:0016082]","GO:0005783; GO:0005911; GO:0006874; GO:0016021; GO:0016082; GO:0019901; GO:0022857; GO:0030672; GO:0031594; GO:0043005; GO:0048786; GO:0098978; GO:0098982"
"g60337",97.6990505856368,0.371343085722908,0.108239870475037,3.43074214790889,0.000601932470894272,0.0374994911913048,0,5644,"sp|Q7YU24|MARF_DROME","Q7YU24","MARF",3.66e-33,"Transmembrane GTPase Marf (EC 3.6.5.-) (Mitochondrial assembly regulatory factor) (Mitofusin)","adult locomotory behavior [GO:0008344]; axonal transport of mitochondrion [GO:0019896]; ecdysone biosynthetic process [GO:0006697]; endoplasmic reticulum organization [GO:0007029]; lipid droplet organization [GO:0034389]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fusion [GO:0010636]; regulation of mitochondrial fission [GO:0090140]; response to endoplasmic reticulum stress [GO:0034976]","GO:0003924; GO:0005525; GO:0005740; GO:0005741; GO:0006697; GO:0007005; GO:0007029; GO:0008053; GO:0008344; GO:0010636; GO:0016021; GO:0019896; GO:0031306; GO:0034389; GO:0034976; GO:0051646; GO:0070584; GO:0090140; GO:1904115"
"g88067",19.8745925929667,-1.32348063768976,0.385848456448648,-3.43005295361575,0.000603463466745024,0.0374994911913048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150436",25.4193587407884,1.69926332827701,0.49547259492955,3.42958086010514,0.000604514279399738,0.0374994911913048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6043",87.0707242046466,0.3462226826238,0.100980130572771,3.42862185521038,0.000606654132491546,0.0375745006582214,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120902",77.2916995925043,-1.24938934987474,0.364417886733453,-3.42845232179446,0.000607033149358161,0.0375745006582214,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6027",65.7056836994891,0.516124037943164,0.150573669271207,3.42771774402032,0.000608677953426725,0.0375952001804365,51719,71298,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.71e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g140076",69.9367185232207,0.583450326330898,0.170213377327448,3.42775835537583,0.000608586911732652,0.0375952001804365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127726",56.304899257984,0.596690295567613,0.174131753014881,3.42665990111878,0.000611053873236277,0.0377013669315028,3460,3811,"sp|P11217|PYGM_HUMAN","P11217","PYGM",2.02e-15,"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)","glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]","GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499"
"g13982",267.483280990117,-0.634842556265462,0.185294791757558,-3.42612196621316,0.000612265384939431,0.037735540051369,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7864",456.66304345899,0.693699900023762,0.202491235675726,3.42582679052178,0.00061293111514237,0.0377360379687437,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52342",37.7099731601601,-0.556602971183259,0.162523296838353,-3.42475806245095,0.000615347130305485,0.03784417828181,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100759",840.159275922062,-1.83642985664319,0.536336472603908,-3.4240256824738,0.000617007895593034,0.0378704441493628,1853,5104,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g135831",51.7892407446204,0.750781185216462,0.219270995398794,3.42398767265591,0.000617094201457898,0.0378704441493628,0,3164,"sp|Q8VCW8|ACSF2_MOUSE","Q8VCW8","ACSF2",2.96e-12,"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)","fatty acid metabolic process [GO:0006631]","GO:0005524; GO:0005739; GO:0006631; GO:0031956; GO:0047760"
"g68935",258.501145236494,0.561454823803161,0.163997540248372,3.42355637135072,0.000618074310183457,0.0378900682888106,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46997",1208.14890356724,-0.460818516505745,0.1346881528252,-3.42137379449996,0.000623056346225223,0.0380507663995927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55974",1854.18395292798,0.444799766660101,0.129979944737389,3.4220645928014,0.000621475475752216,0.0380507663995927,0,12200,"sp|Q9M888|TCPZA_ARATH","Q9M888","TCPZA",6.91e-35,"T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A)","protein folding [GO:0006457]; response to zinc ion [GO:0010043]","GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0016887; GO:0051082"
"g89993",71.0769604568818,-0.860671291988013,0.251566587876282,-3.4212464352034,0.0006233482121927,0.0380507663995927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96994",99.0466524013993,-0.616652267997371,0.180234242257289,-3.42139351698266,0.000623011160098635,0.0380507663995927,0,6840,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.65e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28697",472.381540785013,0.403283866013969,0.117917549357912,3.42004958727467,0.000626097218576641,0.038177957919158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57002",335.031875736936,2.45033140060115,0.716621878302038,3.41928075989943,0.000627869061892015,0.0382453575067556,4396,14144,"sp|P81182|BGBP_PENVA","P81182","BGBP",0,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP) (BetaGBP-HDL) (High density lipoprotein)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; regulation of innate immune response [GO:0045088]","GO:0002752; GO:0005576; GO:0006869; GO:0038187; GO:0045087; GO:0045088"
"g25685",2730.82501038099,-0.584842954886774,0.171082418976326,-3.41848658901477,0.000629704209276096,0.0383164660957183,0,20200,"sp|A6QQJ8|ZC12A_BOVIN","A6QQJ8","ZC12A",4.02e-64,"Ribonuclease ZC3H12A (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12A)","3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; miRNA catabolic process [GO:0010587]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]","GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003729; GO:0003730; GO:0004518; GO:0004521; GO:0004532; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006974; GO:0010508; GO:0010587; GO:0010595; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032689; GO:0032691; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050852; GO:0051259; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900745; GO:1901223; GO:1903003; GO:1903799; GO:1903936; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627"
"g138715",40.4538357191601,0.489728940458104,0.143304815382501,3.41739347104944,0.000632238316930893,0.0384299095609054,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2498",212.053267878649,0.44751180911404,0.130980882038126,3.41661929703434,0.000634038771684158,0.0384985658404624,13655,15709,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.22e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g147015",69.6060381754603,0.742379916586361,0.217320675428452,3.41605746955619,0.000635348368921459,0.0385373038147075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1566",40.2889315492183,-0.488994551809624,0.143218303138709,-3.41433001992786,0.00063939076341441,0.038639898718011,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45765",36.3285527379643,1.50406928343921,0.440535500723888,3.41418405773818,0.000639733422483626,0.038639898718011,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119636",105.425951558622,0.604254812998692,0.176946224277764,3.4149065088281,0.000638039073044465,0.038639898718011,0,4522,"sp|P40301|PSA2_DROME","P40301","PSA2",6.37e-24,"Proteasome subunit alpha type-2 (PROS-Dm25) (Proteasome 25 kDa subunit)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0043161"
"g137528",740.204464655286,0.805705892774639,0.235960837107894,3.41457464997137,0.000638816855691497,0.038639898718011,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6058",1309.07894578945,-0.548411856288215,0.16067454748583,-3.41318438339825,0.00064208484078346,0.0387163976654782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15564",448.920816554907,-0.403687419142879,0.118286766362094,-3.41278599084473,0.000643024171753237,0.0387163976654782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131143",40.5189064020434,-0.980431186661352,0.28726474534696,-3.41298820179685,0.000642547238644267,0.0387163976654782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124038",23.3279823185226,1.81435409317704,0.531732959092051,3.41215277735483,0.000644519794702603,0.0387657712998274,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36397",528.327936738993,0.431927468857114,0.12662048157508,3.4111974894125,0.00064678226721966,0.038861116746664,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130975",63.5053757527076,2.27260049011814,0.666579507442797,3.40934646916545,0.000651187199692003,0.0390848551446937,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5635",52.4263829702046,0.47865144275243,0.140458615390652,3.4077756029502,0.000654947309068564,0.0391515841807265,67415,79560,"sp|Q99J83|ATG5_MOUSE","Q99J83","ATG5",2.29e-12,"Autophagy protein 5 (APG5-like)","aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; C-terminal protein lipidation [GO:0006501]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]","GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009267; GO:0009410; GO:0009620; GO:0010040; GO:0016020; GO:0016236; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061684; GO:0061739; GO:0070257; GO:0071500; GO:1901096; GO:1902017; GO:1902617; GO:1904973; GO:1990234; GO:2000377; GO:2000378; GO:2000619"
"g15085",813.753964582051,-0.384088615477595,0.112743569310471,-3.40674521683715,0.000657424651150475,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34681",61.638490258844,-0.632469594104757,0.185645759029494,-3.40686260440928,0.000657141978778092,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44297",429.298529606877,0.438277238876231,0.128655061716855,3.4066070392224,0.000657757531373655,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45954",94.6758112789017,0.725294152319925,0.212841065494182,3.40767957835538,0.000655177812239483,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54424",83.9418460178451,0.750691298085241,0.220285497043803,3.4078108098781,0.000654862815152141,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120270",139.718869759115,0.47040931513135,0.13806071001628,3.40726420337749,0.00065617577237641,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127546",56.4484959335447,-0.640566282425671,0.187947539783049,-3.40821850163662,0.000653885124368434,0.0391515841807265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113594",343.335549682171,-0.939906998031999,0.27596780728928,-3.40585739787668,0.000659566206890431,0.039218558498832,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92677",414.347229559312,0.583672083632576,0.171435956914714,3.40460714389655,0.000662593012841228,0.0393170497175074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143666",48.6644793966876,0.807496624059459,0.237158976259913,3.40487480926924,0.000661943923095576,0.0393170497175074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8626",3581.37265971949,-0.505439454295909,0.148522339811496,-3.40312073548943,0.000666208341569583,0.0394462338580599,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38662",79.5722870144407,0.363389182940132,0.106782049212046,3.40309242631708,0.000666277374427267,0.0394462338580599,16354,24624,"sp|P10394|POL4_DROME","P10394","POL4",2.03e-39,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g151012",41.314703514374,-0.706749350089291,0.207692451047475,-3.40286489241604,0.000666832465010772,0.0394462338580599,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92714",302.455441547529,-0.537566599577362,0.1580252501124,-3.40177660971902,0.000669493385597521,0.039522150684759,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100350",249.789366504262,-0.620790621438224,0.182483935386503,-3.40189189872184,0.000669211029839399,0.039522150684759,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87382",612.908921000517,0.49085295782507,0.144365576568566,3.40006925121751,0.000673687886088934,0.0396067734669908,4459,8041,"sp|Q2NKZ1|TCPH_BOVIN","Q2NKZ1","TCPH",3.8e-22,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g101291",1094.59308845981,0.388765921120387,0.114332588096239,3.4003071879484,0.000673101880815438,0.0396067734669908,382,4391,"sp|Q9NB32|TCPD_OCHTR","Q9NB32","TCPD",1.62e-19,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g122495",330.929798480202,0.554071123236934,0.162943550196971,3.40038695957684,0.000672905520419404,0.0396067734669908,455,4140,"sp|O88989|MDHC_RAT","O88989","MDHC",2.06e-21,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NAD metabolic process [GO:0019674]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0016615; GO:0019674; GO:0030060; GO:0051287"
"g128451",57.9069219712737,-0.583886932462778,0.171698146936665,-3.40065948806168,0.000672235084584121,0.0396067734669908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94706",146.329685963846,0.981023949162882,0.288568309838571,3.39962468405377,0.000674784064737454,0.039630613750906,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5792",3091.52776258033,-0.374798604792309,0.110256582319915,-3.39933087808591,0.000675509418111447,0.0396326486822442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9417",198.706094604167,-0.443880330706754,0.13059154463244,-3.3989974768741,0.000676333402865599,0.0396404603232156,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35476",498.673673097486,-0.691395109621178,0.203487361362623,-3.39772998672425,0.000679474478471121,0.0397028977338828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37824",378.946997471942,-0.438565658622923,0.129058153237816,-3.39820187737211,0.000678303464766378,0.0397028977338828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105162",25.6554572062857,0.606975864723959,0.178633787258445,3.39787827397846,0.000679106295955596,0.0397028977338828,3024,4554,"sp|P41894|DEI_DROME","P41894","DEI",7.28e-18,"Helix-loop-helix protein delilah (Protein taxi)","cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983"
"g13866",271.68503001375,-0.471521529133065,0.138804445605522,-3.3970203697446,0.000681238956966867,0.0397655049346479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5315",457.162920921439,-0.977132101864224,0.2877844884494,-3.39536056001167,0.00068538275710994,0.0398248915277479,76195,96875,"sp|Q6C5V7|YNG2_YARLI","Q6C5V7","YNG2",3.53e-12,"Chromatin modification-related protein YNG2 (ING1 homolog 2)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of transcription, DNA-templated [GO:0006355]","GO:0005634; GO:0006281; GO:0006325; GO:0006355; GO:0035064; GO:0046872; GO:0051321"
"g13487",59.0868830203586,-0.468620974451223,0.138028906763752,-3.39509299492828,0.000686052935788753,0.0398248915277479,28505,43538,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.63e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22677",164.724206218917,0.383028108703581,0.112804902861725,3.39549167621812,0.000685054568434105,0.0398248915277479,38695,43923,"sp|Q92665|RT31_HUMAN","Q92665","RT31",2.97e-18,"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)","mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543"
"g48548",44.8312201990697,1.15042599306886,0.338857935754109,3.39500974208751,0.000686261586013387,0.0398248915277479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48748",65.131008963951,-0.38517352449641,0.113464216574625,-3.39466958063455,0.00068711471963176,0.0398248915277479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95074",55.4825232892366,1.46274593834917,0.430885319329321,3.39474535968401,0.000686924578539598,0.0398248915277479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121440",53.000243539143,1.04736990637144,0.308473141425494,3.39533581929178,0.000685444700427054,0.0398248915277479,2135,4360,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.28e-28,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g3937",21.8237336943148,-0.788470291056767,0.232359106937598,-3.39332639657854,0.000690493100292798,0.0398424815046889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5437",43.0744515463407,-0.852631062698589,0.251262786104533,-3.39338377925918,0.000690348456071909,0.0398424815046889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8243",67.3783527697969,-0.476951313125488,0.140542214232521,-3.39365162083183,0.000689673681662725,0.0398424815046889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31638",36.2713414550744,1.33281013681892,0.392824003318425,3.39289382919541,0.000691584377460268,0.0398424815046889,0,2914,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.89e-67,"PiggyBac transposable element-derived protein 4",NA,NA
"g69128",180.016459504798,1.20666513921282,0.355639441732773,3.39294520690286,0.000691454678396781,0.0398424815046889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69997",150.175117525359,-0.599484035441609,0.176624765643618,-3.39411086127756,0.000688518141716766,0.0398424815046889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106450",40.587321630454,0.617003836048044,0.181872956319297,3.39249907482028,0.000692581659006215,0.039859915339796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4786",84.639739547458,-0.424038415944192,0.12505968315119,-3.39068839181012,0.00069717319892895,0.0399939886434868,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8820",268.437852406354,-0.256616124102077,0.075674807586171,-3.39103768199037,0.000696285270669376,0.0399939886434868,30158,74504,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.74e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g109645",123.10417352106,-0.513587500484627,0.151459500368115,-3.39092298097101,0.000696576735409732,0.0399939886434868,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161323",222.058511891859,2.25487454832386,0.66506024192745,3.39048165289339,0.000697699244198855,0.0399939886434868,559,1107,"sp|P80067|CATC_RAT","P80067","CATC",7.5e-13,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g19650",631.744018466171,0.499447952605192,0.147387161740931,3.38868017204303,0.000702298732162064,0.040172468676108,0,5931,"sp|Q5EA68|S61A1_BOVIN","Q5EA68","S61A1",1.22e-37,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g28406",3101.98066598097,0.340067165306748,0.100363791090599,3.38834515527387,0.000703157188248251,0.040172468676108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33553",41.281990510874,-0.551558515602837,0.162802740777841,-3.38789453400841,0.000704313410389764,0.040172468676108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37965",304.297031990743,0.495244646541478,0.14618011363944,3.38790711138056,0.000704281114910084,0.040172468676108,18374,21904,"sp|Q25008|TBA1_HOMAM","Q25008","TBA1",1.04e-27,"Tubulin alpha-1 chain (Alpha-I tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g73628",189.780071262411,2.59529283309498,0.765918370510411,3.3884718437625,0.000702832443630639,0.040172468676108,0,5254,"sp|H2N0D4|AMY_ORYLA","H2N0D4","AMY",1.01e-26,"Alpha-amylase (EC 3.2.1.1)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005576; GO:0005975; GO:0046872"
"g55207",25.4179605037238,0.561502716610479,0.165795580433044,3.386717035182,0.00070734302930927,0.0402253151851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98021",19.2876968612771,0.939582141266028,0.277427946786083,3.3867609667692,0.000707229779397615,0.0402253151851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125713",26.8376149554325,1.43402742651043,0.423377648267945,3.38711179576223,0.000706325992264825,0.0402253151851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29686",694.620699529222,-0.252503413633876,0.0745778551158153,-3.38576931773852,0.000709790228091962,0.0402265070413897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34752",29.5917593908234,0.844470055102456,0.249439925511867,3.38546466997834,0.000710578559820669,0.0402265070413897,18052,20594,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.38e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g49492",1738.60144552772,-0.446470812430887,0.13187298324534,-3.38561243890465,0.000710196079183963,0.0402265070413897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100134",23.7355717513441,-0.518057473481499,0.153029112143602,-3.38535240925502,0.000710869260020375,0.0402265070413897,0,6486,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.43e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g143783",48.9437861841877,0.621755899398074,0.183640534262735,3.38572255789959,0.000709911174899443,0.0402265070413897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29719",33.193170558992,-0.511506058987881,0.151195197252052,-3.38308404158612,0.000716766946506377,0.0403510858558084,33141,35835,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.25e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g32889",617.726102170194,-0.363685609346214,0.107507572409793,-3.38288365362705,0.000717290128492935,0.0403510858558084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32908",740.9727989174,-0.482120992350898,0.142474974704816,-3.38389947673105,0.000714641626067892,0.0403510858558084,0,19481,"sp|Q9CXP4|RHG08_MOUSE","Q9CXP4","RHG08",2.56e-23,"Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8)","positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165]","GO:0005096; GO:0007165; GO:0070374"
"g71918",24.1095516126443,0.480887522005118,0.142140559513568,3.38318298204825,0.000716508759016038,0.0403510858558084,0,9204,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g82374",49.6652150207882,0.88722025276494,0.262237872701531,3.3832651387267,0.000716294434875409,0.0403510858558084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142289",89.7128949273185,0.550626534656086,0.162723517520639,3.38381656840873,0.000714857447598259,0.0403510858558084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18893",777.850115053539,-0.32186105818895,0.0951623882108219,-3.38222972584402,0.000718999901941675,0.0404076536468299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34568",109.833819475932,-0.535722043006641,0.158439541104871,-3.38123955213963,0.000721596039733974,0.0405138754989583,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15714",108.083369600117,0.41689012247435,0.12330567266064,3.38094844688701,0.000722360943890978,0.0405171759144324,59275,62016,"sp|Q9VE51|CPSF3_DROME","Q9VE51","CPSF3",6.24e-30,"Cleavage and polyadenylation specificity factor 73 (EC 3.1.27.-)","mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]","GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872"
"g32954",1409.11473381148,-0.774138614183865,0.22902608755922,-3.38013290291087,0.000724507869039489,0.0405331631614539,18500,31555,"sp|Q80U96|XPO1_RAT","Q80U96","XPO1",3.14e-35,"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]","GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0051028; GO:1990904"
"g89158",82.6208421036553,0.400013823566947,0.118346048606131,3.38003531404954,0.00072476516911209,0.0405331631614539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152891",4654.31115083821,-1.78623374637777,0.528393816386576,-3.38049706673886,0.000723548473798266,0.0405331631614539,885,1732,"sp|Q61696|HS71A_MOUSE","Q61696","HS71A",2.62e-82,"Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 3) (HSP70.3) (Hsp68)","ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]","GO:0000723; GO:0001664; GO:0003714; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006402; GO:0006457; GO:0006986; GO:0007041; GO:0008285; GO:0009408; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031249; GO:0031396; GO:0031397; GO:0031625; GO:0032436; GO:0032757; GO:0032991; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0044183; GO:0045121; GO:0045648; GO:0045666; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051787; GO:0055131; GO:0060548; GO:0070370; GO:0070434; GO:0090063; GO:0090084; GO:0097201; GO:0097718; GO:0140545; GO:1901673; GO:1903265; GO:1990904; GO:2001240"
"g91175",239.912364503751,-0.334897723309356,0.0990986058782025,-3.37943930029614,0.000726338445650569,0.0405421206336865,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107455",326.716847309021,0.471590232210726,0.139543121919576,3.37953046859967,0.000726097586536064,0.0405421206336865,0,2834,"sp|Q9NJH0|EF1G_DROME","Q9NJH0","EF1G",4.68e-13,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]; translational elongation [GO:0006414]","GO:0003746; GO:0005634; GO:0005737; GO:0005853; GO:0006414; GO:0006749"
"g130829",37.657267026496,-0.734833426078548,0.21747925802957,-3.37886671463003,0.000727852867313021,0.0405871696077951,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155933",107.596399669498,0.561176475026332,0.166133378483415,3.37786710984363,0.000730503736473523,0.0406954411639328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10730",424.848604776892,-0.377047332522325,0.111664925667838,-3.37659592094209,0.000733887778558688,0.0407258034175024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31891",34.0874754814602,2.24088416332313,0.663646412828733,3.37662363572728,0.000733813843792871,0.0407258034175024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63894",399.001490767101,0.480653715365167,0.142347791187188,3.37661519969148,0.000733836347883229,0.0407258034175024,3526,12284,"sp|Q5XGB9|AMPL_XENTR","Q5XGB9","AMPL",2.27e-20,"Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)",NA,"GO:0004180; GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g93861",53.6218849282071,-0.619422866462573,0.183432895775147,-3.37683632941098,0.000733246670842504,0.0407258034175024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112723",26682.2747560337,0.313007611408871,0.0927130880198826,3.37608872807414,0.000735242040149138,0.0407615345543551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2638",4262.08556436461,-0.370440131390926,0.109782862516031,-3.37429834585369,0.000740041141761724,0.0409411293728851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18713",38.5823869183734,2.18317951885048,0.647145566635375,3.3735524608493,0.000742049051024757,0.0409411293728851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69741",339.036658085812,0.578570919332326,0.1714888950171,3.37380982759633,0.000741355653251115,0.0409411293728851,3075,7330,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.56e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g72757",460.460201361605,1.77898402316647,0.527313867855436,3.37367198477356,0.000741726954659448,0.0409411293728851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79899",90.5979606347136,1.56779016015666,0.464669433336681,3.37399029864893,0.000740869786936138,0.0409411293728851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44584",602.340169829506,-0.281739072628244,0.0835219420109164,-3.37323421660167,0.000742907297927479,0.0409491073535819,0,16131,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.32e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g111770",20.631949070579,0.826407664007488,0.245014403600643,3.37289421300503,0.000743825244394071,0.040960357507996,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6376",94.4414293823423,0.41125542208957,0.121941633612473,3.37255955907996,0.000744729776309337,0.0409708480964811,32035,39627,"sp|Q9VZU4|NDUS3_DROME","Q9VZU4","NDUS3",7.57e-26,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase (Ubiquinone) 30 kDa subunit)","reactive oxygen species metabolic process [GO:0072593]","GO:0005739; GO:0005747; GO:0008137; GO:0072593"
"g2494",171.480570332873,0.402287234651878,0.119345432217561,3.3707803237792,0.00074955602676323,0.0411257719624586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52980",929.14335795248,-0.435354251196217,0.129187547270361,-3.36993975344324,0.000751846197082939,0.0411257719624586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56664",156.401346489698,0.397017786629272,0.117807104261902,3.37006659417284,0.000751500198237084,0.0411257719624586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66006",23.7108254303587,1.4571155263345,0.432260816420146,3.37091744378288,0.000749183052537426,0.0411257719624586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69215",34.6625249359831,0.630269319914178,0.186999968558644,3.37042473735243,0.000750524045655962,0.0411257719624586,4345,11096,"sp|Q5R8G6|MCM3_PONAB","Q5R8G6","MCM3",7.13e-20,"DNA replication licensing factor MCM3 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]","GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0016887; GO:0042555; GO:0071162"
"g77706",46.0828243346003,-0.797017234617274,0.236507558565742,-3.36994402821899,0.00075183453385015,0.0411257719624586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40515",115.368018602707,0.501673412464073,0.14889275639737,3.36936077081675,0.00075342743782475,0.0411338405160648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73585",587.536048010297,0.545484588964413,0.16189405983191,3.36939224039953,0.000753341412961548,0.0411338405160648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28380",2085.4440212906,-0.318987405337039,0.0946959378188283,-3.36854370614423,0.000755664151306725,0.0412100800717849,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55027",65.8740856841281,-0.542041663103389,0.16092314427292,-3.36832632467152,0.000756260270400654,0.0412100800717849,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5629",651.568766652427,-0.210931921443061,0.0626410637292458,-3.36731065670875,0.000759051298898705,0.041322925551051,17665,37500,"sp|Q9VMJ7|KDM5_DROME","Q9VMJ7","KDM5",4.39e-17,"Lysine-specific demethylase lid (EC 1.14.11.67) (Histone demethylase lid) (Jumonji/ARID domain-containing protein lid) (Protein little imaginal disks) (Retinoblastoma-binding protein 2 homolog) ([histone H3]-trimethyl-L-lysine(4) demethylase lid)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone demethylation [GO:0016577]; histone H3-K4 demethylation [GO:0034720]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; histone H3-K9 acetylation [GO:0043970]; larval somatic muscle development [GO:0007526]; locomotor rhythm [GO:0045475]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of stem cell differentiation [GO:2000737]; oocyte karyosome formation [GO:0030717]; positive regulation of transcription, DNA-templated [GO:0045893]; synaptonemal complex organization [GO:0070193]","GO:0003677; GO:0005634; GO:0006325; GO:0006338; GO:0007526; GO:0016577; GO:0030717; GO:0032452; GO:0032922; GO:0033749; GO:0034647; GO:0034720; GO:0034721; GO:0036098; GO:0043970; GO:0045475; GO:0045893; GO:0046872; GO:0070193; GO:0070822; GO:2000737"
"g5170",93.3179835320164,0.707277881523368,0.21012785465153,3.36594062075349,0.000762831274757643,0.041325807406644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15150",767.869504056429,-0.37821692478111,0.112368561794718,-3.36586068861555,0.000763052348941653,0.041325807406644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26539",1028.97852039719,0.811825009243895,0.241227004294225,3.36539854490632,0.00076433170040759,0.041325807406644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28038",2217.90235042986,0.231855687994032,0.0688920466123357,3.36549281659048,0.000764070566720915,0.041325807406644,0,3470,"sp|P31410|VATB_HELVI","P31410","VATB",4.19e-85,"V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)","ATP metabolic process [GO:0046034]","GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:0046961"
"g30674",10856.4736969595,0.318027086692775,0.094458741749105,3.36683594132025,0.000760359081309103,0.041325807406644,23345,34333,"sp|P62083|RS7_RAT","P62083","RS7",1.01e-22,"40S ribosomal protein S7 (S8)","cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005815; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0019901; GO:0022626; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059"
"g99007",26.5329849401549,0.82958705043867,0.246478603271423,3.3657568625749,0.000763339597065874,0.041325807406644,0,6618,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.06e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g136924",126.146737675797,-0.612318654964579,0.181886452935883,-3.36648851566986,0.00076131752171319,0.041325807406644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155557",66.7327413198548,0.494799654702728,0.147033996724495,3.36520577366783,0.000764865937013871,0.041325807406644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134738",54.6879146789979,0.864905599167314,0.257042755741372,3.36483164706479,0.000765903762346875,0.041342951912948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51045",658.814373425708,-0.496118127801839,0.147462389045798,-3.36437061010695,0.000767184474855155,0.0413731627511173,0,6362,"sp|Q92519|TRIB2_HUMAN","Q92519","TRIB2",1.24e-15,"Tribbles homolog 2 (TRB-2)","negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]","GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629"
"g131415",20.6864834287568,-0.856372107949736,0.254569355275169,-3.36400313000779,0.000768206719889112,0.0413893911617251,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17338",1579.29898809395,0.536674912937042,0.159557015847935,3.36353064818233,0.000769522913815854,0.0414214116273487,18597,55264,"sp|P28765|SODM_PALVU","P28765","SODM",8.59e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g132026",62.1891750459448,0.431439289790096,0.128308564950594,3.36251356217898,0.000772363320413111,0.0415353395738559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44065",41.2728917952147,0.416165217606095,0.123776933627588,3.36221948152495,0.00077318640890051,0.0415406705456098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102091",52.5509125290501,0.524292125620782,0.155956392271822,3.36178670193251,0.000774399176363294,0.0415669080820634,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81548",279.246306673714,-0.661505536248427,0.196808510188607,-3.36116327294225,0.000776149300355813,0.0415830502842358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118463",145.231650642498,0.974988435723697,0.290059382139742,3.36134080039506,0.000775650562023749,0.0415830502842358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97015",41.0314074179116,0.736629785992514,0.219204849978596,3.36046299187469,0.000778119545909982,0.0416497197241742,156,6838,"sp|P31335|PUR9_CHICK","P31335","PUR9",1.28e-21,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803"
"g12270",139.480739258931,-0.504113961519178,0.150053553757219,-3.35956029628472,0.000780666136037594,0.041669416637988,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73485",4061.5760464363,-0.528031120358575,0.157167853863721,-3.35966361681331,0.000780374267418636,0.041669416637988,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80029",20.017021284759,1.1136604561883,0.331461291440875,3.35985071242309,0.000779846001596963,0.041669416637988,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26436",160.566251409497,-0.355935998404941,0.105964537430561,-3.35901054292042,0.000782220830844614,0.04167822514458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26666",29.7746011031294,-0.63786292643812,0.189911127549914,-3.35874434882955,0.000782974656274727,0.04167822514458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52112",82.7167806738675,-0.463553734653753,0.138046083442133,-3.3579636820922,0.0007851892886248,0.04167822514458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64326",38.4864523962088,0.967344997792541,0.288036957443269,3.35840583228999,0.00078393426306628,0.04167822514458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105330",288.805143485101,0.677256549242361,0.201673851759686,3.35817729136932,0.000784582734608146,0.04167822514458,0,5919,"sp|Q04820|MDHC_ECHGR","Q04820","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37)","malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]","GO:0005737; GO:0006099; GO:0006108; GO:0030060"
"g140691",294.600568973763,-0.609871178428957,0.181618662863609,-3.35797637100189,0.000785153245687303,0.04167822514458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80510",78.813742967072,0.414908489596899,0.123578390326267,3.35745180449004,0.000786644561830166,0.0417168807373521,4335,9039,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.07e-27,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g39260",1064.12771245924,-0.770689475163387,0.229590678727079,-3.35679775606016,0.000788507671273737,0.0417356710093406,2425,23731,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.29e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g65981",1097.80964446981,0.385865250621981,0.114973982166935,3.35610929837787,0.000790473222174297,0.0417356710093406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107812",128.838540488576,0.573062120026538,0.170754815290884,3.35605247237283,0.000790635663770534,0.0417356710093406,955,5663,"sp|Q8JJC0|ZIC1_CHICK","Q8JJC0","ZIC1",8.29e-66,"Zinc finger protein ZIC 1 (Zinc finger protein of the cerebellum 1)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]","GO:0003677; GO:0005634; GO:0005737; GO:0007389; GO:0008589; GO:0021510; GO:0030154; GO:0042472; GO:0046872"
"g110314",67.7813235441445,-0.507533371443045,0.151219925676038,-3.35625989216756,0.000790042887811394,0.0417356710093406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124869",38.5352205800277,0.525247377516801,0.156482759715315,3.35658304130353,0.000789120195909762,0.0417356710093406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162655",164.273943013465,0.46708184820689,0.139195481682473,3.35558196689444,0.000791981831368346,0.0417683065109519,0,1019,"sp|P46471|PRS7_MOUSE","P46471","PRS7",3.17e-34,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0036464; GO:0043161; GO:0043197; GO:0140296"
"g104011",98.0339826795397,1.42091630891424,0.42360985496571,3.35430418404514,0.000795648448708128,0.0418462951300389,0,2914,"sp|P50903|LIPP_CAVPO","P50903","LIPP",4.31e-17,"Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0005576; GO:0016042; GO:0046872; GO:0047376"
"g110234",2378.97566321067,0.480590447991838,0.143273035054798,3.35436774832073,0.000795465678321162,0.0418462951300389,0,2975,"sp|Q5UAP0|RS4_BOMMO","Q5UAP0","RS4",2.78e-20,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g112131",306.422619643949,0.412835577515117,0.123062391172042,3.35468516078133,0.0007945535851302,0.0418462951300389,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150244",188.209401900039,0.555911747178644,0.165760904445813,3.35369639202451,0.000797398040661335,0.0418999080340177,0,1204,"sp|Q3T084|TCPW_BOVIN","Q3T084","TCPW",2.91e-23,"T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (CCT-zeta-2)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g100480",125.816307074246,-0.726628293448703,0.216684882346094,-3.3533871194951,0.000798289683523565,0.041908382470798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127082",171.482041699825,0.358503447601949,0.106929991808002,3.35269311762092,0.000800293882555541,0.041975194681021,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17274",602.635016856496,-0.523647880716105,0.156256031799274,-3.35121706782354,0.000804572084639009,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18498",524.132734576231,-0.521317827587334,0.155583526243226,-3.35072639228107,0.000805998958702398,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21581",361.924659272531,-0.308879914513986,0.0921898484581252,-3.35047643184148,0.000806726740813461,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52514",360.310230607738,0.730944829829164,0.218142262918334,3.35077128132116,0.000805868324807876,0.04197759248645,715,16145,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.53e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g53091",507.597416696477,0.747025668066069,0.222839161309201,3.35230873997741,0.000801405930140943,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55019",10053.2829502988,0.8158225485531,0.243476851397472,3.3507191499749,0.000806020036749353,0.04197759248645,3658,5934,"sp|Q7Z1E6|CALR_BOMMO","Q7Z1E6","CALR",8.63e-101,"Calreticulin","protein folding [GO:0006457]","GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082"
"g74760",72.0007486572109,-0.561773362536971,0.167710739933368,-3.34965645468004,0.000809118460962246,0.04197759248645,0,9971,"sp|P21328|RTJK_DROME","P21328","RTJK",2.45e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g82313",28.9788833691244,0.660812986558841,0.197264153643078,3.34988883867107,0.000808439973029246,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85389",69.7025802171353,0.422762784971673,0.126204253791175,3.34982991675701,0.000808611956449666,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87527",168.931836665777,0.485645097377361,0.144932995517526,3.35082494944109,0.000805712168250344,0.04197759248645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110840",20.4967304715779,1.17970359868864,0.352164286914712,3.34986721403225,0.000808503087866535,0.04197759248645,0,5355,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.17e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g140741",7661.05328600311,-2.15111113367238,0.642141657354438,-3.34990123913584,0.000808403782426433,0.04197759248645,1445,2786,"sp|Q9I8F9|HSP71_ORYLA","Q9I8F9","HSP71",0,"Heat shock 70 kDa protein 1 (HSP70-1)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192]","GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787"
"g70772",51.983046614142,2.62346516435885,0.783400471775648,3.34881744251765,0.000811572511845175,0.0420668750945584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37455",77.8402115683304,0.491705585670747,0.146864662934964,3.34801834453866,0.000813916236248629,0.0421502830649335,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27600",48.2776151150112,0.392169055005131,0.117144946922184,3.34772489389267,0.000814778491413648,0.0421568889425745,28649,38621,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.53e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g21076",575.54209830296,-0.350346019952917,0.104672262559389,-3.3470760198208,0.000816688108189248,0.0421796252456337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27727",5431.64377730539,0.266841591411756,0.0797213724418179,3.34717759163644,0.000816388911525491,0.0421796252456337,5341,17844,"sp|Q6GPM1|ZFR_XENLA","Q6GPM1","ZFR",4.17e-30,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0008270"
"g19146",38.3205170955402,1.38338359652053,0.413404635786653,3.3463185382238,0.000818922606638104,0.0422569956554806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51515",61.1345461763036,1.42127751716157,0.424798461414711,3.34576898519893,0.000820547284591759,0.0422648143535684,3485,10490,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.95e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g74524",4868.2198741703,-0.251981355855631,0.0753118703714495,-3.34583850610562,0.000820341590494739,0.0422648143535684,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20936",7422.21946518132,-0.420509429030967,0.125693359304401,-3.34551826252482,0.000821289504646089,0.04226510473237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13240",336.609316930409,-0.323519385061547,0.0967231766476582,-3.34479693776042,0.000823428334014607,0.0422794567558541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33515",69.7898879529964,-0.803739121818821,0.240339449343387,-3.34418308777296,0.000825252554314337,0.0422794567558541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48697",1400.38550993003,0.595483637939345,0.178055402430087,3.34437276157998,0.000824688487722889,0.0422794567558541,0,7584,"sp|Q8VEM8|MPCP_MOUSE","Q8VEM8","MPCP",3.54e-53,"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)","mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]","GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877; GO:1990547"
"g59545",2251.76858617908,0.850767558610719,0.254343604417628,3.3449536132773,0.000822963330237878,0.0422794567558541,2732,13264,"sp|Q86TX2|ACOT1_HUMAN","Q86TX2","ACOT1",8.46e-37,"Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)","acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991"
"g95880",24.9880813695473,0.649899098167952,0.194327945108019,3.34434194632531,0.000824780104161842,0.0422794567558541,625,6974,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.47e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g84395",8577.91269512077,0.93293748422432,0.279000822940942,3.34385208756822,0.00082623776563158,0.0422805468495112,4076,7935,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",5.47e-119,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g94486",48.2241577567951,-0.45891216297782,0.137257379419177,-3.34344255237691,0.000827458243960987,0.0422805468495112,0,4228,"sp|Q9P255|ZN492_HUMAN","Q9P255","ZN492",9.92e-53,"Zinc finger protein 492 (Zinc finger protein 115)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g101236",289.657317259443,1.27625800582245,0.381741449599384,3.34325236927195,0.000828025587573174,0.0422805468495112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161980",23.6834216165467,0.997634654715322,0.298408288515305,3.34318681186416,0.000828221238390563,0.0422805468495112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16460",36.6114099152163,-0.679952830276124,0.203472846772055,-3.34173744095623,0.000832557739769496,0.0424641449848655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113851",23.9246796874039,1.7851298410044,0.534236176742041,3.34146192025173,0.000833384473376976,0.0424685622401162,0,5074,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.83e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g3891",189.411742704506,-0.401986094998589,0.120378398275943,-3.33935407644415,0.000839734560557584,0.0425730407899851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56555",315.491653708974,1.31769657693493,0.394533184341967,3.33988781991225,0.000838122376115293,0.0425730407899851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71804",75.5644368430865,-0.543470385127686,0.162749605619544,-3.33930385304985,0.000839886409450386,0.0425730407899851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80346",41.1275762749411,-0.440002257502867,0.131753487006213,-3.33958719044845,0.000839030080857527,0.0425730407899851,0,9065,"sp|P21328|RTJK_DROME","P21328","RTJK",2.22e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g145194",65.8590143057014,0.687856577683308,0.205937198529368,3.3401278768256,0.000837398215095066,0.0425730407899851,0,1674,"sp|P18422|PSA3_RAT","P18422","PSA3",6.98e-14,"Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit K)","proteasomal protein catabolic process [GO:0010498]; regulation of endopeptidase activity [GO:0052548]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0010498; GO:0019773; GO:0031625; GO:0045202; GO:0052548"
"g147451",329.222033785738,0.272275534517899,0.0815352791721955,3.33935858541524,0.000839720929067548,0.0425730407899851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17630",172.499335757213,2.20734164137132,0.6611573598845,3.33860254048587,0.000842009469146109,0.0425969992063248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37773",106840.4881937,0.535777488839544,0.160479034008811,3.3386136210798,0.000841975886573783,0.0425969992063248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121232",280.32033620866,0.295659319607817,0.0885628529250511,3.33841232348315,0.000842586164154387,0.0425969992063248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6353",23.3651599953083,1.28911035036035,0.386288136761344,3.33717302625005,0.000846352411386517,0.0426033529304556,106125,110714,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.52e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g14069",1581.52023429744,-0.466415282756447,0.139761192275349,-3.33723027947232,0.000846178074350068,0.0426033529304556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15197",431.505215998512,0.551428337723704,0.165238651937888,3.3371631349969,0.000846382533795344,0.0426033529304556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64423",200.621527784754,-0.735266510521428,0.220265516644249,-3.33809177997189,0.000843558808621772,0.0426033529304556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76182",59.4696618464014,0.367774229284726,0.110206101192578,3.33714944367794,0.000846424230406402,0.0426033529304556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20093",31.6309321828155,1.26892696333937,0.380286036332121,3.33676980511365,0.00084758117041297,0.0426194815725683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76888",93.4807681920068,0.476974726377459,0.142954164880555,3.33655704803001,0.000848230183964325,0.0426194815725683,5271,9414,"sp|P37227|MDHM_SCHMA","P37227","MDHM",3.72e-19,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37) (Fragment)","tricarboxylic acid cycle [GO:0006099]","GO:0005759; GO:0006099; GO:0030060"
"g119235",1350.05334163264,1.00204739254129,0.300367099308554,3.33607573814845,0.000849700116513497,0.0426559866015262,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14627",326.000123022028,-0.391820899321861,0.117511931633795,-3.33430736670128,0.000855121076594171,0.0428363275555164,26373,44984,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.18e-16,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g43630",128.843709049231,0.305687934937782,0.0916727584344088,3.33455587197694,0.000854357349196871,0.0428363275555164,8966,21370,"sp|O00370|LORF2_HUMAN","O00370","LORF2",9.19e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g99546",145.71159359005,0.377655082002619,0.113276210471434,3.33393110902009,0.000856278628549621,0.0428363275555164,1685,6556,"sp|P21328|RTJK_DROME","P21328","RTJK",1.15e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g129364",18.5348872428344,1.93038852871894,0.578984699047743,3.33409247583545,0.000855782007752566,0.0428363275555164,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100619",1040.2503106889,0.413078910584566,0.123915312933162,3.33355822461888,0.000857427236130394,0.0428564240497927,2426,6427,"sp|Q66LN0|PGES2_BOVIN","Q66LN0","PGES2",7.37e-14,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form]","glutathione metabolic process [GO:0006749]; prostaglandin biosynthetic process [GO:0001516]","GO:0001516; GO:0005739; GO:0005783; GO:0006749; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220"
"g114648",72.8202537464,-1.13706765825769,0.341193327631233,-3.33261985558714,0.000860324048759994,0.0429637893105731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22196",168.684494496742,-0.421658523289016,0.126556671318426,-3.33177634095711,0.000862935782084965,0.0430408533205319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37753",95.8044287761472,1.71087023574394,0.513522376914813,3.3316371645237,0.000863367413243852,0.0430408533205319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5037",1255.40529019907,-0.265453915771026,0.0796875000314167,-3.33118639267603,0.000864766777238784,0.043073192428786,10335,37240,"sp|Q01484|ANK2_HUMAN","Q01484","ANK2",4e-22,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"g69303",177.080629537534,-0.347895551270537,0.104445795701498,-3.33087175921191,0.000865744762863166,0.0430801171923636,3805,9110,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g80375",17.8063940308206,-0.972037402435887,0.29184538813616,-3.33065877327616,0.000866407376089014,0.0430801171923636,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49949",22.2420458783988,-0.903184246384727,0.271201254331336,-3.33030998920556,0.000867493481861865,0.0430967757482544,0,5623,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.41e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g45499",21.8546810538216,0.883130238821788,0.265283224400615,3.32900898960779,0.000871555912079708,0.0432611403418111,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106475",71.7534493065473,0.849790434070541,0.255296706018228,3.32863845885213,0.000872716134193319,0.0432812893517827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38387",518.792165022314,0.371063515885039,0.111489572686322,3.32823516087046,0.000873980585924792,0.0433065682386568,2174,5474,"sp|Q9NQP4|PFD4_HUMAN","Q9NQP4","PFD4",5.23e-23,"Prefoldin subunit 4 (Protein C-1)","negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]","GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907"
"g136695",44.7984982315985,-0.499493361838318,0.150099554038113,-3.32774714115064,0.000875512935168531,0.0433450666263765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26668",151.229818673534,-0.647096712432434,0.194510302355786,-3.32679916999361,0.000878496622142245,0.0434552898090707,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115103",129.281726820776,-0.523578105663573,0.157395287813102,-3.32651703197933,0.000879386454660107,0.0434618387324694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9747",66.4798306562775,-0.369246420093978,0.111022223012094,-3.32587845997062,0.000881403527845761,0.0435199431099994,80631,83434,"sp|P21328|RTJK_DROME","P21328","RTJK",8.89e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g77074",88.5794160340773,-0.597984185126595,0.179808910524978,-3.3256649149405,0.000882079014237178,0.0435199431099994,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44756",194.937802801851,0.473363297753321,0.142363696295617,3.32502815022718,0.000884096080795085,0.0435785142917364,0,3307,"sp|Q8CIE6|COPA_MOUSE","Q8CIE6","COPA",2.77e-12,"Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463"
"g91720",54.8902775347598,1.48290998781368,0.44601724268292,3.32478174810811,0.00088487775053434,0.0435785142917364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134456",615.845266104985,0.479214230824179,0.144143147730741,3.32457170783692,0.0008855445741402,0.0435785142917364,688,3224,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.85e-14,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113088",17.8353103346356,4.03483113484501,1.21372985374679,3.32432387848867,0.000886331967373499,0.0435798871361537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10686",858.626054034817,-0.774747520599636,0.233076995888191,-3.32399822490972,0.000887367607295776,0.043593453173486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3453",150.93597798677,-0.482999257579781,0.145379812346703,-3.32232687457267,0.000892700492010638,0.0437976771913193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73858",1557.06536942418,0.585206528106679,0.176149385201897,3.32221726142235,0.00089305127768985,0.0437976771913193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31717",74.5662596647419,0.521899391128402,0.157149651349373,3.32103435576908,0.000896844968352368,0.0438338707700672,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41788",183.334966910704,0.541054299281726,0.162908847167713,3.3212088151647,0.000896284523038534,0.0438338707700672,0,22424,"sp|P06795|MDR1B_MOUSE","P06795","MDR1B",1.53e-19,"ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)","carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell barrier remodeling [GO:0061843]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0000139; GO:0005524; GO:0005654; GO:0005739; GO:0005886; GO:0008559; GO:0009410; GO:0009986; GO:0014045; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046581; GO:0046943; GO:0047484; GO:0061843; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225"
"g87491",57.5728601806093,-0.847103005937955,0.255066440005605,-3.32110726099185,0.000896610723124086,0.0438338707700672,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150432",408.930749310668,1.28694137316769,0.387476042540796,3.32134437197415,0.000895849275188526,0.0438338707700672,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16826",205.352550475426,-0.422166591579901,0.127198314468506,-3.31896372482537,0.000903521657763576,0.0439729200360255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36871",56.366653769979,0.337865225154592,0.101795077919403,3.31907231724993,0.000903170363135035,0.0439729200360255,5066,21604,"sp|Q6ZN19|ZN841_HUMAN","Q6ZN19","ZN841",9.07e-29,"Zinc finger protein 841","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g46094",83.0582096166245,-0.630486652960524,0.189913503985271,-3.31986214634544,0.000900619085815077,0.0439729200360255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49142",22.4012839014304,-0.49960860044571,0.150515924403976,-3.31930725884385,0.000902410764280019,0.0439729200360255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85664",33.535975357962,0.783604484898521,0.236096333613943,3.31900319206077,0.000903393967288423,0.0439729200360255,4913,7964,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.61e-42,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g58981",58.1234250540746,0.366618990644876,0.110484715500479,3.31827790825317,0.000905743189626169,0.0440401149836554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129479",50.3031089162611,-0.647422899196224,0.195120682807876,-3.31806392781898,0.000906437361374992,0.0440401149836554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61871",22.4907102517745,1.59039065358685,0.479357406477852,3.31775546198916,0.000907438919978515,0.0440514765045408,4085,12868,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",4.31e-68,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g6440",28.7067770480336,-0.645055852504963,0.194491564531539,-3.31662637430406,0.000911113712272101,0.0441814265500214,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83571",54.4178141315437,-0.500431470057732,0.150903989006853,-3.31622426518496,0.000912425766151539,0.0441814265500214,1681,4154,"sp|P51522|ZNF83_HUMAN","P51522","ZNF83",8.6e-41,"Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g130292",88.1994247537412,0.425852348735623,0.128411183580673,3.3163182275949,0.000912119016714533,0.0441814265500214,0,3608,"sp|Q6DEU3|VPS29_XENTR","Q6DEU3","VPS29",1.34e-29,"Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0032456; GO:0042147; GO:0046872"
"g56280",32.3810593817185,-0.536689089552529,0.161859154945266,-3.31577839841073,0.000913882645198754,0.0442123953194927,0,14683,"sp|P21328|RTJK_DROME","P21328","RTJK",1.82e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g69150",23.9404866747002,4.99463953411482,1.50642540661157,3.31555715417025,0.000914606365357927,0.0442123953194927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5462",371.068852652167,-0.529155096631157,0.159630957231444,-3.31486514776673,0.000916873442883025,0.0442131291329838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11359",185.632951196035,-0.393824702722708,0.118793713343262,-3.31519818380225,0.000915781736545102,0.0442131291329838,16021,47354,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.02e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g148232",3772.82130847014,0.318436088025712,0.0960635869922617,3.31484694665173,0.000916933141656512,0.0442131291329838,0,308,"sp|P31009|RS2_DROME","P31009","RS2",9.82e-13,"40S ribosomal protein S2 (Protein strings of pearls)","cytoplasmic translation [GO:0002181]; oogenesis [GO:0048477]; translation [GO:0006412]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0022626; GO:0022627; GO:0048477"
"g38753",77.9473436646551,0.563279666864485,0.169968852776852,3.31401699583159,0.000919659170009429,0.0442255635358144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47028",456.313708304543,-0.600735058630879,0.181272660178648,-3.31398600339865,0.000919761112010338,0.0442255635358144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97263",39.9410489053727,0.638783928188158,0.192771540933272,3.31368377871333,0.000920755754985262,0.0442255635358144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138677",90.2396140735972,-0.807137655733329,0.243525613285027,-3.31438506547827,0.00091844929549705,0.0442255635358144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139444",211.231466608214,-0.347159261110949,0.104768130759054,-3.31359602004685,0.000921044761681739,0.0442255635358144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20022",87.0599183395617,0.344188673554042,0.103896835125531,3.31279266724712,0.000923694271121535,0.0442786777585244,1590,37014,"sp|Q62824|EXOC4_RAT","Q62824","EXOC4",2.14e-15,"Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8)","chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030426; GO:0031252; GO:0031267; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0043209; GO:0044091; GO:0044877; GO:0045202; GO:0047485; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0090522; GO:0090543"
"g91791",267.668924917562,0.642892221305812,0.194061867760474,3.31282095099342,0.000923600869682425,0.0442786777585244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1039",200.411078520084,0.492924828184003,0.148835946486778,3.311866789034,0.000926756636436931,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20094",31.0296032043028,1.07727869479588,0.325231238391954,3.312346932362,0.00092516737806589,0.0443088449772263,18795,22063,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.11e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g30260",678.848503039758,-0.460356333035709,0.139086118385598,-3.30986541560841,0.00093340840037173,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30568",198.011559336742,-0.540375144272777,0.163174843488414,-3.31163268013888,0.000927532446066756,0.0443088449772263,0,10013,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.17e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g49006",49.5788716955269,-0.600783496465464,0.181484720529424,-3.31038059134053,0.000931691947841992,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51273",277.556193052877,-0.738817391615536,0.223156668344977,-3.31075650615738,0.000930441328109049,0.0443088449772263,5655,16736,"sp|P21328|RTJK_DROME","P21328","RTJK",7.58e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g79426",87.1724358459149,-0.361237756578897,0.109090248848861,-3.31136614308555,0.000928416451359695,0.0443088449772263,0,9216,"sp|Q9BYN7|ZN341_HUMAN","Q9BYN7","ZN341",7.29e-24,"Zinc finger protein 341","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872"
"g86487",240.602290668087,0.276432192749568,0.0835248679404804,3.3095795248255,0.000934362189307143,0.0443088449772263,458,7124,"sp|Q7QJ33|WDR12_ANOGA","Q7QJ33","WDR12",8.87e-22,"Ribosome biogenesis protein WDR12 homolog","maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0000466; GO:0005654; GO:0030687; GO:0043021; GO:0070545"
"g95072",91.8496766823414,0.964865237603454,0.291531633585543,3.30964165273111,0.000934154841407541,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101327",289.902409695418,1.26970964768818,0.383587028295682,3.31009537347922,0.000932641869507533,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112547",249.204606402329,2.46693827896015,0.745326982372703,3.30987383699273,0.000933380318627945,0.0443088449772263,926,4814,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.02e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g118044",182.762571015899,0.341567109259887,0.103188437898585,3.31012966390268,0.000932527617385938,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158988",25.8597329221777,2.54751420045555,0.769243841785044,3.31171218029383,0.000927268924356308,0.0443088449772263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48950",39.1785426025154,-0.672247311138678,0.203198900757592,-3.30832159343539,0.0009385696373523,0.0444714433809791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55952",17.655618941691,-0.665937375272656,0.201309588596558,-3.30802611000936,0.000939560493726142,0.0444714433809791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128345",136.714696134803,0.500543609550565,0.151319440880662,3.30786055405346,0.000940116082626833,0.0444714433809791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6771",44.8626345313075,1.00291895295434,0.30332817066359,3.30638249246769,0.000945089812002189,0.0446245557661528,4925,24051,"sp|P21328|RTJK_DROME","P21328","RTJK",6.35e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g53850",655.005689322329,0.468645751524807,0.141747301006084,3.30620581978272,0.000945685950011186,0.0446245557661528,8572,13184,"sp|Q5ZJF4|PRDX6_CHICK","Q5ZJF4","PRDX6",5.72e-15,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0008379; GO:0016042; GO:0045454; GO:0047184"
"g84416",91.8399182349981,0.341683918505256,0.103333138556672,3.30662479895413,0.000944272775175918,0.0446245557661528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61425",21.1293874145142,0.544186711379112,0.16469129314714,3.30428343223292,0.000952195122698048,0.0448634430435593,0,2414,"sp|P21328|RTJK_DROME","P21328","RTJK",1.05e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g83867",176.989449729587,0.406838981894784,0.123126007068241,3.30424896885756,0.000952312192873043,0.0448634430435593,1796,6184,"sp|P26640|SYVC_HUMAN","P26640","SYVC",2.47e-18,"Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)","tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]","GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438"
"g16947",149.301139032795,-0.278147668510849,0.0842162540619749,-3.30277891849903,0.000957318303484926,0.0449378104142772,30855,58819,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.85e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g31812",1744.65645160394,-0.490388807972254,0.148473094455815,-3.30287995794545,0.000956973445125345,0.0449378104142772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44366",39.6296263467603,0.699343523401666,0.211735092028971,3.30291741770409,0.000956845620231606,0.0449378104142772,0,20802,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.36e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51272",3859.05245768381,-0.45859622092197,0.13887622768208,-3.30219382090218,0.000959317567945441,0.0449378104142772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82061",193.077360408886,0.866155713010671,0.262280322353768,3.30240448554271,0.000958597286822988,0.0449378104142772,0,8384,"sp|P15144|AMPN_HUMAN","P15144","AMPN",4.12e-11,"Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062"
"g100342",289.252025886571,0.67404286104869,0.204091314336881,3.30265334043608,0.000957747075179873,0.0449378104142772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127077",28.1880381711713,1.38736460473585,0.420148832831891,3.30207892137824,0.000959710630851988,0.0449378104142772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142290",324.29635892476,0.337834119835788,0.102313556061722,3.30194876260567,0.000960156074728195,0.0449378104142772,0,2480,"sp|P33731|SRP72_CANLF","P33731","SRP72",9.85e-12,"Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022"
"g4868",37.0366708001707,0.502716106088994,0.15231891270229,3.30041816324912,0.000965408648294246,0.0450424630219795,3845,16340,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.55e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g16922",47.3332082059638,0.820503290380413,0.248560379602455,3.30102203614558,0.000963333161037012,0.0450424630219795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43009",1926.03358663381,0.30084411412462,0.0911424899172659,3.30081078976128,0.000964058736086668,0.0450424630219795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81889",29.0250102517507,-0.469539662173246,0.142276094789456,-3.30020066173507,0.000966157206263736,0.0450424630219795,0,8820,"sp|Q8R180|ERO1A_MOUSE","Q8R180","ERO1A",1.48e-16,"ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase alpha) (Endoplasmic reticulum oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha)","animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","GO:0005783; GO:0005789; GO:0006457; GO:0006979; GO:0010260; GO:0015035; GO:0016491; GO:0016972; GO:0018401; GO:0022417; GO:0030176; GO:0030198; GO:0030425; GO:0030968; GO:0034975; GO:0034976; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456; GO:0071949"
"g98162",22.7063329205082,-0.944244886106252,0.28612144087933,-3.3001542394178,0.00096631704391873,0.0450424630219795,1185,6304,"sp|P04323|POL3_DROME","P04323","POL3",6.72e-83,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g12158",71.4532094209095,1.23658663154766,0.374815387351321,3.29918854262135,0.000969647613373603,0.0451610227722219,31558,46724,"sp|Q9GKT2|FXDC2_MACFA","Q9GKT2","FXDC2",5.85e-24,"Fatty acid hydroxylase domain-containing protein 2","lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]","GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654"
"g123197",30.5488843981624,-0.541805236017303,0.164237639165697,-3.29891027884713,0.000970609282014271,0.0451691489067144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9701",105.493615675377,0.344585834096038,0.10449122390741,3.29774904733988,0.000974631993943035,0.0452788310295308,0,8330,"sp|Q9JMD1|SMBT1_MOUSE","Q9JMD1","SMBT1",9.43e-19,"Scm-like with four MBT domains protein 1","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]","GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635"
"g9872",530.087829131143,-0.367681858256596,0.111516983318671,-3.29709293880296,0.000976911690738221,0.0452788310295308,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12119",307.947828777955,1.90648542790871,0.57817312996533,3.2974300068615,0.000975739907237121,0.0452788310295308,19729,54734,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.13e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17388",2827.96495452855,-0.43485948357244,0.131874678010478,-3.29752072295402,0.000975424764142031,0.0452788310295308,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81361",70.5066614794581,0.362326147925231,0.109885320600526,3.29731165132077,0.000976151210122787,0.0452788310295308,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29333",274.711368663003,-0.63914862569567,0.193938899214893,-3.29561850811304,0.000982052735061522,0.0453372263081248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33441",161.352889737009,-0.590731861435792,0.179261018186545,-3.29537267729371,0.000982912330556069,0.0453372263081248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42886",4989.84773878519,-0.262034925744441,0.0795044229756311,-3.29585343729564,0.00098123190978719,0.0453372263081248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50670",169.59757225934,0.292578051598827,0.0887797760952349,3.29554842856301,0.000982297710941271,0.0453372263081248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85491",1797.10257419744,0.607712406751511,0.184352782992418,3.29646451161252,0.000979099835410165,0.0453372263081248,6748,8298,"sp|Q08013|SSRG_RAT","Q08013","SSRG",1.02e-18,"Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005783; GO:0005784; GO:0006614; GO:0016021"
"g131915",32.3485490142348,1.24324232507939,0.377170395506151,3.29623517617548,0.000979899496918594,0.0453372263081248,0,3329,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.71e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g6744",261.875005437876,-0.2947584745085,0.0894722260940323,-3.2944131086972,0.000986274321166621,0.0454248692586853,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15378",447.246153946867,-0.607788436530475,0.184517843018194,-3.29392771229472,0.000987979031628429,0.0454248692586853,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66077",237.396415697342,0.370009821724629,0.112329441087216,3.29397011276272,0.000987830012659253,0.0454248692586853,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73724",22.9979479160935,0.487981457614975,0.148129266633405,3.2942946974999,0.000986689929538247,0.0454248692586853,5085,9751,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.75e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g38786",8680.09365285046,0.416323506863629,0.126400651578509,3.29368165167287,0.000988844237296749,0.0454282484676441,0,3768,"sp|Q5E973|RL18_BOVIN","Q5E973","RL18",4.42e-23,"60S ribosomal protein L18","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g4807",189.201096228226,1.54656546053561,0.469696773689416,3.29268912874897,0.000992341302676023,0.0454433710674782,99995,119783,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.81e-11,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g65225",29.9356490397484,-1.17846507491072,0.357839927014209,-3.2932744111138,0.000990277730132837,0.0454433710674782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68614",38.3413908247586,0.963030458395525,0.292458475879893,3.29287928995097,0.00099167040128997,0.0454433710674782,2221,11234,"sp|P29291|TNNCB_HOMAM","P29291","TNNCB",1.46e-20,"Troponin C, isoform 2B",NA,"GO:0005509"
"g125561",50.7270937283,-0.967661872563712,0.293870212838031,-3.29282053876296,0.00099187763455082,0.0454433710674782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7789",2247.16445533227,0.528549123212023,0.160604840300685,3.2909912442394,0.000998350206086841,0.045573058731315,82615,86896,"sp|O61661|CHK1_DROME","O61661","CHK1",3.13e-17,"Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes)","centrosome separation [GO:0051299]; DNA damage checkpoint signaling [GO:0000077]; intracellular signal transduction [GO:0035556]; mitotic DNA replication checkpoint signaling [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; spindle assembly [GO:0051225]; wound healing [GO:0042060]","GO:0000077; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0007348; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299; GO:0051726; GO:0106310"
"g27676",2466.21267982032,-0.373333229490555,0.113418596455706,-3.29164035843412,0.000996048990213068,0.045573058731315,9505,35294,"sp|C9J069|AJM1_HUMAN","C9J069","AJM1",1.42e-22,"Apical junction component 1 homolog","cell-cell junction organization [GO:0045216]","GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216"
"g41532",2553.31892626963,-0.444322147623668,0.134994470788921,-3.29140997425306,0.000996865177017386,0.045573058731315,6976,22863,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.48e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g130376",305.932926632151,2.11087527023751,0.64136940783226,3.29120042905068,0.000997608074797759,0.045573058731315,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44890",1552.36446315377,-0.355909933885261,0.108156562130416,-3.29069200125004,0.000999412728065972,0.045585295974901,5487,20034,"sp|Q9VE46|SC5A7_DROME","Q9VE46","SC5A7",4.48e-27,"High-affinity choline transporter 1","acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]","GO:0003333; GO:0005307; GO:0005886; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021"
"g6170",197.149027947145,0.474098810213193,0.144124327494783,3.2895127315016,0.00100361016084228,0.0456152038022828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36469",35.6765191475583,1.16478563882815,0.35409793456298,3.28944488271501,0.00100385215413736,0.0456152038022828,1283,11884,"sp|Q2QEI3|IOD1_XENLA","Q2QEI3","IOD1",1.72e-11,"Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)","hormone biosynthetic process [GO:0042446]","GO:0004800; GO:0005789; GO:0016021; GO:0042446"
"g87316",40.9028532651413,0.712656634206572,0.216603247766381,3.29014750035148,0.0010013487731836,0.0456152038022828,0,8051,"sp|Q86WI1|PKHL1_HUMAN","Q86WI1","PKHL1",5.34e-12,"Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","immune response [GO:0006955]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016021; GO:0032426; GO:0038023; GO:0120234"
"g109090",195.719742116687,-0.49376334212647,0.150107814903106,-3.28939131147296,0.00100404326250058,0.0456152038022828,0,5538,"sp|Q8TBB1|LNX1_HUMAN","Q8TBB1","LNX1",1.83e-24,"E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005737; GO:0006511; GO:0030165; GO:0042802; GO:0046872"
"g147477",24.0649250501207,1.60531275114266,0.487992239847464,3.28962762121883,0.00100320051186223,0.0456152038022828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9410",241.182255254997,-0.34706671912103,0.10555426522796,-3.28804069045896,0.00100887256816206,0.0456441607810364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21235",3313.9166494069,-0.610553874183462,0.185696643954614,-3.28791011609605,0.00100934059034873,0.0456441607810364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21282",18.5590299390192,1.3615870325575,0.414039189126852,3.28854627367251,0.00100706228299992,0.0456441607810364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31893",262.114076903185,2.59122312096869,0.788167146459198,3.28765685376462,0.00101024894025647,0.0456441607810364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32544",6347.85023641859,-0.313524115641075,0.0953625147124732,-3.28770813758823,0.00101006494477423,0.0456441607810364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68271",19.8479853836937,0.925950165798619,0.281631542260057,3.28780703456718,0.00100971021097402,0.0456441607810364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99379",27.4324874412438,0.786656092803306,0.23918514651642,3.2889002693539,0.00100579656059041,0.0456441607810364,0,6574,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.24e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g125505",28.7535341382102,0.623819404747316,0.189810737117426,3.28653380847149,0.00101428597557637,0.0457905029729129,0,3995,"sp|Q80ZD3|S2611_MOUSE","Q80ZD3","S2611",1.66e-15,"Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)","sulfate transport [GO:0008272]","GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231"
"g152272",23.8051972230482,1.24964585188752,0.380300781268017,3.28594079591657,0.00101642370993745,0.0458509374812977,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7897",129.826540490022,-0.368591353117269,0.112249279463995,-3.28368569381774,0.00102459120469426,0.045918274956901,45125,55655,"sp|Q8C863|ITCH_MOUSE","Q8C863","ITCH",2.17e-25,"E3 ubiquitin-protein ligase Itchy (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Itchy homolog)","apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0002669; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006915; GO:0016020; GO:0016567; GO:0016874; GO:0031410; GO:0031901; GO:0032088; GO:0032991; GO:0035519; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046642; GO:0050687; GO:0051607; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0090085; GO:1990763; GO:2000646"
"g11602",25.2966890729077,-0.540231073066898,0.164461290815392,-3.28485244393045,0.00102035793350281,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32218",169.994965018182,-0.650043580875295,0.198022208772072,-3.28268018474386,0.00102825248606102,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33248",903.123686713081,-0.379872324586388,0.11573259467028,-3.28232790138885,0.00102953808940832,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37846",376.455582267129,-0.45047127681702,0.137182522829264,-3.28373664171254,0.00102440601367097,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38164",84.9554410001051,-0.660685372941993,0.201212403160675,-3.28352210183789,0.00102518605635118,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43798",156.326910047086,0.704769543709716,0.214704603481701,3.28250783765697,0.0010288812542236,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52879",570.447793101261,0.4009561963365,0.122134570731258,3.28290502792001,0.00102743273274314,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60478",135.089092816334,0.410050262085974,0.124920955485236,3.28247779160188,0.00102899090666739,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61723",30.1087137106587,0.67981393412023,0.207057913544998,3.28320672454034,0.00102633373053436,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73806",1447.83910354989,0.565952065516009,0.172287896266867,3.28492063446738,0.00102011102201064,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98366",64.6403868673633,0.426712393830866,0.130007119430893,3.28222327899275,0.00102992017897406,0.045918274956901,0,5744,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.1e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g102435",35.296943630113,0.522068190529822,0.159046924694652,3.28247900128922,0.00102898649173001,0.045918274956901,0,6228,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.5e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g121439",131.50723681001,1.06821022114922,0.32527515061183,3.28402037210638,0.00102337524570143,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138966",20.2632649790438,0.767533362189376,0.233730360156105,3.28384109653856,0.0010240264266202,0.045918274956901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113993",4807.86147436893,0.654919234431153,0.199559300277856,3.28182767487798,0.00103136614423105,0.0459470414254483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73253",203.413021085764,0.399921144325172,0.121877453813438,3.28133819514595,0.00103315783281981,0.0459911531785886,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59682",18.7503348507202,0.777804207211676,0.237085644051726,3.28068875837112,0.00103553947344527,0.0460141512686378,0,13531,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.62e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62700",71.6911528188597,-0.636141368574729,0.193906620683383,-3.28065832065343,0.00103565122040679,0.0460141512686378,4685,12625,"sp|A6NJL1|ZSA5B_HUMAN","A6NJL1","ZSA5B",2.66e-24,"Zinc finger and SCAN domain-containing protein 5B","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g102807",119.002668343264,0.344142077360261,0.104909849078413,3.28036004611005,0.00103674687587063,0.0460141512686378,0,6187,"sp|Q4U0S5|PAF1_DANRE","Q4U0S5","PAF1",2.84e-23,"RNA polymerase II-associated factor 1 homolog (PD2-like protein)","heart development [GO:0007507]; histone modification [GO:0016570]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0000791; GO:0000993; GO:0003682; GO:0005634; GO:0006368; GO:0007507; GO:0016570; GO:0016593"
"g126738",59.4780747587004,-0.573468732430572,0.174820799751263,-3.28032324097882,0.00103688214692138,0.0460141512686378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55888",33697.8124588886,-1.00754759138592,0.30729786206978,-3.27873283790411,0.00104274303044355,0.0462384815199776,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76791",25.673964287986,1.41723219708891,0.432286932900093,3.27845254905368,0.00104377911041618,0.0462486836723399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13564",86.9185134980066,-0.457896552708588,0.139721655519623,-3.27720531943081,0.00104840102063455,0.0464176316080328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31851",2505.98389944127,-0.270984861519576,0.0827098458072257,-3.27633135904,0.00105165096747013,0.0465175778078756,0,22596,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.38e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g107663",41.3169379045689,0.482790754684355,0.147374497592292,3.27594504186189,0.00105309051189317,0.0465175778078756,0,5678,"sp|Q9N5X6|ODD2_CAEEL","Q9N5X6","ODD2",5.68e-19,"Protein odd-skipped-related 2","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g146491",29.4438632031635,1.26063713061657,0.384790970260101,3.27616089786214,0.00105228593709697,0.0465175778078756,378,2299,"sp|P10394|POL4_DROME","P10394","POL4",1.87e-41,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g82308",281.66026838714,0.512976367227983,0.156599906539187,3.27571311225283,0.00105395563324956,0.0465199801814304,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g130704",132.88198684571,0.464547718150805,0.141833028038477,3.2753141110742,0.00105544548761319,0.046549932420634,0,3576,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",2.25e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g138234",251.051790596882,0.393020228140613,0.120012763155011,3.27482025918343,0.00105729220904637,0.046595566017727,0,2983,"sp|Q00725|SGS4_DROME","Q00725","SGS4",1.61e-11,"Salivary glue protein Sgs-4","puparial adhesion [GO:0007594]","GO:0005576; GO:0007594; GO:0062130"
"g26057",32.9476717570992,-0.5234550736575,0.159870306308001,-3.274248268775,0.00105943485968696,0.0466183836264094,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157241",41.7662055976357,0.847750865247995,0.258901819962677,3.2744106061912,0.0010588263430277,0.0466183836264094,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15700",256.083201131501,-0.481798453615378,0.147171380156479,-3.27372382526487,0.00106140293124824,0.0466691955517424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52339",70.3015401390328,0.830813627703791,0.253815675357278,3.27329518373645,0.00106301399947721,0.0467042444793277,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78101",477.900272708263,0.586914917118124,0.179347932248971,3.27249335834755,0.00106603377143358,0.0468010847780099,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6827",52.5999269230191,-0.730116109099669,0.223174571849837,-3.27150222826876,0.00106977745504956,0.0468936824833796,9645,39902,"sp|P21328|RTJK_DROME","P21328","RTJK",1.84e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g85298",632.172665735983,0.469888514391131,0.143627142892054,3.27158575273119,0.00106946149889882,0.0468936824833796,115,7219,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.23e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g4978",1129.54727823262,-0.698650573407573,0.21363952628366,-3.27023086767164,0.00107459742770796,0.0470690079403685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10432",24.7060816171518,-0.652902438564413,0.199678875626538,-3.26976219450245,0.00107637931973714,0.0470751870171624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133752",621.459076467841,0.992335471499764,0.303484311877494,3.26980813393852,0.00107620453758757,0.0470751870171624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55003",471.931252614741,-0.48452481807663,0.148195234652646,-3.2695033629948,0.00107736456637131,0.0470823905699817,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54899",104.234034228214,-0.589803133462489,0.180468743245955,-3.2681733293763,0.00108244053207089,0.0472322720381958,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87896",90.0327151083769,1.89639096735949,0.580231536144565,3.26833487879742,0.00108182281372572,0.0472322720381958,0,7725,"sp|Q64380|SARDH_RAT","Q64380","SARDH",3.59e-20,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053"
"g27775",119.732550114603,-0.373763846972729,0.114400905812288,-3.26714062549479,0.00108639700829046,0.0473181482384258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37447",49.7043133573684,0.780317521401136,0.238860220263582,3.26683748570631,0.00108756092871936,0.0473181482384258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39776",741.875448926747,-0.510038556460756,0.156133892572345,-3.26667418622403,0.00108818840314912,0.0473181482384258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86262",23.9266439976752,0.596758081914338,0.182675762446955,3.26676113963188,0.00108785424505457,0.0473181482384258,0,3664,"sp|A7YWE4|AL4A1_BOVIN","A7YWE4","AL4A1",5.9e-17,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0005759; GO:0010133; GO:0016620"
"g125509",34.3516387922232,-0.600447657405984,0.183815111188864,-3.26658484997485,0.00108853181726598,0.0473181482384258,0,3995,"sp|Q13905|RPGF1_HUMAN","Q13905","RPGF1",1.67e-45,"Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G)","cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0007165; GO:0007169; GO:0007265; GO:0007399; GO:0010976; GO:0017124; GO:0032486; GO:0038180; GO:0043231; GO:0043547; GO:0061028; GO:0071320; GO:1901888; GO:1990090"
"g72777",542.987841424313,0.465486591518702,0.142508839432536,3.26636995552171,0.00108935829553617,0.0473182278560676,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1553",37.2985102234978,-0.436306104599596,0.133591055192183,-3.2659829205775,0.00109084828556745,0.0473471063735706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9822",130.017380103359,-0.986893255311778,0.302217188616755,-3.26551001228216,0.00109267142547195,0.0473903903201665,0,10062,"sp|P18700|TBB_STRPU","P18700","TBB",3.69e-62,"Tubulin beta chain (Beta-tubulin) (Fragment)","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874"
"g1505",247.82116611434,-0.431909756874944,0.132349964301603,-3.26339156307359,0.00110087303628081,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6555",125.009645843852,-0.527848713802671,0.161859839879714,-3.26114689224295,0.00110962540680664,0.0474065381958497,0,30018,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.25e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10782",30.3617543349733,-0.506836171012794,0.15531859443709,-3.26320343581324,0.00110160411950733,0.0474065381958497,48555,52001,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.38e-19,"PiggyBac transposable element-derived protein 4",NA,NA
"g22103",165.355561859275,0.428053393523704,0.131283419296241,3.260528982398,0.00111204601623586,0.0474065381958497,9477,22094,"sp|B7Z0W9|OTOP_DROME","B7Z0W9","OTOP",1.42e-31,"Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)","proton transmembrane transport [GO:1902600]","GO:0005886; GO:0015252; GO:0016021; GO:1902600"
"g33764",128.370787432097,-0.474989147619833,0.145668647239417,-3.26075072859813,0.00111117678316283,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39188",670.022104761544,0.208925180972664,0.0640291503751884,3.2629697528147,0.00110251286255383,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45411",380.037626156026,0.536530213739145,0.164447787460198,3.26261740595933,0.00110388437458193,0.0474065381958497,16400,20038,"sp|Q21217|GABT_CAEEL","Q21217","GABT",3.96e-20,"Probable 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (L-AIBAT)","gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0003867; GO:0005739; GO:0005759; GO:0009450; GO:0030170; GO:0034386; GO:0042135; GO:0047298"
"g52749",53.1291106686227,2.07490013266992,0.636197151925506,3.26141059636946,0.00110859385230128,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61854",28.4486105036425,-0.763269061416993,0.234089236164707,-3.26059016605083,0.00111180611685178,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64061",92.5204683101873,0.437997816775177,0.134167123654666,3.26456888128975,0.0010963080286197,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65359",52.8244471285893,0.519186682922843,0.159034755326949,3.26461144833079,0.00109614330488684,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81370",799.510484334378,0.342485487993077,0.10496236435163,3.26293610198919,0.00110264378048034,0.0474065381958497,4394,8904,"sp|P09623|DLDH_PIG","P09623","DLDH",1.98e-45,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]","GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077"
"g82652",905.946770711139,-0.518493536276842,0.15893640039554,-3.26227053706064,0.00110523610458672,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83262",226.305496019593,0.608104224491476,0.186482725591196,3.26091450327979,0.00111053519869141,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85549",1107.60254862949,0.481578091049011,0.147676231015648,3.26103996382452,0.00111004394091231,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87729",356.102339192226,0.415464049629893,0.127381882014688,3.26156312859302,0.00110799758352378,0.0474065381958497,0,7995,"sp|P54385|DHE3_DROME","P54385","DHE3",7.42e-29,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g94257",103.136665449461,-0.356573677617623,0.109247144904668,-3.26391758730883,0.00109883122876685,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95266",112.603649892135,0.335543812351833,0.102897245236626,3.26096011200498,0.00111035658829001,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99029",451.951737011472,-0.361755602456897,0.110895450008629,-3.26213205707492,0.00110577618124566,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110286",223.540390355468,-0.536817725802714,0.16464042889042,-3.26054620618126,0.00111197847742551,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110507",67.3802119358137,0.908505668871457,0.278500355364911,3.26213468446411,0.00110576593206761,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118985",19.7698833586859,1.27944861654082,0.39211767401168,3.26292003992329,0.00110270627472484,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153403",19.1064401616278,0.716787711440058,0.219768950689809,3.26155132101332,0.0011080437303337,0.0474065381958497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104176",1912.16969237888,-0.275084479144115,0.0843855258087235,-3.25985382573368,0.00111469646665198,0.047484248891233,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12506",14118.8109268392,1.99566607085384,0.612271638140645,3.25944555739068,0.00111630203101044,0.0475173668689758,58930,68894,"sp|P04069|CBPB_ASTAS","P04069","CBPB",4.45e-24,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g33112",87.332240262392,0.441730224385896,0.135562783244214,3.25849185015718,0.00112006093433972,0.0476309847294703,5666,12764,"sp|Q9HD20|AT131_HUMAN","Q9HD20","AT131",5.39e-38,"Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase)","cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]","GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569"
"g90102",57.1517970801362,-0.632828132106885,0.194217515764205,-3.25834737210411,0.00112063139394885,0.0476309847294703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26322",946.019705367494,-0.385236221507537,0.118250210118236,-3.25780580958246,0.00112277210009372,0.0476866492252982,13075,37190,"sp|Q0IHQ9|PXYP1_XENTR","Q0IHQ9","PXYP1",2.18e-37,"2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2)","chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]","GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650"
"g75576",127.237482148977,1.77828407195975,0.545930759600892,3.25734361122971,0.00112460208253132,0.0476937675503673,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112944",18.9831099213403,0.674735225127546,0.207137060502905,3.25743362143581,0.00112424548895354,0.0476937675503673,1945,3528,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g114749",27.6615396498497,-1.12854169640144,0.346492374293483,-3.25704627324799,0.00112578079028485,0.0477084946429429,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35122",73.135487790029,-0.424331543531065,0.130338400988787,-3.25561415754649,0.00113147400106426,0.0478790399565392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63151",95.1652870142654,0.328936452925618,0.101030984457407,3.25579776038205,0.0011307426246802,0.0478790399565392,7837,11134,"sp|O17953|DLDH_CAEEL","O17953","DLDH",9.61e-21,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]","GO:0004148; GO:0005739; GO:0005759; GO:0006633; GO:0045252; GO:0045454; GO:0050660"
"g18002",28.0162992482505,1.15198654852625,0.353874434284986,3.25535398128965,0.00113251115433829,0.047887612406729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155784",83.3706296984475,-0.462370808517816,0.142054054662644,-3.25489342501257,0.00113434924735022,0.0479300145898053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g228",23.5452232692253,0.611145454406999,0.18780289557565,3.25418547213411,0.00113718008560852,0.0480058533582498,156605,169469,"sp|Q8IMX7|MIRO_DROME","Q8IMX7","MIRO",1.6e-21,"Mitochondrial Rho GTPase (Miro) (dMiro) (EC 3.6.5.-)","axonal transport of mitochondrion [GO:0019896]; cellular homeostasis [GO:0019725]; establishment of mitochondrion localization, microtubule-mediated [GO:0034643]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle transport [GO:0048489]","GO:0000226; GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0019725; GO:0019896; GO:0031307; GO:0034643; GO:0047497; GO:0048489; GO:0051646; GO:0097345; GO:1904115"
"g21412",187.652286901381,-0.460737457002133,0.141617204142606,-3.25340031807279,0.00114032725910238,0.0480058533582498,12873,48184,"sp|Q13136|LIPA1_HUMAN","Q13136","LIPA1",1.72e-81,"Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)","cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077"
"g28357",3427.93112406764,-0.271805142725988,0.0835432722732631,-3.25346536387677,0.00114006622710347,0.0480058533582498,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146500",428.81436925209,0.502606288492958,0.154471240318996,3.25372080560133,0.00113904166122201,0.0480058533582498,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162064",71.3569312570301,0.918040330991351,0.2821366635743,3.25388526028836,0.00113838249092262,0.0480058533582498,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1754",11393.3926490457,0.405825375320216,0.124789468470319,3.25208032612736,0.00114563640224227,0.0480179815636682,69535,71911,"sp|Q9V3G1|RL8_DROME","Q9V3G1","RL8",1.4e-42,"60S ribosomal protein L8","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626"
"g14457",260.134122237856,-0.361329340062282,0.111096004260501,-3.25240626310039,0.00114432333015771,0.0480179815636682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32313",21.9775569216464,1.82474967957472,0.560926306878185,3.25310055385046,0.00114153094174198,0.0480179815636682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82899",82.0980658708661,0.329816668806521,0.101402503851205,3.25254955528992,0.00114374650252677,0.0480179815636682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85062",282.882253389199,-0.366794249062405,0.11276142636356,-3.25283442123022,0.00114260056307882,0.0480179815636682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96771",42.6473965949224,0.634357548960426,0.195060112631984,3.25211310708743,0.00114550427766291,0.0480179815636682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146264",55.1693361216049,-0.857647704134461,0.26375926238637,-3.25163065886243,0.00114745022121827,0.0480589005062075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8520",29.8982176286224,-0.57192867681254,0.17602695863602,-3.2490970771991,0.00115771961327418,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8759",156.769468740753,-0.549274699088976,0.169038472543005,-3.24940642698505,0.00115646118588039,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20119",115.317830637238,0.473138430884531,0.145569622443461,3.25025525891089,0.00115301464915196,0.0481092443038457,22295,46064,"sp|O43102|CBF5_ASPFU","O43102","CBF5",8.59e-29,"H/ACA ribonucleoprotein complex subunit cbf5 (EC 5.4.99.-) (Centromere-binding factor 5) (H/ACA snoRNP protein cbf5) (Small nucleolar RNP protein cbf5)","box H/ACA RNA 3'-end processing [GO:0000495]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]","GO:0000454; GO:0000495; GO:0003677; GO:0003723; GO:0005874; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:1990481"
"g31813",287.490057941712,-0.576169280388723,0.177350027138252,-3.24876905679623,0.0011590553746705,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34083",623.515027780212,0.562422599467447,0.173064335865749,3.24978914144238,0.00115490606233168,0.0481092443038457,7441,12924,"sp|Q9Z2K9|IDHC_MICME","Q9Z2K9","IDHC",1.25e-17,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287"
"g36186",110.097956932178,-0.559916380827064,0.172278454577599,-3.2500661919675,0.00115378150030611,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56697",70.4586846967067,0.438900762659654,0.135102623271494,3.24864722854171,0.00115955184510663,0.0481092443038457,0,14540,"sp|P21328|RTJK_DROME","P21328","RTJK",5.88e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g67064",72.6198574752645,0.548994744492467,0.168953806252509,3.24937778360535,0.00115657765331945,0.0481092443038457,8809,9664,"sp|Q3TA59|JMJD8_MOUSE","Q3TA59","JMJD8",1.9e-12,"JmjC domain-containing protein 8 (Jumonji domain-containing protein 8)","positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302]","GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672"
"g82359",251.054813131348,0.582973175321718,0.179392987894677,3.24969878791465,0.00115527303085359,0.0481092443038457,0,5534,"sp|P21328|RTJK_DROME","P21328","RTJK",3.06e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g97061",1002.00722849024,-0.265651891581992,0.0817659386404028,-3.24893098519053,0.00115839579357194,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122260",45.7063974208748,-0.654799405441396,0.201528884632224,-3.24915908027953,0.00115746728488772,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124191",219.488113572936,2.44821409596051,0.753122675399152,3.2507507421191,0.00115100721506752,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140037",41.4968587703466,-0.48141128312073,0.148127909734214,-3.24997013719108,0.00115417127681136,0.0481092443038457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27597",37.9742309212369,0.533611492318122,0.164316565290457,3.24746011684747,0.00116439982143437,0.0481363557304784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60598",253.858500832105,0.57072814638751,0.175739336524196,3.24758336793273,0.00116389561346686,0.0481363557304784,6565,11007,"sp|Q54TH8|TCPG_DICDI","Q54TH8","TCPG",2.59e-12,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0005856; GO:0006457; GO:0016887; GO:0045335; GO:0051082"
"g87660",988.068872650656,0.486098049669277,0.14965039924936,3.24822420860568,0.00116127724822978,0.0481363557304784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91648",26.0425602430417,-0.51111661283188,0.15738235280427,-3.24761069919659,0.00116378383131284,0.0481363557304784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162699",42.8792268406143,-0.429652368287654,0.132296131105487,-3.24765633505238,0.00116359720730954,0.0481363557304784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7832",64.1633539002423,-1.22274737663103,0.376554029016368,-3.24720301048187,0.00116545226788253,0.0481451772002155,55205,64583,"sp|Q6DE58|ATGA1_XENLA","Q6DE58","ATGA1",3.27e-13,"Autophagy-related protein 101","autophagy [GO:0006914]","GO:0000407; GO:0006914"
"g61544",260.246488094107,0.353506145406637,0.108888308238084,3.24650232083409,0.00116832495476407,0.0482291265499009,0,4895,"sp|Q0V9J0|TMM69_XENTR","Q0V9J0","TMM69",1.72e-28,"Transmembrane protein 69",NA,"GO:0016021"
"g15455",475.282027024615,-0.577968008922956,0.178058992233068,-3.24593552774033,0.00117065347842758,0.0482558165173666,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152027",397.836655282715,0.589591057113006,0.181638124054909,3.24596535105577,0.00117053085019439,0.0482558165173666,0,1655,"sp|A1ZA47|ZASP_DROME","A1ZA47","ZASP",4.7e-17,"PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]","GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061"
"g4066",32.1900826024705,-0.697962214370216,0.215066249005417,-3.24533587951607,0.00117312164703279,0.0483228428619824,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154398",135.812316229428,2.14214630995478,0.660114848353198,3.24511153672553,0.00117404628353111,0.0483262379835115,0,1604,"sp|Q3ZCJ8|CATC_BOVIN","Q3ZCJ8","CATC",7.31e-20,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","zymogen activation [GO:0031638]","GO:0005764; GO:0008234; GO:0008239; GO:0031638"
"g115365",617.899576061874,0.440859794445666,0.135902389590003,3.24394439108593,0.00117886758910146,0.0484899084320014,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57213",123.52652048012,-1.25548453064635,0.387225899035842,-3.24225351086381,0.00118588482147903,0.048743603908644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1298",1485.10855180806,-0.328246652911416,0.101249574822311,-3.24195586487623,0.00118712405380766,0.0487596121742903,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45814",140.734094218845,0.987909179997485,0.304865121245518,3.2404795142239,0.00119328846116233,0.0489427390289452,0,19480,"sp|Q13231|CHIT1_HUMAN","Q13231","CHIT1",1.82e-18,"Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)","chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]","GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0044245; GO:1904724"
"g117607",29.9593498096404,0.603786094210302,0.186320931734899,3.2405703888889,0.00119290816732948,0.0489427390289452,0,4711,"sp|Q9XYU1|MCM3_DROME","Q9XYU1","MCM3",6.08e-13,"DNA replication licensing factor Mcm3 (EC 3.6.4.12) (Minichromosome maintenance 3 protein) (DmMCM3)","DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g156269",177.536885121187,0.650830256131465,0.200856505034463,3.24027472259261,0.00119414588729926,0.0489429221523083,0,1307,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",8.57e-22,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g159612",297.12895417261,0.462980105278392,0.14289615785628,3.2399758833547,0.00119539809537829,0.0489592738849437,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22676",18.2640810002388,0.682612712640685,0.210729528695496,3.2392836299039,0.00119830346466666,0.0490095885594997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68629",26.142807001443,1.32999519370276,0.410584070725791,3.23927616420122,0.00119833483354789,0.0490095885594997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123576",873.080050720144,0.559499552690583,0.172767251028758,3.23845838467067,0.00120177552026598,0.0491152986843745,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20384",469.180566425173,-0.440977958476905,0.136216824119169,-3.23732373976886,0.00120656448812452,0.0492710277765388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95312",70.2199352200967,0.458079061070349,0.14150694112207,3.23714905741047,0.0012073033296238,0.0492710277765388,0,5094,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.21e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g18840",32.8658550157594,0.802669163569819,0.248040049397782,3.23604662036887,0.00121197587906876,0.0493205080954288,0,42430,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",4.95e-152,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g28906",81.2880544711103,0.406148415504268,0.125515239871491,3.23584941494039,0.00121281347024486,0.0493205080954288,18810,23564,"sp|P48506|GSH1_HUMAN","P48506","GSH1",2.15e-25,"Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)","aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]","GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237"
"g30813",497.70562342868,-0.318896565061317,0.0985496847124519,-3.23589635006741,0.00121261407407612,0.0493205080954288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53864",85.2085484089684,0.644729454482398,0.199207647315413,3.23646939849439,0.00121018201268458,0.0493205080954288,0,10780,"sp|Q66I12|CCD47_DANRE","Q66I12","CCD47",2.15e-16,"PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47)","endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein insertion into ER membrane [GO:0045048]","GO:0005509; GO:0005783; GO:0030176; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048"
"g66779",115.643547946838,-0.624401912102445,0.192932182306124,-3.23638028989747,0.0012105599003082,0.0493205080954288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98066",226.301308210899,-0.679452004525455,0.210013005675353,-3.23528536882987,0.00121521209751649,0.0493481034363029,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108199",26.6281165717554,3.09345549495265,0.956102230448419,3.23548611899148,0.00121435789812664,0.0493481034363029,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21283",29.0997691614969,1.2769799750162,0.394775503099606,3.23469912643999,0.00121770975853274,0.0493493686050843,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54053",26.6853013035349,0.540637123705795,0.167147169115152,3.23449763802661,0.00121856928573483,0.0493493686050843,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103288",36.9673912545044,-0.408488522955776,0.126274636786714,-3.2349213852481,0.00121676227670717,0.0493493686050843,0,5904,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.09e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g108212",24.8506944412017,0.785271896883713,0.242782180942968,3.23447089005343,0.00121868343174284,0.0493493686050843,0,5625,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",7.02e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g24919",137.656741682834,-0.647499634001764,0.200212296585091,-3.23406526495027,0.00122041563309137,0.0493846608087327,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25860",82.1718565558545,0.370303203381085,0.114535726285871,3.23308032689155,0.0012246312303128,0.0494158509109343,25555,31132,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.51e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g67827",775.196328773768,0.685176747928279,0.211894413160682,3.23357627843025,0.00122250684816616,0.0494158509109343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93930",65.7331042762786,2.22254606895963,0.687401437200162,3.23325781513089,0.00122387057739462,0.0494158509109343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144083",188.132659093895,0.596186419873341,0.184387627808441,3.23333201342941,0.00122355271863049,0.0494158509109343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113172",51.6846314856231,-1.20280296445465,0.372084259070147,-3.23260910703532,0.00122665283384426,0.0494626420280983,0,464,"sp|P41383|TBA2_PATVU","P41383","TBA2",4.13e-35,"Tubulin alpha-2/alpha-4 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g60561",44.8211274848561,1.286415846843,0.398041992475745,3.23185963079357,0.0012298745493354,0.0495106378799352,0,13267,"sp|Q9Y3Q0|NALD2_HUMAN","Q9Y3Q0","NALD2",8.33e-16,"N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016021; GO:0016805; GO:0046872"
"g102736",269.458750764016,0.541308643651418,0.16749809195095,3.23173020866372,0.00123043167683492,0.0495106378799352,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128880",143.001836174962,-1.18154697289848,0.36560686474627,-3.23174176097177,0.00123038193778007,0.0495106378799352,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3092",77.569142580386,-0.535460286775145,0.165806141479926,-3.22943578564592,0.00124034732516895,0.0495620679096059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5727",1094.3904970666,0.202430834499325,0.0626681449674611,3.23020307373758,0.00123702320694284,0.0495620679096059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9290",1154.42399440002,0.298422761224547,0.0923699283473305,3.23073500828553,0.00123472354047662,0.0495620679096059,50798,60474,"sp|Q562A2|ZFR_RAT","Q562A2","ZFR",6.02e-12,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g18793",3825.08435317466,0.267321307927937,0.0827354722205029,3.23103622610002,0.00123342306313026,0.0495620679096059,0,9879,"sp|Q99PV0|PRP8_MOUSE","Q99PV0","PRP8",0,"Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)","cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0005634; GO:0005682; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157; GO:0140492"
"g37150",202.239762541522,-0.445849446011253,0.138049549996903,-3.22963346147276,0.00123949014729603,0.0495620679096059,0,12714,"sp|P21328|RTJK_DROME","P21328","RTJK",9.69e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g65153",74.7257261648775,1.01775690714305,0.315105070788991,3.22989695022898,0.00123834843662261,0.0495620679096059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85771",26.0012001423881,0.906485526135465,0.280605715071072,3.23045995661873,0.00123591215408096,0.0495620679096059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93045",125.424999453988,-0.768053167737525,0.237798375884308,-3.2298503506651,0.00123855028427375,0.0495620679096059,3986,7124,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.79e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g138482",111.318607273656,2.09205163156479,0.647748045404592,3.22973052007909,0.00123906947420157,0.0495620679096059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154442",17.7954262906358,2.5550771039786,0.790921871915197,3.2305050532887,0.00123571720006271,0.0495620679096059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20773",1079.22967619343,-0.664803128208155,0.205919459452939,-3.22846189463745,0.00124457838752771,0.0496619665343114,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38846",1086.21959692549,-0.405188282819965,0.125500684133969,-3.22857429516029,0.00124408938484487,0.0496619665343114,0,20154,"sp|A8WGS4|TLCD2_DANRE","A8WGS4","TLCD2",7.81e-17,"TLC domain-containing protein 2","lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035]","GO:0005886; GO:0007009; GO:0016021; GO:0055088; GO:0055091; GO:0071709; GO:0097035"
"g22510",948.866651541798,-0.376971595746113,0.116781799814748,-3.22799953712058,0.00124659175844708,0.0497029205213872,4094,23524,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.01e-45,"PiggyBac transposable element-derived protein 4",NA,NA
"g28887",993.53965706979,-0.272503981434318,0.0844337002467762,-3.22743147153168,0.00124906956068038,0.0497029205213872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46972",265.531781003379,0.276108178900803,0.0855462178508806,3.22759072039982,0.00124837448676986,0.0497029205213872,5585,12597,"sp|Q8CC12|CDAN1_MOUSE","Q8CC12","CDAN1",8.24e-63,"Codanin-1","chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; nuclear envelope organization [GO:0006998]; protein localization [GO:0008104]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006998; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497"
"g83201",1110.21273191209,0.213442911689221,0.0661296405005581,3.22764361145165,0.00124814371209185,0.0497029205213872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g351",652.077954014716,-0.326759732096757,0.10125382328314,-3.22713475404308,0.00125036559749791,0.0497200124632224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4357",1620.63558275881,-0.311582682617117,0.0965657595446882,-3.22663731001799,0.00125254117696441,0.0497720309793753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25175",22.8826021419486,-0.519178634033437,0.16092390666313,-3.22623682707542,0.0012542952346946,0.0497727943062078,0,37844,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.17e-30,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g27028",24.0850225582682,1.48438497132842,0.460093212888131,3.22627008994661,0.00125414946177974,0.0497727943062078,18585,21884,"sp|P40939|ECHA_HUMAN","P40939","ECHA",3.04e-148,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]","cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403"
"g65302",351.648639669642,1.4790880431651,0.458519155645246,3.22579335008081,0.00125624024636379,0.0497811224698581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139361",29.1808831707007,-0.524400279285537,0.162559189082989,-3.22590363696894,0.00125575628759041,0.0497811224698581,0,2650,"sp|Q5RBN1|FND3A_PONAB","Q5RBN1","FND3A",1.28e-13,"Fibronectin type-III domain-containing protein 3A",NA,"GO:0000139; GO:0016021"
"g15980",8395.87634252281,0.430525967790436,0.133475191301914,3.22551302299022,0.00125747114750993,0.0497955103134024,0,18120,"sp|P56649|G3P_PANVR","P56649","G3P",3.66e-177,"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287"
"g45673",98.4151395517422,0.598032861190621,0.185441482940232,3.22491414385079,0.00126010452507022,0.0498653776886407,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49051",728.388101295948,-0.284022737724445,0.0880842698235367,-3.22444334605305,0.00126217827997514,0.0498854356419614,2565,10450,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.28e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g79363",2130.32164887751,-0.780300088775882,0.242013008448301,-3.22420721835938,0.00126321955363837,0.0498854356419614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84000",47.427911828235,-0.534179974359436,0.16567418158153,-3.22428014588719,0.00126289787390111,0.0498854356419614,0,6146,"sp|Q6ZQT0|YD023_HUMAN","Q6ZQT0","YD023",1.29e-13,"Putative uncharacterized protein FLJ45035",NA,NA
"g27767",725.86982493952,-0.361308906305695,0.112085581356834,-3.22350923224851,0.00126630216509634,0.0499420669982124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56895",105.970828924059,0.336520455060039,0.104409103711047,3.22309495148395,0.00126813509265241,0.0499420669982124,3935,13169,"sp|Q9VHI4|SF3B5_DROME","Q9VHI4","SF3B5",4.54e-28,"Splicing factor 3B subunit 5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit)","mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000124; GO:0000398; GO:0005686; GO:0007283; GO:0010468; GO:0071011"
"g87510",154.896148111853,0.367621366122169,0.114049605753757,3.2233462245884,0.0012670230777406,0.0499420669982124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124341",23.1572926490796,-1.29061884994087,0.400426751136388,-3.22310846185519,0.00126807527928023,0.0499420669982124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70533",27.6525712550615,0.513522392588108,0.159348856069579,3.22262992816139,0.00127019544114423,0.0499720566247749,3452,10794,"sp|Q07598|SCP2_CHICK","Q07598","SCP2",6.18e-13,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X) (Fragment)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032385; GO:0033814; GO:0050632; GO:0050633; GO:0120019; GO:0120020"
"g91343",70.3856721530641,0.931195927998152,0.288964234551436,3.22253004578114,0.00127063838646822,0.0499720566247749,NA,NA,NA,NA,NA,NA,NA,NA,NA
